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Abstract 
 
A new all-atom force field for the simulation of phospholipid bilayers using the AMBER molecular 
dynamics package has been developed, which is compatible with other AMBER protein, nucleic acid, 
carbohydrate and small molecule force fields. The force field has been validated by simulating 
bilayers of six different lipid types, finding favourable comparison to experiment for properties such 
as area per lipid, volume per lipid, bilayer thickness, NMR order parameters, scattering data, and 
lipid lateral diffusion. The modular nature of this force field allows numerous combinations of head 
and tail groups to create different lipid types, enabling the easy insertion of new lipid species. 
 
The lipid bilayer model has then been applied to the study of the interaction between radioimaging 
agents and membranes in an effort to understand the phenomena of non-specific binding, which 
remains poorly understood yet of serious detrimental consequence to the development of new 
imaging tracers. The effect of different concentrations of imaging agent on a homogeneous 
membrane has been examined using unbiased simulations, whilst the permeability coefficient of 
each imaging agent through a membrane has been calculated using biased simulations. 
 
It is found that radiotracers with low non-specific binding must adopt a certain orientation to cross 
the head group region of a membrane – this requirement may act as a barrier to membrane entry. 
Furthermore, once partitioned into the membrane, simulations predict that those radiotracers 
displaying a high degree of non-specific binding act to order lipid tail groups to a greater extent than 
those with low non-specific binding, reducing the permeability of the membrane and possibly acting 
to ‘trap’ radiotracer in the membrane. These simulations also predict that non-specific binding is not 
related to radiotracer membrane permeability through a homogeneous bilayer. 
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1 Introduction 
 
1.1 Positron Emission Tomography 
 
Medicine has been advanced over the last century in part by the advent of medical imaging 
techniques, which aid in the diagnosis, treatment and study of disease in the human body.1 A scan 
with the correct imaging modality at the right time can facilitate early diagnoses, be less invasive and 
result in more effective treatments, as well as provide significant cost savings. Imaging techniques 
have also impacted on drug discovery,2 given that they allow the non-invasive isolation and 
visualisation of biological functions within the body. Consequently they may increase understanding 
of disease and drug activity during the preclinical and clinical drug development stages. 
 
One such medical imaging method is positron emission tomography (PET) scanning, which is a non-
invasive nuclear imaging technique exploiting the decay characteristics of position emitting 
radioisotopes.3 PET may be used to study in vivo metabolic function,4 biological processes,5 and 
receptor binding in the brain,6 making it distinct from other imaging modalities such as computed 
tomography scanning which only provides anatomical images. 
 
1.1.1 Workings of PET 
 
When performing a PET scan, a radiotracer must first be administered to the patient. This radiotracer 
may be either a pharmaceutical compound or naturally occurring molecule that has been labelled 
with a radionuclide such as 11C or 18F.7 The radiotracer then binds to the target receptor, or is taken 
up by the organ of interest. As the radionuclide decays, positrons are emitted from the nucleus, 
which then undergo an annihilation event with electrons from the surrounding tissue (within a 
maximum distance of ≈4 mm from the site of positron emission), causing the emission of energy in 
the form of two gamma photons at 180° to one another along the line-of-response (LOR) – see 
Figure 1.1. 
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Figure 1.1 - A PET radiotracer emits a positron, which collides with an electron in the surrounding 
tissue. The annihilation event causes the emission of two high energy gamma photons at 180° to one 
another, along the line-of-response. 
Such events are recorded in a PET scanner, which uses a ring of detectors to record incident gamma 
photons emitted by the patient. If two gamma photons are received within a 10 ns timing window 
(the coincidence timing window) then an annihilation event is deemed to have occurred along the 
line-of-response. Many such events are recorded by a PET scanner and from this data an image is 
constructed. The full process is detailed in Figure 1.2. 
 
Figure 1.2 – The PET imaging process. A radiotracer administered to the patient allows the 
localisation of disease within the body using a PET scanner. This figure was originally published in 
JNM. Phelps, M. E., PET: The Merging of Biology and Imaging into Molecular Imaging. Journal of Nucl 
Med. 2000, 41 (4): 661-681 © by the Society of Nuclear Medicine and Molecular Imaging, Inc.8 
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1.1.2 Applications of PET 
 
PET scanning has many clinical applications, including the imaging of brain and heart function,9-10 the 
imaging of cancerous tumours11 and early detection of “silent” diseases such as Alzheimer’s and 
Huntingdon’s disease.5 Radiotracers have high specific activities, defined as the activity of the tracer 
divided by its mass,12 allowing doses as low as 10 nmol per human subject, meaning that the tracers 
are at concentrations substantially lower than the naturally occurring ligands. As a result, biological 
processes may be detected and observed with minimal interference; even potent or toxic 
compounds may be introduced into the body without the threat of pharmacological or toxicological 
effects. The short half-lives of radionuclides used for PET scanning also make it possible to undertake 
more than one scan on the same patient in a single day, providing direct comparisons of ligand 
efficiency and eliminating inter-patient variations; this does however come with the requirement 
that often difficult radioligand synthesis must be performed in-house or nearby.  
 
Neuroimaging applications of PET involve the administration of a radiotracer that is designed to pass 
through the blood-brain barrier and bind specifically to a receptor in the brain, allowing the imaging 
of this receptor and providing quantitative data on changes in receptor binding upon receptor 
stimulation.13 
 
PET scanning is also increasingly being applied in the drug development arena, as the sub-
pharmacological doses involved and easy incorporation of radionuclides such as 11C, 13N, 15O and 18F 
into candidate compounds make it ideal for imaging drug action in human at the early stage of drug 
discovery.14 PET scanning may thus identify drugs that fail to perform their desired action in the early 
stages of the development process and the project may be abandoned, avoiding the huge expense of 
clinical trials. 
 
Popular PET techniques to aid drug development include biodistribution and drug occupancy 
studies.14 A biodistribution study involves administering a candidate pharmaceutical that has been 
radiolabelled, allowing quantitative tissue delivery and drug turnover data to be collected using a PET 
scan. Receptor occupancy studies measure the displacement of a radiotracer from a receptor by a 
candidate pharmaceutical, which is being developed to bind to the same target. Briefly, the 
radiotracer is administered and an initial scan is taken. The ‘cold’ pharmaceutical compound is then 
given to the patient and a second PET scan performed. This technique provides quantitative 
information on the amount of receptor occupancy per concentration of ‘cold’ pharmaceutical 
administered, generating a direct measurement of its binding efficiency in vivo. 
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As previously touched upon, PET scanning does however come with a number of practical 
limitations. The short half-lives of the radionuclides used to label tracers (such as 11C, which has a 
half-life of 20 mins) mean that radiotracers must be synthesised within the vicinity of the PET 
scanner, with a cyclotron nearby to produce the radionuclides. Furthermore, images obtained by PET 
scanning are inherently limited in spatial resolution to 1-2 mm due to the distance travelled by the 
positron prior to annihilation.7 
 
1.1.3 Non-specific binding of PET tracers 
 
Another limitation of PET scanning may arise from the action of radiotracers within the body. In 
order to obtain a useful image, a radiotracer must bind specifically to its target. If however the 
radiotracer undergoes high non-specific binding (NSB), which is the binding of the tracer to off-target 
sites such as other receptors or cell membranes, the resulting scan will have a high background 
signal, obscuring the target signal and creating an image with poor contrast (see Figure 1.3). The 
commonly accepted definition of NSB is that it is the binding of a radiolabelled compound to all non-
saturable components other than the target site under investigation, thereby obscuring the 
visualisation of the region of interest.15-16 In reality these tissues are saturable in nature but have a 
capacity far in excess of the radiotracer concentration.  
 
Figure 1.3 - Specific and non-specific binding of the [18F]MK-9470 PET tracer in the brain, which 
allows the in vivo imaging of the cannabinoid-1 receptor. The cerebellum (Cb) and reticular nucleus 
(Rt) regions of the brain are labelled. Copyright Proceeding of the National Academy of Sciences of 
the USA (2007).17 
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The degree of NSB of a radiotracer may be determined in two ways. The first involves incubating a 
low concentration of radioligand with an affinity for the target with a tissue sample until equilibrium 
is reached, thereby providing a measure of total radioligand bound, both specifically and non-
specifically. Next, a high concentration of either an unlabelled derivative or unlabelled ligand with 
high affinity for the target receptor is added, which, due to its high concentration, displaces all the 
specifically bound radioligand, leaving an image of NSB only (see Figure 1.4). 
 
 
Figure 1.4 - Measuring non-specific binding. Total binding of a PET tracer is first quantified a) before 
addition of a ‘cold’ compound then b) after addition of ‘cold’ compound which displaces specifically 
bound tracer, leaving an image of non-specifically bound PET tracer only. 
The second method involves fitting the curves of the radioactivity concentration as a function of time 
to a mathematical model, such as the two tissue compartment model.18 Compartments are defined 
as a theoretical region of biochemical space in which the concentration of radiotracer is 
homogeneous at all times.19 For example, the two tissue compartment model contains 
compartments for free radiotracer in plasma, free and non-specifically bound tracer in tissue and 
specifically bound tracer in tissue. Movement between compartments is assumed to be by diffusion 
only and determined by fractional rate constants. By fitting time-activity curves these rate constants 
may be obtained and a measure of the distribution volume of in vivo NSB calculated. 
 
NSB is clearly an undesirable characteristic for a radiotracer. Those seeking to develop new tracers 
for imaging a new target will wish to avoid this phenomenon. Indeed a number of criteria exist for 
the development of a new PET tracer:  
 High affinity and high selectivity for the target, 
 Amenable to radiolabelling in a position that avoids the possible production of radioactive 
metabolites, 
 Tracers for central nervous system (CNS) applications must be able to penetrate the blood-
brain barrier, 
 Low NSB. 
a) b) 
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Radioligands, particularly those developed for CNS applications, are often small drug-like molecules 
which cross the blood-brain barrier by passive diffusion. The development process follows a similar 
path to conventional drug discovery, using large screening libraries of molecules to identify lead 
compounds with affinity for the target receptor. PET radioligands are administered intravenously, 
however to pursue suitable biodistribution lead compounds are often optimised such that they 
adhere to Lipinski’s rule-of-five,20 which states that orally active molecules with the best chance of 
success should have: 
 Less than 5 hydrogen bond donors, 
 Molecular weight below 500 Da, 
 Lipophilicity, log P, less than 5, 
 Fewer than 10 hydrogen bond acceptors. 
 
Lipophilicity is defined in terms of the partition coefficient, which is the ratio of concentrations of a 
compound in the two immiscible phases of a 1-octanol/water biphasic system.12 The lipophilicity of 
PET tracers is often restricted to a log P value of between 1-3, as this has traditionally been assumed 
enough to limit the NSB of a tracer, given that NSB is thought to arise in part from radiotracers 
adhering to cell membranes and highly lipophilic molecules will find the hydrophobic environment of 
a membrane interior highly favourable. This is, however, an oversimplification of a complex 
phenomenon, with numerous low lipophilic tracers exhibiting high NSB and vice versa (see Figure 
1.5). 
 
 
Figure 1.5 - Non-specific binding (V2-1) versus lipophilicity (log P) for ten common PET radiotracers. 
Copyright Journal of Computational Chemistry (2008).18 
Consequently NSB remains poorly understood and as such there is a drive to determine the 
molecular basis of NSB to allow this phenomenon to be avoided when designing new PET tracers. 
Given that NSB is thought to arise predominantly from tracers adhering to cell membranes, a study 
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of NSB logically starts with an investigation of drug-membrane interactions. 
 
1.2 Lipid membranes 
 
Biological membranes are integral components of the cell, partitioning the interior of the cell from 
the outside environment and also partitioning organelles from the cytosol in the cell interior. They 
are selectively permeable, acting as a barrier to maintain an unequal ion concentration on either side 
of the cell wall whilst controlling the transport of matter to and from the cell via transport 
processes.21 
 
Plasma membranes exist as a lipid bilayer structure – a back-to-back arrangement of amphiphilic 
lipid molecules. Lipid molecules have a hydrophilic (‘water-loving’) head group attached to a 
hydrophobic (‘water-fearing’) tail group. There are three main classes of membrane lipid: glycolipids, 
cholesterol and phospholipids. Of these, phospholipids are the major class and consist of two fatty 
acids and a phosphate group attached to a backbone. A commonly occurring phospholipid, 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC), which has a carbon-carbon double bond in each acyl 
tail group, is shown in Figure 1.6. 
 
 
Figure 1.6 - The phospholipid DOPC and its constituent parts. 
When placed in an aqueous environment, lipids will spontaneously aggregate, bringing non-polar tail 
groups together due to the hydrophobic effect whilst leaving polar head groups exposed to water. 
The resulting lipid aggregate may take a range of structures depending on the shape of the lipid, 
including the micelle, inverse micelle, hexagonal, inverse hexagonal and the most biologically 
relevant bilayer (i.e. membrane) phase. A balance of non-covalent forces acts to maintain the bilayer 
structure, creating a non-uniform lateral pressure profile along the bilayer normal. 
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Figure 1.7 - The internal forces within a lipid bilayer. 
Although difficult to access experimentally, the internal lateral pressure profile of a membrane may 
be calculated from computational simulations of membrane structures and due to the balance of 
different forces and often takes a shape shown in Figure 1.7. The membrane lateral pressure displays 
a local maxima at the head group-water interface due to the repulsive electrostatic, steric and 
hydration forces. There is then a large trough just below the head group region, arising from 
attractive hydrophobic effects, whereby the carbon chains act to avoid exposure to water. The lateral 
pressure then rises, the origin of which is thought to be related to entropy loss – the tighter packing 
of the membrane chains results in stretching of the lipid tails and a consequent loss in entropy in 
comparison to “free” tails.22-23 Finally the lateral pressure drops again to a trough at the membrane 
centre due to the greater available free space in this region. 
 
Accordingly, cell membranes are a dynamic, fluid mosaic24 approximately 50 Å thick containing many 
hundreds of different lipid components,25 with the exact lipid composition varying between cell type 
and host species. The individual lipid molecules are able to rotate about their vertical axes (~107s-1) 
and diffuse freely within the plane of the bilayer (~10-8 cm2/s).26 Lipids may also exchange between 
the leaflets of a bilayer (“flip-flop”), however this event generally occurs on a much longer timescale 
due to the associated high energetic penalty. Without the assistance of a facilitator enzyme, this 
transbilayer movement occurs on the order of once a month for a given lipid molecule.21 Membranes 
may also contain glycolipids and sterols such as cholesterol (see Figure 1.8). Cholesterol has a 
condensing effect on a bilayer, ordering lipid chains and reducing the fluidity and permeability of the 
membrane.27-28 
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Figure 1.8 - The structure of cholesterol, a common cell membrane component. 
 
1.2.1 Physical properties of lipid membranes 
 
Experimental studies of the cell membrane structure typically involve the use of a pure lipid bilayer in 
the physiologically relevant liquid crystal phase as a model system, given that lipids are the 
predominant species structuring a cell membrane. Techniques for the determination of bilayer 
structure include nuclear magnetic resonance (NMR), Infrared/Raman spectroscopy, fluorescence 
spectroscopy, and X-ray and neutron diffraction. 
 
NMR studies of lipid bilayers may report the structure and ordering of lipid molecules using 
deuterium magnetic resonance spectroscopy.29 Acyl chains are labelled with deuterium allowing 
calculation of the carbon-deuterium order parameter SCD from the quadrupolar splitting. The order 
parameter SCD describes the tail orientation as a function of depth and is defined as: 
    
 
 
            1.1 
where θ is the angle between the vector joining carbon Ci to its deuterium atom and the bilayer 
normal (see Figure 1.9). SCD=0 indicates a random orientation, SCD=1 indicates alignment of Ci-D 
vector with the bilayer normal and SCD=-0.5 indicates alignment of the Ci-D vector with the bilayer 
plane. A value of SCD=-0.5 hence indicates a perfectly ordered acyl chain in the all-trans 
conformation;30 experimental values are usually either expressed as –SCD or as absolute values |SCD|. 
A sample order parameter plot is shown in Figure 1.9, showing typical behaviour for a saturated 
carbon tail group of higher ordering of the lipid chains (|SCD| closer to 0.5) near the head group 
region with values decreasing towards zero (random orientation) down the acyl tail group. 
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Figure 1.9 – a) Illustrative NMR order parameter profile of DPPC and b) carbon atom numbering (the 
sn-1 chain is on the left of the DPPC figure, the sn-2 chain is on the right). c) Calculation of the 
carbon-deuterium order parameter. 
Whilst NMR typically deals with the ordering of lipid acyl chains, techniques such as X-ray and 
neutron scattering allow structural determination of the full bilayer.31 Metrics such as the average 
surface area per lipid, average volume per lipid, and bilayer thickness may be extracted from 
scattering data. An X-ray or neutron beam is fired at the sample and the resulting diffraction pattern 
collected. From the two-dimensional diffraction pattern the repeating unit may be determined and 
the atomic form factor, which is a measure of the scattering amplitude, quantified. A typical lipid 
bilayer X-ray scattering form factor is shown in Figure 1.10. 
 
a) b) 
c) 
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Figure 1.10 - X-ray scattering form factor for a DMPC bilayer measured using orientated multilamellar 
arrays and unilamellar vesicle samples. Copyright Biophysical Journal (2005).32 
X-ray scattering form factors may be converted from reciprocal space into a model of the electron 
density by way of a Fourier transform, yielding an electron density profile such as that shown in 
Figure 1.11. Also shown are contributions from different lipid components (see Figure 1.9): the lipid 
acyl tail group, glycerol linkage and head group (containing the phosphate and choline moieties). 
 
Figure 1.11 - Electron density profile of a membrane. Contributions from the tail group, glycerol and 
head group regions are also shown. 
The electron density profile then allows calculation of the bilayer thickness, DHH, which is simply 
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taken as the distance between the two peaks of the profile. By combining this information with 
volumetric data the lateral area per lipid molecule may then be determined. Area per lipid is an 
important metric, with a large variation in the area per lipid indicating a phase change of the bilayer. 
 
 
Figure 1.12 - The area per lipid AL of a lipid molecule is the surface area of the bilayer that each lipid 
occupies. 
An intrinsic limitation of X-ray scattering is that it is poor at detecting light atoms, such as hydrogen, 
due to the fact that X-rays are scattered by electron density which decreases with atomic number. 
However neutron scattering interacts with matter by scattering off nuclear density so the signal does 
not decrease with atomic number; neutron scattering may thus provide complementary information 
to X-ray scattering.33 
 
The area per lipid of a bilayer may also be extracted from neutron scattering results by using the 
Luzzati thickness of the bilayer, DB, defined as the distance between the points along the membrane 
normal at which the water density is half of its bulk value.34 Neutron scattering is generally not used 
as frequently for bilayer structure determination compared with X-ray scattering, as it presents the 
limitations that neutron beams are much weaker than X-ray beams so acquisition times are much 
longer, and that there are fewer sources of neutrons.35 
 
Whilst these techniques allow the detailed study of membrane structure, a range of alternative 
experimental techniques exist to allow the study of the dynamic properties of lipid membranes. Lipid 
lateral diffusion in the bilayer plane has been measured by various methods, including fluorescence 
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recovery after photobleaching,36 fluorescence correlation spectroscopy,37 Förster resonance energy 
transfer,38 single-particle tracking39 and pulsed field gradient NMR spectroscopy.40 Consequently lipid 
bilayer structure and dynamics have been extensively studied experimentally at the macroscopic 
level, however their complexity, lack of long-range order, and the fact that many structural 
parameters are derived via modelling of the experimental data make the thorough experimental 
characterisation of lipid bilayers challenging. Other membrane properties that remain challenging to 
study experimentally include internal properties of the membrane, such as the dipole potential. 
 
1.2.2 Membrane electrostatic properties 
 
In addition to membrane structure, the electrostatic properties of a bilayer are also important and 
have been shown to influence membrane protein regulation,41 peptide-membrane interaction41 and 
drug-membrane interaction.42 
 
The total electrical potential across a lipid bilayer is a summation of three separate potentials (see 
Figure 1.13). These are: 
i. The transmembrane potential (ΔΨ), due to differences in the ion concentration on either 
side of the membrane, 
ii. The surface potential (ΨS), spanning from the membrane surface to bulk water, which is 
caused by the charged lipid head groups and attracted ions which accumulate at the 
membrane surface, 
iii. The membrane dipole potential (Ψd), originating from alignment of dipoles. 
 
The latter contributor to the overall electrical potential, the dipole potential, is one to two orders of 
magnitude higher than either of the other two components, with experimental measurements by 
methods including transport in planar lipid bilayers, electrostatic characterisation of monolayers and 
electron microscopy estimating that Ψd takes a membrane dependent range of 100-500mV.
43-44 This 
region of internal positive charge explains the experimentally observed faster permeation of 
negatively charged hydrophobic ions than positively charged ions across membranes.45 
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Figure 1.13 - The three separate potentials that form the total electrical potential across a bilayer – 
the transmembrane potential (ΔΨ), the surface potential (ΨS), and the dipole potential (Ψd). 
Although experimental techniques provide a means for the in depth study of pure lipid bilayers,  lipid 
molecules constitute approximately half of the mass of an in vivo plasma membrane, with the 
remainder being membrane proteins. 
 
1.2.3 Membrane proteins  
 
Lipid membranes act as a matrix to accommodate membrane proteins, which provide each cell 
membrane with its individual functional properties. Membrane proteins are one of the three main 
protein classes, constituting 20-30% of all protein sequences46 and accounting for 70% of drug 
targets,47 yet to date comprise only ≈2% of protein structures within the Protein Data Bank (PDB).48 
The lack of structural data on membrane proteins makes the elucidation of membrane protein 
function difficult and drug design targeting membrane proteins harder still. The under-
representation of these protein structures in the PDB may be attributed to the difficulty in applying 
biophysical structural determination techniques such as X-ray crystallography and NMR spectroscopy 
to biological molecules whose native environment is the membrane. Membrane proteins are 
involved in numerous cellular functions including cell signalling,49 cell recognition and adhesion,50 
activation of enzymatic activity51 and transport of molecules and ions across the membrane.52 
 
An important class of membrane proteins are transmembrane proteins, which are embedded in the 
bilayer spanning the entire hydrophobic core of the membrane, and may be classified into two main 
types by their secondary structures, as either alpha-helical or beta-barrels. As with lipid molecules, 
transmembrane proteins have hydrophobic and hydrophilic regions. The hydrophobic region is 
positioned in the bilayer core whilst the hydrophilic regions remain exposed to water on either side 
of the membrane.  
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Many targets of PET tracers are membrane bound proteins, particularly neurological receptors.  
 
1.2.4 Membrane transport 
 
The hydrophobic core of the cell membrane acts as a barrier against translocation across the 
membrane for most polar molecules. In order to ensure their survival, cells have evolved transport 
mechanisms to allow the ingestion of nutrients, the excretion of waste products and the regulation 
of intracellular ion concentrations. There are three different types of transport mechanisms: passive 
diffusion, facilitated transport and active transport.21 
 
Passive diffusion involves molecules passing directly through a membrane without the expenditure 
of energy and is the most common way by which solutes cross cell membranes: most small 
molecules and drugs are passively transported.53 Molecules diffuse down their chemical 
concentration gradient, at a rate proportional to the magnitude of this gradient. Fick’s first law of 
diffusion54 relates the permeability coefficient P, which represents this proportionality constant, with 
the solute’s flux J, its concentration gradient ΔC across the interface and interfacial area A as follows: 
  
 
   
 1.2 
with higher values of P leading to faster equilibrium. 
 
This mechanism is suitable for the translocation of lipophilic substances, however transport 
processes across the membrane of polar molecules such as sugars and amino acids are controlled by 
proteins. 
 
Facilitated transport involves the movement of a molecule across the membrane via assistance from 
an integral membrane protein, such as a channel protein or carrier protein. Ions and other small 
polar molecules may cross the membrane by diffusing through channel proteins such as ion 
channels, driven by a concentration gradient. Larger molecules bind to carrier proteins which then 
change their conformation, allowing the molecule to cross the membrane. This process is also driven 
by a concentration gradient, thus facilitated transport does not require the expenditure of energy.  
 
Finally active transport involves the movement of a molecule against a concentration gradient via the 
expenditure of cellular energy, usually provided by the hydrolysis of ATP. Transporter proteins or ion 
pumps consume energy to move molecules across the membrane against a concentration gradient; 
again, these processes are generally limited to specifically recognised molecules (although a number 
of efflux pumps, evolved to eliminate potentially harmful species, are less selective). 
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Passive diffusion      Facilitated transport  Active transport 
 
Figure 1.14 - Depending on the solute, three mechanisms exist by which it may cross the cell 
membrane: passive diffusion, facilitate transport and active transport. 
 
1.2.5 Drug-membrane interactions  
 
Drugs are known to interact with membranes upon introduction into the body. This interaction may 
influence how a drug reaches its target and can thus affect drug pharmacokinetics and 
pharmacodynamics; consequently drug-membrane interactions have received considerable attention 
from the pharmaceutical sciences, with drug-membrane interactions known to influence properties 
including absorption, distribution, toxicity and efficacy of clinical candidates.  
 
In fact it is thought that the action of some drugs – such as a number of anaesthetics and anti-
inflammatory drugs is either via direct interaction with the membrane, or by indirect modulation of 
membrane proteins through drug-membrane interactions.55 
 
Drug-membrane interactions may arise from the drug adhering to the membrane surface or 
partitioning of the drug into the membrane. Drugs may affect membranes in a number of different 
ways. They can, for example:56 
 Change conformation of lipid tails (trans/gauche population). 
 Alter membrane curvature. 
 Promote phase separation or domain formation. 
 Alter membrane thickness. 
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 Impact membrane electrostatic potential. 
 Raise/lower phase transition temperature. 
 Alter membrane fusion. 
However membranes may also affect a drugs’ activity: 
 Limiting/blocking diffusion of drug to the active site. 
 Binding of drug to membrane (accumulation, selectivity, toxicity). 
 Conformational change of drug in membrane may alter efficacy of the drug. 
 
The interaction of drugs with lipid membranes may be studied experimentally in a number of ways. 
The localisation, orientation, and conformation of drugs embedded in membranes may be obtained 
by a variety of techniques including fluorescence spectroscopy, NMR spectroscopy and X-ray 
scattering.57  
 
The displacement of Ca2+ ions from the head group region of phospholipid monolayers may be 
monitored to quantify the tendency of drugs to accumulate at the membrane surface.58 The 
partitioning of a drug into a membrane may be examined using a range of techniques, the simplest 
of which is UV spectroscopy.59 Differential scanning calorimetry may be used to provide a measure of 
drug-membrane interaction, by quantifying the extent to which a certain drug alters the phase 
transition temperature of a membrane.60 For example, using differential scanning calorimetry, Saija 
et al. found that introducing increasing concentrations of the plant metabolites flavonoinds into a 
membrane was found to correspond to a lower melting point of the DPPC lipid membrane.61 The 
diffusion of a drug within the membrane, and the effect of a drug on lipid lateral diffusion, may both 
be measured by NMR, fluorescence spectroscopy and other techniques.62 Furthermore, these 
techniques may also be applied to monitor membrane properties such as stability, fluidity (ordering), 
and phase of a membrane when certain drugs are introduced.  
 
The influence of certain drugs on membrane electrostatic properties may also be examined 
experimentally. Using fluorescent probes, Asawakarn et al. found the antiretroviral drug saquinavir to 
decrease the magnitude of the membrane dipole potential across both model and Caco-2 cellular 
membranes.42 It is known that addition of cholesterol to a membrane increases the membrane 
dipole potential.63 Thus, by adding the cholesterol scavenging compound methyl-β-cyclodextrin, 
Asawakarn et al. were able to reduce the membrane dipole potential of cellular membranes. 
Interestingly, they found that as the membrane dipole potential was reduced, the binding capacity of 
the membrane for the drug saquinavir decreased, despite the affinity of the compound for the 
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membrane remaining the same. 
 
The affinity of a drug for a membrane, and the rate at which a drug may permeate a membrane, may 
be investigated experimentally. This area of drug-membrane interaction has been studied by a 
variety of techniques, due to the impact of these drug properties on the absorption, distribution, 
toxicity and efficacy of clinical candidates.  
 
The rate of passive permeation of drug molecules across lipid membranes may be predicted using 
modelling techniques or measured experimentally. The partition coefficient of a molecule between 
the oil and water phase, or log P, is frequently employed as a measure of how quickly a drug will 
transverse a lipid membrane, as Overton’s rule64-65 proposes that drugs with higher lipophilicity will 
cross a membrane faster than more hydrophilic compounds. However this is an oversimplification of 
a complex phenomenon, as lipid membranes are heterogeneous systems consisting of a hydrophobic 
core and hydrophilic extremities and cannot be represented as a simple oily slab. Indeed, 
experimental work has questioned the applicability of Overton’s rule.66 
 
To account for the effect of the heterogeneity of bilayers on passive diffusion, experimental 
permeability assays have been developed such as the parallel artificial membrane permeability assay, 
the Caco-2 cell monolayer assay and the immobilised artificial membrane HPLC assay. 
 
Caco-2 cell assays measure the rate of permeation of a drug through a suspended monolayer of 
human carcinoma (Caco-2) cells using UV/-Vis spectroscopy or a combination of liquid 
chromatography and mass spectroscopy.67 This method gives reasonable agreement with in vivo 
results, however being a live-cell assay has the drawbacks that the outcome can depend on the state 
of the cells for any given assay. It is a slow process, requiring up to 30 days preparation time for a 
stable monolayer. 
 
The parallel artificial membrane permeability assay (PAMPA)56 overcomes the shortcomings of Caco-
2 cell assays, being much quicker to carry out and removing the possibility of active transport by 
measuring passive permeation only. The setup is similar to that of a Caco-2 cell assay, involving an 
artificial lipid membrane sandwiched between two plates, one containing the donor drug and the 
other the receiving solution. Either UV/-Vis spectroscopy or a combination of liquid chromatography 
and mass spectroscopy measures the permeation of the drug. 
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Using a HPLC assay it is possible to measure the binding of drugs to an immobilised artificial 
membrane (IAM), providing a more accurate picture of drug behaviour than a simple log P 
measurement. The retention time of drugs on the artificial membrane can be converted into a 
chromatographic hydrophobicity index, with longer retention times corresponding to a higher value 
of this index. This method was found to better predict the transport through a biological membrane 
of several molecules than n-octanol/water partitioning methods by Pidgeon et al.68 
 
1.2.6 Tracer-membrane interactions 
 
The interaction of PET radiotracers with membranes has also received experimental attention. An 
electrokinetic chromatographic method for the measurement of in vitro NSB has been developed by 
Jiang et al.69 PET radiotracers are introduced into a vesicle system, mimicking the tracer-brain tissue 
interaction and the resulting retention time found to be highly correlated with an in vitro estimation 
of NSB. 
 
A more thorough study of the translocation mechanism of CNS PET tracers across lipid bilayers has 
been conducted by Baciu and co-workers.70 Using small angle X-ray scattering (SAXS), solid-state 
NMR and fluorescence anisotropy the permeation process of cationic amphiphilic drugs (CADs) 
across lipid bilayers was investigated; it was found that the tracers undergo a degradative transport 
process.70-71 The CADs were observed to first bind to one face of an artificial DOPC membrane, at the 
polar-apolar interface between lipid head groups and tails, before redistributing to both faces. They 
then acted as a catalyst for chain hydrolysis; converting di-chain phosphatioylcholines (PCs) into 
mono-chain PCs (MOPCs) and a fatty acid. The MOPCs then formed phase-separated micelles on 
both sides of the membrane, with any CAD located in these micelles transported to a neighbouring 
membrane to repeat this hydrolysis process. This transport process degrades the membrane and may 
be a prominent mechanism for CAD transport across cell membranes. It has been proposed that the 
rate at which this hydrolysis process proceeds may be correlated to NSB, with slower hydrolysis rates 
corresponding to higher NSB. Furthermore, it has recently been reported that the hydrolysis rate 
depends on lipid chain length, at least when using 5mol% of the PET radiotracer raclopride, with the 
hydrolysis process occurring faster as saturated lipid chain length increases.72 
 
In addition to the partitioning of a PET tracer into the membrane and movement across the 
membrane, an interesting review by Vauquelin and Packeu highlights other factors that may prevent 
or slow the rate at which PET tracers reach membrane bound targets and should be taken into 
consideration.73 They point to a number of studies which suggest drugs approach membrane bound 
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targets via a mixed 3D-2D approach; first undergoing 3D diffusion in solution before adhering to a 
membrane and undergoing 2D diffusion to the target site. Given that a number of PET targets are 
membrane bound receptors, in particular neurotransmitters, it is thus likely that some PET tracers 
approach their targets via this “reduction of dimensionality” approach. Consequently a number of 
factors should be considered in order to determine drug-receptor binding via the 3D-2D approach: 
prevalence and distribution of a receptor in a membrane, concentration of the drug in solution, the 
partitioning of a drug into a membrane, the rate of drug 3D diffusion (in solution) and 2D diffusion 
(within membrane), the location of the receptors binding domain, the preferred positioning of a drug 
in a membrane and the affinity of the drug for its receptor. This review hence suggests that a study of 
NSB should consider more than the passive permeation of a drug through a membrane, rather the 
partitioning of a tracer into a membrane and subsequent ease of diffusion within the bilayer plane 
should also be examined. 
 
Computational methods have also been utilised to identify potential molecular descriptors that may 
predict in vivo NSB. Using ab initio quantum chemistry methods, the energy of interaction between a 
single PET tracer and a single lipid molecule in the gas phase was calculated and correlation found 
with NSB for a data set of ten radioligands.18 This work was extended to a second data set and 
correlation found to hold for those tracers that are known to enter the cell via passive diffusion.74 
However this method is extremely slow and untenable as a potential virtual screening method. The 
use of a single lipid molecule in the gas phase is also an unrealistic representation of drug-membrane 
interaction in the body. 
 
More approximate computational modelling methods have received far wider use for the study of 
drug-membrane interactions. Molecular dynamics (MD) in particular allows the modelling of a fully 
solvated lipid membrane, into which the partitioning of drugs may be simulated, furthermore the 
permeation of a drug can also be simulated at the atomistic level. It may thus be of interest to study 
the interaction of PET radiotracers with model cell membranes using such methods. 
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1.3 Summary 
 
The imaging method of PET scanning is a useful technique both for medical and drug discovery 
purposes. However the in vivo NSB of new candidate PET radiotracers is of serious detrimental effect 
to the development efforts of new tracers, which are required for the imaging of a new target within 
the body. To date, the molecular basis of NSB remains unclear. NSB is thought to arise from tracers 
adhering to cell membranes, thus a logical starting point for the investigation of NSB is the study of 
drug-membrane interactions. 
 Experimental studies have been performed to investigate NSB and drug-membrane 
interactions. However, currently no assay for NSB of PET tracers exists. 
 Computational investigations of NSB have so far been limited to QM methods. These 
considered a system of a single tracer and single lipid molecule interacting in the gas phase, 
which is unrepresentative of a fully hydrated membrane system as exists in vivo. 
 Drug-membrane interactions may also be studied via classical simulation methods such as 
molecular dynamics; these allow the modelling of a fully hydrated bilayer system. 
 The interaction of PET tracers with membranes using molecular dynamics is the focus of this 
work. First a background on the theory of MD simulation and their application to membrane 
and drug-membrane systems is required. 
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2 Molecular dynamics simulation – theory and membrane modelling 
 
The molecular dynamics method simulates the movement and interactions of a system of atoms and 
molecules over a given timescale. This method is a popular technique to investigate chemical and 
biological systems at the atomic level, such as proteins, small molecules and soft-matter systems. This 
chapter covers the underlying theory of molecular dynamics and its application to the simulation of 
lipid membrane structures. 
 
2.1 Quantum chemistry 
 
Theoretical calculations have long been used to help the interpretation of experimental results and 
predict previously unobserved phenomena in many areas of science, including chemistry, physics and 
biology. In the early 20th century quantum mechanics was formulated, allowing the description of 
matter on the atomic and subatomic scale, with the Schrödinger equation allowing the full 
description of how the quantum state of a physical system changes with time. Quantum chemical 
methods are often used in the development more approximate, classical molecular simulation 
models and will thus be briefly reviewed. 
 
The time-independent form of the Schrödinger equation may be written as: 
                 2.1 
With the solution to this equation revealing the wavefunction (Ψ) of the system, which contains all 
measurable information for a physical system. The wavefunction of the system depends on the 
nuclear coordinates R and the electronic coordinates r, whilst   represents the Hamiltonian operator 
containing potential and kinetic energy terms. On a molecular level this Hamiltonian takes the form: 
                                          2.2 
The operators       and      are the kinetic energy operators for nuclei and electrons respectively, 
          is the nuclei-nuclei potential energy operator,         the electron-electron potential 
energy operator and the          electron-nuclei potential energy operator. 
 
Solving the Schrödinger equation for a system larger than the hydrogen atom is however non-trivial, 
as it presents a many-body problem. Therefore computer algorithms for quantum chemical 
applications frequently use approximations to arrive at an estimated solution. 
 
Firstly, the Born-Oppenheimer approximation is assumed.75 This states that since the mass of the 
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nucleus is much greater than that of an electron, the nucleus may be treated as stationary on the 
electronic timescale. This approximation allows the electronic part of the Schrödinger equation to be 
solved, using nuclear positions as parameters.76 The electronic Schrodinger equation has the form: 
                     2.3 
In which     is the electronic Hamiltonian: 
                           2.4 
The resulting potential energy surface (PES) is then used as the basis for determining nuclear motion. 
 
The Hartree-Fock (HF) method is commonly used to arrive at an approximate solution to the 
electronic Schrödinger equation of a system. It uses the one-electron approximation, which states 
that the motion of an electron is considered to be independent of the dynamics of all other 
electrons. The one-electron approximation may be expressed as: 
                                  2.5 
This allows the wavefunction of the electronic system to be represented as a product of all the single 
electron wavefunctions. Consequently all electron-electron interactions are taken into account in an 
averaged fashion. 
 
As Hartree-Fock equations depend on their own solutions they must be solved iteratively using the 
variational principle to determine the ground-state energy and wavefunction. The variational 
principle states that a trial wavefunction (an approximation of the true wavefunction) will always give 
an energy that is greater than the true energy. Thus the more accurate the trial wavefunction, the 
closer the energy will be to the true energy, with the most accurate wavefunction being obtained 
when the energy is at a minimum.77  To arrive at a solution a trial wavefunction is selected and the 
variational principle used to derive the Hartree-Fock equations by minimising the energy. Small 
iterative changes to a trial wavefunction are made until a minimum energy is achieved.  
 
Hartree-Fock methods generally use a basis set expansion, whereby each molecular orbital      is 
expanded in terms of the basis functions      which are themselves atomic orbitals. Each molecular 
orbital becomes a linear combination of atomic orbitals: 
               
      
    2.6 
The Hartree-Fock equations may then be written as: 
                  
      
   
      
    2.7 
Multiplying by a specific basis function and integrating yields the Roothaan-Hall equations for a 
closed system,78,79 which may be written as the following matrix equation: 
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       2.8 
Where F is the Fock matrix, C is the matrix of molecular orbital expansion coefficients, S is the 
overlap matrix of basis functions and ε  is the diagonal matrix of orbital energies.77 The molecular 
orbitals may be obtained by solving the Roothaan-Hall equation using the variational principle.  
 
A molecular orbital would be fully represented by expansion with a complete basis set. However as a 
complete basis would contain an infinite number of basis functions, a molecular orbital can only ever 
be approximated in the above way. Whilst the precision of the molecular orbitals increases as the 
number of basis functions increases, the cost of a Hartree-Fock calculation scales as the fourth 
power of the number of basis functions.76 The basis functions      must be chosen such that they 
have a behaviour that agrees with the physics of the system, allowing rapid convergence as more 
basis functions are added. 
 
Since Hartree-Fock theory takes electron-electron interactions into account in an average fashion, 
one limitation is the neglect of electron correlation effects. Post-Hartree-Fock methods, such as 
Møller–Plesset (MP) and Coupled Cluster (CC), use techniques to add in the effects of electron 
correlation but this greatly increases computational cost. 
 
Despite large advances in computing power over the past decades, computationally intensive 
quantum mechanical methods remain only suitable for performing calculations on reasonably small 
systems comprised of tens of atoms. However, they are extremely useful to derive parameters such 
as bond lengths, angles, torsions and atomic charges as input for more approximate classical 
simulation methods, such as molecular dynamics. 
 
2.2 Molecular mechanics 
 
Although the theoretical framework exists to calculate the time evolution of a molecular system 
using a full quantum treatment, in reality the computational expense is enormous for any system size 
of biological interest. Consequently classical molecular mechanical (MM) treatments, which neglect 
electronic motion, have been developed and may be used to study systems composed of up to a 
million atoms on the nanosecond to millisecond timescale.80 Rather than use quantum mechanical 
theory to describe the energy and interactions of a system, MM methods apply the Born-
Oppenheimer approximation, calculating the energy of a system based on nuclear positions only. 
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2.2.1 The force field 
 
MM methods are also commonly called force field methods as they describe the potential energy of 
a system using a mathematical function, or force field, composed of a number of terms representing 
bonded and non-bonded interactions. A number of MM packages are available, whose force fields 
differ slightly. In this work the Assisted Model Building with Energy Refinement (AMBER) molecular 
dynamics force fields were used exclusively,81 thus the functional form of these force fields will be 
described. 
 
Atoms are represented as hard, charged spheres with electrons represented implicitly in the 
presence of point charges centred on each atom. As such the following atomic interactions are 
present in any given system: 
 
Figure 2.1 - The basic bonded (top) and non-bonded (bottom) interactions that are evaluated by a 
molecular mechanics force field to determine the energy of a system. 
These are described in a force field by a set of mathematical terms and empirical parameters, 
derived from either experimental or high-level computational data. The AMBER set of force fields 
have the form:82 
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The first term uses Hooke’s law to describe bond stretching, with the force constant kl determining 
the size of the energetic penalty for stretching of the bond away from the reference bond length l0. 
The second term again uses Hooke’s law to describe angle bending, with the force constant kθ 
determining the size of the energetic penalty for distortion of the angle away from the reference 
angle θ0. The third term describes rotation about a torsion or dihedral angle, which is represented by 
a cosine series expansion with periodicity n, torsion angle ω, offset γ and barrier height VN. The 
fourth and fifth terms are combined and contain the non-bonded interactions – the van der Waals 
(vdWs) interactions described by a 6-12 Lennard-Jones potential and the electrostatics by a 
Coulombic potential. The coefficient εij is the well-depth, σij is the distance at which the inter-particle 
potential is zero, qi is the partial charge on particle i and likewise qj is the partial charge on particle j, 
ε0 is the permittivity of free space and rij is the particle separation. 
 
In the AMBER force field the parameters for the bond and angle terms kl, l0, kθ and θ0 are fitted to 
reproduce experimental normal mode vibrational frequencies; whilst the torsion barrier heights VN 
are fitted to quantum mechanical energy profiles for rotation about a given torsion. Similarly, the 
vdWs radius (rij) and well-depth (εij) are fitted to reproduce experimental liquid phase properties 
whilst the atomic point charges are derived from quantum mechanical calculations of molecular 
electrostatic potential (MEP) via the restrained electrostatic potential (RESP) charge fitting method.83-
84 
 
To derive partial charges using the RESP fitting method, the MEP around a molecule is calculated at a 
suitable level of theory using quantum mechanics, for the AMBER force field this is generally the 
HF/6-31G* level. This level of theory has been shown to overestimate molecular polarisation such 
that charges derived in the gas phase approximate solution phase charges. The MEP is sampled at a 
large number of points around the molecule and partial charges fitted such that they reproduce the 
QM derived MEP. This least-squares fitting involves two stages: partial charges are first fitted to atom 
centred points with weak hyperbolic restraints on non-hydrogen atoms; then charges for methyl and 
methylene carbon and hydrogen atoms are refitted with a higher hyperbolic penalty, with hydrogen 
atoms in the same methyl or methylene groups constrained to have equivalent charge (as they are 
rotationally degenerate). During the second stage all other atoms retain charges derived during the 
2.9 
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first stage of the fit.  This fitting procedure ensures that buried atoms do not receive an unreasonably 
high partial charge. 
 
2.2.2 Energy minimization 
 
Each atom has a radius, mass, partial charge and vdWs parameters, with the force field determining 
bonded and non-bonded interactions between all atoms in the system. Consequently MM may be 
used to calculate the energetic state of a given collection of atoms or molecules. This makes it 
possible to vary the coordinates of a system until a minimum on the potential energy surface is 
reached, since at a minimum the first derivative of the energy is zero with respect to all coordinates 
and the second derivatives are all positive. The steepest descent and conjugate gradient energy 
minimisation methods are commonly used to prepare a system for further simulation. 
 
The steepest descent method moves in a direction negative to the gradient towards a minimum. This 
minimum is then used as a starting point for the next step. The workings of the steepest descent 
method however mean that it undergoes oscillatory behaviour in narrow valleys. Therefore the 
conjugate gradient method is normally used for the final stages of energy minimisation, as this 
method uses the current gradient and the previous search direction to determine the next line 
search direction, allowing better performance when close to a minimum. 
 
2.2.3 Molecular dynamics simulation 
 
The ability to evaluate the potential energy of a system using an MM force field then allows the 
modelling of the movement of a system of atoms over an interval of time by solving Newton’s 
equations of motion. Newton’s second law relates force and acceleration: 
   
   
   
 2.10 
Where F is the force, m is mass and 
   
   
 is the second derivative of position with respect to time (i.e. 
the acceleration). The force acting on a given atom may be determined from the negative gradient of 
the potential energy: 
     (r) 2.11 
By combining these equations with the following relationship between position, velocity and 
acceleration: 
  
   
   
 
  
  
 where velocity   
  
  
 2.12 
Newton’s equations of motion may be integrated to derive an expression to determine the 
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propagation of a system of atoms over time. However the analytical integration of Newton’s 
equations of motion is not computationally tractable, they may instead be solved numerically using a 
variety of schemes.  
AMBER uses a variant of the Leapfrog scheme, the derivation of which is as follows. The position 
vector r may be expressed as a Taylor series, starting at a half time step    
  
 
  and expanding about 
a half time step 
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   2.13 
Repeating the same series half a time step back  
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   2.14 
By subtracting the second expression equation 2.14 from the first equation 2.13, and truncating 
terms beyond the third order, we get: 
                    
  
 
    2.15 
By repeating the same expansions about the velocity the following expression may also be obtained: 
     
  
 
       
  
 
          2.16 
The Leapfrog algorithm thus uses velocities to calculate a new set of positions (equation 2.15), which 
are then used to calculate new velocities (equation 2.16), and so on; as a half time step offset 
separates the two quantities they essentially ‘leap’ over one another. 
 
The time step Δt determines the length of time between each MD step; this value is typically chosen 
such that it is at least ten times shorter than the highest frequency vibration in the system to avoid 
atoms coming into unreasonably close contact between steps, as this would introduce instabilities 
into the system. Since the length of time a simulation covers is determined by the number of steps 
taken multiplied by the time step, too short a time step will limit the amount of phase space that 
may be sampled in any given simulation. Consequently a compromise must be sought, simulations 
using AMBER typically use a 2fs time step. Although the highest frequency motion in a system is on 
the order of 10fs (bond stretches involving hydrogen atoms) theoretically limiting the time step to 
1fs, constraints of these motions, such as the SHAKE algorithm85 allow a larger time step. 
 
2.2.4 Constraints 
 
The SHAKE algorithm constrains internal coordinates of a system, such as bond lengths involving 
hydrogen.85 The undetermined forces required to satisfy position restraints are Lagrange multipliers, 
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which are obtained by approximating the solution of a linear system of constraint equations. With 
each MD step, this procedure is repeated iteratively until all constraints are satisfied to a predefined 
tolerance (the AMBER default is 1x10-5 Å). The constraint contribution to the virial is then added. 
 
2.2.5 Explicit solvation 
 
Simulations of biologically relevant systems require solvation, either by implicit or explicit addition of 
waters to the system. In this work all simulations used explicit solvation by adding TIP3P waters, a 
popular water model for MD simulations, which has been parameterised to reproduce experimental 
water properties including dipole moment, self-diffusion, density and expansion coefficient.86 The 
TIP3P water model consists of a three-point, rigid water model, with a single oxygen atom bonded to 
two hydrogen atoms. The hydrogens are also bonded to each other with an artificial H-H bond. All 
three atoms have a partial charge, whilst only the oxygen atom has Lennard-Jones (L-J) parameters, 
with a vdW radius that encompasses the hydrogens also. The rigidity of the TIP3P model allows it to 
be used with constraint techniques such as the SHAKE algorithm. 
 
2.2.6 Periodic boundary conditions 
 
In order to limit the number of explicit waters required, and to avoid discontinuities at the edge of 
the simulation, a technique called periodic boundary conditions is often implemented. This 
technique allows the simulation of the bulk phase of a system. The system is enclosed in a 
3-dimensional periodic box, images of which are repeated in all directions (tessellates) infinitely. 
When a molecule exits one side of the box, it is mapped to the corresponding opposite side. This 
method introduces the limitation that the box size must be greater than double the non-bonded cut-
off value to avoid atoms interacting with their own images. 
 
2.2.7 Long-range forces 
 
The most time consuming step in evaluating the energy of a system using a force field potential 
function such as equation 2.9 is evaluation of the non-bonded term, which determines the 
electrostatic and vdWs forces and scales as N2, where N is the number of particles in the system, due 
to the pairwise nature of these interactions. To improve computational efficiency a non-bonded cut-
off of length rC is typically employed, meaning that non-bonded interactions are only calculated using 
equation 2.9 for particles with separation r<rC. However, truncating non-bonded interactions beyond 
a certain cut-off distance results in the improper evaluation of the system energy and introduces 
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simulation artefacts, as although vdWs interactions quickly fall to zero due to their 1/r6 dependence, 
electrostatic interactions remain important over longer distances falling as 1/r. For this reason a 
number of methods are employed to recover non-bonded energies and forces beyond the cut-off 
distance. 
In order to recover the electrostatic interactions lost due to this truncation, the particle mesh Ewald 
(PME) method is employed in many MD codes, including AMBER. Beyond the cut-off, atomic partial 
charges are mapped onto a ‘PME grid’, which typically has side 1 Å. The charge distribution is then 
determined by a Fast Fourier Transform (FFT) of the Poisson equation in reciprocal space. This 
method allows the full evaluation of electrostatic interaction energies in a system and is 
computationally efficient, scaling as N ln (N).87 Alternative methods to PME include the reaction field 
(RF) method,88 which constructs a sphere around a given molecule with radius equal to the cut-off 
distance. Electrostatic interactions within the sphere are calculated explicitly, whilst matter outside 
of the sphere is treated as a dielectric continuum.  
 
The treatment of long-range vdWs forces is generally via a simpler analytical correction, which uses 
the L-J interaction parameters, system density and cut-off distance to evaluate the following 
expression for correction of the energy due to long-range vdW:89 
          
 
 
       
     
   
 
 
       
    
    2.17 
In many systems vdWs interactions typically fall to zero at distances beyond ≈10 Å, making this 
correction to the energy small, thus results are comparable to using a very long cut-off distance. A 
similar expression is also evaluated to correct the pressure of the system due to the neglect of long-
range vdWs forces. However it should be noted that this correction is only strictly valid for a 
homogeneous isotropic system, as the derivation of this expression makes the assumption that the 
pair correlation function g(r)=1 in all directions. 
 
2.2.8 Simulation protocol 
 
To begin a simulation, the system is first minimised to remove bad contacts. Initial velocities are then 
randomly assigned to each atom from a Maxwell-Boltzmann distribution at an initial temperature 
and the system heated to the desired temperature in the canonical ensemble (NVT), often with weak 
restraints on the solute. The system is then equilibrated in the constant temperature and constant 
pressure regime (NPT); this may also initially involve weak restraints on the solute. The 
isobaric-isothermal (NPT) ensemble may be achieved in a number of ways, in this work temperature 
was controlled using the Langevin thermostat and constant pressure achieved using the Berendsen 
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barostat. 
 
Langevin temperature regulation90 couples each atom to a heat bath by simulating random collisions 
with a solvent at a specific temperature. A slight modification to the Leapfrog algorithm is made – a 
small amount of random white noise and a frictional force directly proportional to the atomic 
velocity is added to the velocity of each atom. Pressure control using the Berendsen barostat91 
involves weak coupling of the system to an external bath. With each step both the periodic cell 
dimensions and the atomic positions are scaled such that the system remains at the desired 
pressure. 
 
Once equilibration of the system has been achieved, which may be determined by observing the 
system energy, density, temperature, and in the case of lipid bilayer simulations properties such as 
the area per lipid, a production run is then performed, usually in the NPT ensemble. 
 
2.3 Molecular dynamics simulation of lipid bilayers 
 
Lipid membranes have been studied using molecular dynamics since the 1980s.92-97 Due to the 
numerous competing forces causing a non-zero lateral pressure profile along the bilayer normal (see 
section 1.2), lipid membrane structures are challenging systems to simulate and consequently there 
has been a great deal of research directed towards developing suitable force field methods for the 
molecular dynamics simulation of membranes. 
 
Lipid molecules may be represented during a simulation in all-atom (AA) detail (with each atom 
represented explicitly) in a united-atom (UA) fashion (with methyl and methylene groups combined 
into a single site) or using a coarse-grained approach (whereby a number of connected atoms are 
combined into a single unit or ‘bead’) - see Figure 2.2. The increasing simplicity of each method 
allows longer length and timescales to be accessed, at the expense of atomic detail.  
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Figure 2.2 - Three levels of lipid resolution: DOPC in a) all-atom b) united-atom and c) coarse-grained 
representation. Figure created with VMD.98 
Coarse-grained models, such as the MARTINI99 or ELBA100 lipid force fields, are well-suited to study 
large scale bilayer properties, such as membrane fluctuations, raft-formation and phase 
transitions.101 They are also used to study membrane proteins and the interaction of solutes with 
lipid membranes, using either a coarse-grained or all-atom representation of the proteins or small 
molecules.102-104 However in order to study such membrane interactions in greater detail a UA or AA 
representation of the bilayer may be required, with AA models able to replicate the unique hydrogen 
bond network that exists around the choline head group region105-106 and lipid NMR order 
parameters. 
 
2.3.1 All-atom lipid force fields 
 
All-atom simulations involving lipid bilayers have been used to study numerous phenomena including 
the interaction of small molecules,107-110 peptides,111-112 and small proteins with membranes,113 as 
well as the behaviour of mixed bilayers,114 the influence of cholesterol on membranes,115 the 
properties of lipid rafts,116 and transmembrane proteins.117-121 
 
A number of force fields exist for the AA simulation of lipid membranes, such as the Chemistry at 
HARvard Molecular Mechanics  (CHARMM),122 L-OPLS/AA123 and Slipids124-125 force fields. Of these, 
the CHARMM lipid force field has undergone the greatest number of reparameterisation 
a) b) c) 
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generations. 
 
The CHARMM C27r lipid force field used updated alkane parameters,126 parameterised to reproduce 
energies of different local minima conformations of alkane chains including pentane, hexane and 
heptane; additionally, liquid alkane properties including the 13C NMR T1 relaxation time, density, heat 
of vapourisation and the average population of trans/gauche states were also assessed. However the 
application of a surface tension is required when simulating lipid bilayers with this force field in order 
to achieve experimental values for the area per lipid.127 
 
The revised CHARMM C36 force field focussed on head group parameters, updating partial charges, 
torsions and vdWs parameters for a number of head group moieties.128 The resulting parameter set 
allows the simulation of bilayers without the requirement to apply a surface tension. Simulation 
results reproduce experimental properties including area per lipid, NMR order parameters, X-ray 
scattering and neutron scattering data. 
 
The Slipids force field is essentially a further modification of C36, with the only changes being the 
lipid partial charges (RESP fits from QM calculations, rather than the arbitrarily assigned C36 charges) 
and the alkane chain torsion and vdWs parameters.124-125 Like C36, Slipids reproduces area per lipid, 
NMR order parameters and scattering data in NPT simulations (without an applied surface tension), 
however importantly Slipids is also able to better reproduce both the DHH and DB bilayer thicknesses 
in comparison to C36. 
 
Finally, the OPLS/all-atom force field for small molecules has been modified to correctly model long 
chain hydrocarbons (termed L-OPLS/AA). L-OPLS/AA uses updated alkane parameters for the lipid tail 
groups,123 correcting the observed gel phase of GMO bilayers using standard OPLS/AA alkane 
parameters. A GMO bilayer simulated with updated alkane parameters reproduces experimental 
area per lipid values and remains in the liquid phase. 
 
2.3.2 Simulation of lipids with AMBER 
 
Another popular force field for the all-atom simulation of biological systems is AMBER.81 The AMBER 
package provides a well parameterised force field for protein simulation, ff99SB129 (now updated to 
ff12SB) and the ability to run simulations at speeds upwards of 100ns/day using the CUDA 
implementation of the code on Graphics Processing Units (GPU cards).130-132  It is also reasonably 
simple to add small molecules into a system using the General Amber Force Field (GAFF)133 and the 
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RESP charge fitting methodology.83-84 Furthermore, carbohydrates may be modelled by use of the 
GLYCAM force field.134 Consequently, there has been a great deal of interest in the simulation of lipid 
molecules using the AMBER package as lipids present a large class of molecules of biological interest 
that scientists may wish to investigate at the atomic scale using MD simulation. 
 
Among the first lipid simulations to be performed using AMBER parameters were those of DMPC by 
Moore et al. and Takaoka et al.135-137 using AMBER94 parameters.82 Although seeming to reproduce 
experimental results for properties such as the area per lipid and NMR order parameters, the 
simulations by Moore et al. were performed in an NVE ensemble, meaning the volume of the 
periodic box was fixed and the bilayer was not able to equilibrate to its true structure or area per 
lipid value; whilst those by Takaoka et al. involved the application of a surface tension. 
 
The application of a surface tension term during bilayer simulations is not ideal, given that the 
surface tension of an experimental lipid bilayer is thought to be identically zero; 138 furthermore, 
although a single component bilayer may be simulated at a given surface tension, complications arise 
for simulations of bilayers composed of a mixture of lipids, or those containing a membrane protein. 
 
On the release of GAFF in 2004,133 a number of research groups also tested this force field for 
simulation of lipid membranes. Jójárt et al. simulated POPC bilayers using GAFF, only achieving area 
per lipid values close to experiment with the application of a surface tension term.139 Similarly, Siu et 
al. ran DOPC bilayers using GAFF parameters, again only achieving area per lipid values close to 
experiment using a surface tension ensemble.140 
 
Rosso et al. tested both the AMBER94 and GAFF parameters for the simulation of DMPC and DOPC 
bilayers in the absence of a surface tension. Results for the GAFF runs show area per lipid to drop 
below experiment after 20 ns of simulation time and order parameters to be above those found by 
NMR, indicating bilayers are too ordered and the system is transitioning to the gel phase.141 
 
More recently, Coimbra et al. simulated twelve different lipid types (including common phospholipids 
such as DMPC and DOPC) using GAFF.142 In all cases, area per lipid values dropped significantly below 
experiment, suggesting bilayers are either gel phase or close to transitioning from liquid to gel phase. 
These results should not be surprising considering previous publications in the field. 
 
These studies serve as evidence that neither the AMBER94 nor GAFF force fields are suitable for lipid 
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simulation using the AMBER package, as bilayer simulations achieving experimentally comparable 
results are only possible using the physically unrealistic surface tension term. Consequently the need 
exists to revise current AMBER lipid parameters to allow the proper simulation of lipids in the 
absence of an applied surface tension. 
 
2.4 Lipid bilayer simulation considerations 
 
In addition to suitable parameters, care must be taken in how a bilayer simulation is performed. 
Specifically the treatment of electrostatics, vdWs forces, and temperature and pressure regulation, 
have all been shown to affect results of bilayer simulations. These are discussed in turn below. 
 
2.4.1 Treatment of long-range forces 
 
A number of studies have compared treatment of electrostatics in bilayer simulations, using either a 
simple cut-off (i.e. electrostatic interactions beyond the cut-off are neglected), the RF method to 
treat electrostatics beyond the cut-off, or PME to treat electrostatics beyond the cut-off distance.143-
144 When using a simple cut-off, Anézo et al. found bilayers to contract to a greater degree with 
longer cut-off values, thus the area per lipid drops as the cut-off distance is increased.143 This 
contraction is due to the build up of favourable interactions inside the cut-off sphere, reducing 
outward pressure of the system, with the effect becoming more dominant as the cut-off radius is 
increased. Other studies have found similar results, whereby the truncation of electrostatics and 
neglect of long-range electrostatic interactions cause enhanced ordering of lipid chains.145 When 
PME or RF methods are applied to smooth electrostatic interactions to zero beyond the cut-off 
distance, avoiding the abrupt truncation of electrostatic interactions, bilayer simulations remain far 
more stable. Results using the PME and RF method converge to be virtually identical, a result found 
by Poger et al.,144 making PME the method of choice to treat electrostatics beyond the cut-off due to 
the greater computational efficiency of this method. 
 
The analytical dispersion correction typically used to account for long-range vdWs forces (equation 
2.17), as previously noted, is only strictly valid for a homogeneous isotropic system. Consequently it 
may not be suitable for modelling anisotropic systems such as lipid bilayers. However in many cases 
the analytical correction is the only method available in simulation packages to treat vdWs 
interactions beyond the cut-off meaning that many bilayer simulations typically employ this method.  
A select group have chosen to insert more rigorous long-range vdWs schemes to determine the 
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influence of the thorough treatment of these long-range forces on bilayer simulations. 
 
The effect of the proper treatment of long-range vdWs interactions was first investigated by Lagüe et 
al., who implemented a long-range correction method suitable for anisotropic systems.146 
Simulations were carried out with a standard cut-off distance of 10-12 Å, with the pressure 
determined using a long cut-off (30 Å) after a certain number of steps. The difference in the pressure 
ΔP between pressure values determined using a short and long cut-off was calculated and the 
simulation is propagated with an applied pressure of P0+ΔP, where P0 is the target pressure. This 
method is available in CHARMM and is normally employed for bilayer simulations with this MD 
package. 
 
An alternative method to include long-range vdWs interactions was introduced by Venable et al.147 
The 3D-IPS/DFFT method extends the 3D isotropic periodic sum method to evaluate both 
electrostatic and vdWs interactions in heterogeneous systems. They find traditional PME treatment 
gives similar results for bilayer simulations as the 3D-IPS/DFFT method, while monolayer simulations 
require the more rigorous treatment afforded by 3D-IPS/DFFT. 
 
Recently the PME method has been applied to the evaluation of vdWs forces beyond the cut-off 
distance. Although this method was previously thought to be difficult to apply for vdWs treatment to 
any system containing more than a few atom types, Wennberg et al. use an approximation for 
combination rules in reciprocal space that significantly reduces the computational cost of this 
method.148 Results for simple, homogeneous isotropic systems such as a box of pentadecane carbon 
chains are found to be comparable using both the traditional analytical dispersion correction and 
Lennard-Jones PME; however anisotropic systems such as lipid bilayers are observed to behave 
differently when vdWs interactions are treated by the L-J PME method. Wennberg et al. find DPPC 
and POPC bilayers to become slightly more ordered, resulting in a lower area per lipid and higher 
order parameters when simulated with the L-J PME method.148 
 
It may thus be concluded that the PME method is suitable for treatment of long-range electrostatics 
during lipid bilayer simulations. The long-range analytical dispersion correction, which is often the 
only method available in MD simulation codes, and indeed is the only option in AMBER, is not 
theoretically suitable for heterogeneous systems such as lipid bilayers. However although the more 
thorough treatment of long-range vdWs interactions using methods such as PME is seen to have an 
effect on bilayer simulations, the differences are negligible. 
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2.4.2 Temperature and pressure regulation 
 
Finally, in addition to the treatment of non-bonded interactions, the temperature and pressure 
regulation schemes should also be carefully chosen. When evaluating AMBER parameters for lipid 
simulation, Rosso et al. tested both the Berendsen and Langevin thermostats for temperature control 
during bilayer simulations.141 The Langevin thermostat was seen to give bilayer properties such as 
area per lipid closer to experimental values, in addition it has been shown that the Berendsen 
thermostat does not properly conserve the canonical ensemble.149 Consequently the Langevin 
method remains the thermostat of choice for simulations using the AMBER code. Bilayer simulations 
using the CHARMM or GROningen MAchine for Chemical Simulations (GROMACS) packages typically 
employ the Nose-Hoover piston or Parrinello-Rahman barostats for pressure control. Currently, the 
AMBER code only supports the Berendsen barostat, which has been shown to give equivalent results 
as the Parrinello-Rahman method for bilayer equilibrium properties, including isothermal area 
compressibility modulus values, which depend on volume fluctuation.143 Some caution should exist 
however when using the Berendsen barostat to compute values which depend on volume 
fluctuation, as it has been shown that this method is unable to properly represent the canonical 
ensemble (much like the Berendsen thermostat).150 
 
2.4.3 System size and simulation timescale 
 
Simulation timescales are also of considerable importance when performing lipid bilayer simulations. 
Early work replicated experimental bilayer results using simulations up to multiple tens of 
nanoseconds in length. However it is unlikely that the membrane had reached equilibrium after such 
a short period. In order to obtain equilibrated properties, bilayers should ideally be simulated for  
timescale of at least hundreds of nanoseconds and possibly even longer, as phospholipid head group 
conformations have been found to require a long timescale to reach an equilibrium distribution in 
MD simulation.151 
 
System size should also enter consideration depending on the properties being studied. Previous 
publications have found little deviation in bulk membrane properties with an increase in system 
size,152 thus typical all-atom membrane sizes of 64-128 lipids should be appropriate to study bilayer 
structural properties. However if properties such as membrane undulations are to be examined, 
bilayers composed of many more lipids must be used.153 
 
Suitable temperature, pressure, long-range electrostatic and long-range L-J treatments are thus 
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contained in the AMBER MD package for the simulation of lipid membranes. However to date 
adequate force field parameters do not exist for lipid simulation with AMBER, as both the AMBER94 
and GAFF force fields require the application of a surface tension term to achieve experimental 
results for lipid membrane simulation. The need thus exists for new lipid force field parameters to 
allow the proper simulation of membranes using AMBER. 
 
2.5 The need for AMBER lipid parameters 
 
As highlighted, previous attempts to apply GAFF to lipid simulation have been met with some 
success. However, in all cases bilayers are observed to display too low an area per lipid and high 
order parameters in comparison to experiment, indicating that the bilayer has either transitioned 
from the liquid to gel phase, or is close to doing so. This behaviour may be corrected for by applying 
a surface tension to the bilayer, however using the NPγT ensemble is not physically appropriate given 
that in reality the surface tension of a lipid bilayer has been shown to be identically zero.138 Although 
bilayer simulations performed by Rosso et al.141 gave reasonable results for DOPC and DMPC, on 
extending the exact bilayer end structures out for a further 25 ns of simulation time the area per lipid 
was seen to continue to decrease and a transition to the gel phase occurs (see Figure 2.3). 
 
Figure 2.3 - Time evolution of the area per lipid for a DMPC and DOPC bilayer simulated using GAFF 
parameters devised by Rosso et al. Experimental values shown as dashed line (----). 
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Consequently it was determined that lipid parameters for AMBER required updating to correctly 
model membranes in the liquid phase. The development of lipid parameters for other molecular 
dynamics simulation packages has in most cases involved updating parameters to model long 
hydrocarbon chains.123-124, 126, 154 Initial DPPC simulations by Berger also displayed similar behaviour, 
in that the lipid volume was too low. It was identified that the simulated density of pentadecane 
(carbon-15 alkane chain) was incorrect (too high) and may thus be responsible for the low lipid 
volume. Berger parameters optimised the density and heat of vapourisation of pentadecane by 
modifying hydrocarbon vdWs radii and well-depth, with resulting lipid parameters found to model 
DPPC with an area per lipid close to that of the experimental value.154 
When a box of pentadecane carbon chains was simulated using GAFF parameters at a temperature of 
298.15 K, the alkane chains were observed to ‘freeze’ (see Figure 2.4). 
 
Figure 2.4 - Box of 144 pentadecane chains simulated for 10 ns at 298.15 K at constant pressure 
using GAFF parameters. 
Experimentally, pentadecane is in the liquid phase at room temperature, these results thus show that 
GAFF parameters are not suitable for modelling long chain hydrocarbons. Given that lipids possess at 
least one hydrocarbon tail group, this is a fundamental issue that requires attention if lipids are to be 
simulated with AMBER. 
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2.6 Summary and Aims 
 
The overall aim of this research is to investigate any possible link between PET radiotracer 
interactions with membranes and the phenomenon of NSB. The high in vivo NSB of candidate 
radiotracers is a serious hindrance to the development of new imaging agents, as currently no robust 
experimental or virtual screening method exists to identify candidate structures that may exhibit 
high NSB in vivo. NSB is therefore not identified until after design, synthesis and in vivo testing is 
performed; abandoning a candidate radiotracer after these stages of development due to high NSB 
characteristics is hence a costly procedure. Therefore any insight into the molecular basis of NSB that 
may be identified using in silico methods is of benefit, and could even potentially be developed into a 
virtual screening tool, or inspire an experimental assay for NSB.  
The molecular basis of NSB has previously been investigated using quantum mechanical methods, 
finding a possible link between drug-lipid interaction energy and NSB.18, 74 However these methods 
come at a high computational cost, furthermore a single drug-lipid system in the gas phase is not 
representative of the cell membrane structure as found in vivo. Classical simulation methods, such as 
molecular dynamics simulation, come at a lower computational cost and allow a detailed, atomic 
resolution investigation of molecular systems and interactions. It is therefore proposed to study 
radiotracer-membrane interactions using molecular dynamics, which allows the modelling of a fully 
hydrated lipid bilayer structure. Specifically, it is intended to use the AMBER molecular dynamics 
package in order to utilise GAFF, which has been designed for the modelling of small drug like 
molecules. However to date suitable parameters for the modelling of lipid bilayers with AMBER are 
not available, past attempts to model lipids in AMBER required the application of a physically 
unrealistic surface tension term to achieve bilayer properties with good comparison to experiment. 
The objectives of this study may be summarised as follows: 
 In order to perform molecular dynamics simulations of tracer-membrane systems using the 
AMBER package, suitable lipid force field parameters will be developed. Previous successful 
all-atom lipid force field development has required updating Lennard-Jones and torsion 
parameters such that alkanes are correctly modelled in the condensed phase. 
 These parameters will then be validated for the simulation of lipid bilayers via the calculation 
of various experimentally accessible membrane properties, such as the area per lipid, 
volume per lipid, NMR order parameters and X-ray scattering profiles. 
 PET tracer-membrane systems may then be simulated allowing the examination of tracer-
membrane interactions and the investigation of possible causes of NSB. These include, but 
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are not limited to, drug partitioning into the membrane, drug orientation in the membrane, 
drug diffusion in the membrane plane, drug hydrogen bonding characteristics and drug 
permeation through the membrane. 
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3 Development of lipid parameters for AMBER 
 
In this chapter the iterative development of suitable parameters for the molecular dynamics 
simulation of lipid membranes using AMBER is described. This work involved a number of stages, 
with suitable lipid parameters finally found to be intricately linked to the quality of alkane 
parameters. Unlike the development of other all-atom lipid parameters, it was found that only 
updating AMBER alkane van der Waals and torsion parameters did not result in a suitable parameter 
set; rather the underlying alkane bond and angle parameters also required parameterisation. The 
resulting lipid parameter set reproduces membrane properties such as area per lipid, volume per 
lipid, NMR order parameters and X-ray scattering data in good comparison to experiment. Work in 
this chapter has been published as Dickson et al.155-156 
 
3.1 GAFFlipid 
 
3.1.1 Parameter development strategy 
 
It was decided to simulate lipids using GAFF parameters in a similar manner to Rosso et al.,141 
however parameters for long hydrocarbon chains would first be updated to reproduce the 
experimental density and heat of vapourisation of pentadecane. This may be achieved by adjusting 
the GAFF Lennard-Jones parameters for alkane chains, as the heat of vapourisation of such a liquid 
system is intimately dependent on non-bonded forces. It was hypothesised that these alterations 
would allow better simulation of lipids using AMBER, similar to the Berger work.154 Modifying 
Lennard-Jones parameters will also alter the performance of related dihedral parameters, since for 
atoms separated by exactly three bonds, scaled electrostatic and vdWs interactions are calculated in 
addition to specific dihedral terms. It was thus also necessary to refit the related torsion parameters, 
which is possible by fitting the torsion parameter such that it reproduces a high-level quantum 
mechanical dihedral scan on a model compound (in this case an alkane chain). 
The lipid parameterisation follows the strategy outline in Figure 3.1 – after updating GAFF 
hydrocarbon parameters, lipid partial charges were calculated to allow the simulation of bilayers of a 
number of lipid types in order to validate resulting parameters. 
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Figure 3.1 - The GAFFlipid parameterisation strategy. 
 
3.1.1.1 Hydrocarbon parameters 
 
Van der Waals parameters 
GAFF treats all saturated alkane chains using just two atom types – methyl and methylene carbon 
atoms have atom type c3, whilst hydrogens bonded to these carbons have atom type hc. The alkane 
carbon and hydrogen atom vdWs parameters were scaled until agreement with experiment was 
found for the density and heat of vapourisation of pentadecane (see Table 3.1 and Table 3.2). The 
CHARMM vdWs parameters were used as a starting point for the carbon and hydrogen L-J 
parameters. While adjusting the vdWs parameters, the CH2-CH2-CH2-CH2 torsion parameter was 
corrected by fitting the AMBER dihedral parameter to reproduce a QM torsion scan. 
Table 3.1 - Experimental and calculated density and heat of vapourisation for pentadecane. All values 
at 298 K. Data taken from the CRC Handbook of Chemistry and Physics.157 
 ΔHvap (kJ/mol) Density (kg/m
3) 
Experiment 76.77 769.0 
GAFF 105.88 842.0 
GAFFlipid 77.01 751.0 
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Table 3.2 - Original and modified Lennard-Jones parameters for GAFF c3 and hc atom types.* 
 GAFF GAFFlipid 
c3 radius R (Å) 1.9080 2.010 
c3 well-depth ε (kcal/mol) 0.1094 0.055 
hc radius R (Å) 1.4870 1.340 
hc well-depth ε (kcal/mol) 0.0157 0.024 
*Note that the in this table and the remainder of this work, L-J well-depths and force constants are 
reported in kcal/mol as AMBER uses these internal units. 
 
The heat of vapourisation of pentadecane was calculated according to:158 
                           3.1 
This calculation involved simulating a single pentadecane molecule in the gas phase and a second 
simulation of a box of 144 pentadecanes in the liquid phase using AMBER 11.159 From the second 
simulation the density was also obtained. 
 
The gas phase simulations consisted of a single pentadecane, run for 10ns in the NPT ensemble, at a 
temperature of 298 K. The liquid phase simulations consisted of a box of 144 pentadecane 
molecules, run under the NPT ensemble with periodic boundary conditions using PME to treat long 
range electrostatics,87 with a real space cut-off of 10 Å. The temperature was maintained at 298 K 
using Langevin dynamics and a collision frequency of 5 ps-1.  
 
Pressure regulation was achieved with isotropic position scaling, a Berendsen barostat91 and a 
pressure relaxation time of 1 ps. The system was heated from 0 to 298 K over 20 ps, with the chains 
restrained using a force constant of 20 kcal/mol/Å2. This restraint was gradually decreased to 10, 5 
and finally 1 kcal/mol/Å2, with the system simulated for 20 ps for each value of the force constant. 
The pentadecane box was then run for 10 ns. The final 5ns of the gas and liquid phase simulations 
were then used for data collection. 
Torsion fitting 
A torsion scan was performed on a pentadecane chain using the same level of quantum chemical 
theory used for the development of the GAFF parameters – optimisation of the structure using 
MP2/6-31G* and a singlepoint energy calculation at the MP4/6-311G(d,p) level. The energy scan was 
performed using Gaussian 09160 from 0-360° at 15° increments due to the computational expense 
involved in these calculations. Torsion scans performed for the development of the original GAFF 
parameters used a larger step size of 30°.133 The Paramfit module of AmberTools159was then used to 
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fit the CH2-CH2-CH2-CH2 torsion parameter such that the AMBER force field reproduces QM energies. 
The simplex algorithm option of Paramfit was applied to find the torsion parameters that best 
reproduce QM energies. The torsion was fitted for periodicity n=1 to n=3 (see equation 2.9), as these 
are the terms present in the GAFF force field. 
 
Figure 3.2 illustrates the ability of Paramfit to identify the torsion parameter that better replicates 
quantum mechanical data. However the fit is not perfect, this is due to the fact that only the n=1 to 
n=3 periodicity of the torsion, as is present in the GAFF force field, was fitted. 
 
Figure 3.2 - Torsion profile for the  CH2-CH2-CH2-CH2 torsion calculated with a pentadecane molecule 
using quantum mechanics (MP4/6-311G(d,p)//MP2/6-31G* level at 15° increments), standard GAFF 
parameters, GAFF parameters with modified Lennard-Jones and finally GAFF with modified Lennard-
Jones and Paramfit corrected torsion parameter. Reproduced by permission of The Royal Society of 
Chemistry.155 
Torsion scans were also performed on an unsaturated pentadecene chain about the C=C double bond 
using the same method as the pentadecane torsion scans and the following torsion parameters 
updated using Paramfit: CH2-CH-CH-CH2, CH-CH2-CH2-CH2, CH-CH-CH2-CH2. 
The Paramfit program 
The Paramfit tool is available in AmberTools81, 159, 161 (v12 and above) and allows the fitting of AMBER 
bond, angle and dihedral force field parameters to quantum mechanically generated data. 
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It takes as input a number of conformations of the desired molecule with relevant energies 
generated using a QM package and a topology file describing the molecular connectivity with an 
optional initial guess for the parameters. Given accurate parameters, the energy calculated for each 
structure using the AMBER equation should match the QM value for the energy of that structure 
within the limits of agreement possible given the restrictions imposed by the AMBER classical 
potential function. Paramfit optimises the parameters of the AMBER covalent terms to minimise the 
difference between the MD and QM energies such that: 
                                           
 
             3.2 
where the bond, angle, dihedral and nonbonded energies are calculated as classical harmonic 
potentials with the AMBER equation and EQM is the previously calculated quantum energy for each 
structure. K is a constant representing the intrinsic difference in the origin between the quantum and 
classical energies for the system and is used simply to rebase the calculation such that a perfect fit 
would give a difference of zero.  
 
Paramfit conducts this fitting using either a simplex or genetic algorithm. The simplex algorithm is 
recommended when a known parameter starting point exists, whilst the genetic algorithm is used 
when no good starting point exists or when coupled parameters are to be fit, such as those involving 
multiple dihedrals. 
 
3.1.1.2 Charge fitting 
 
The resulting hydrocarbon parameters were applied to the simulation of DLPC, DMPC, DPPC, DOPC, 
POPC and POPE bilayers, using the updated torsion and L-J parameters for the lipid carbon tails. All 
other parameters were taken directly from GAFF as per previous work by Rosso et al.141 In order to 
allow the simulation of these lipids, partial charges were calculated for five structures of each lipid, 
extracted from previous bilayer simulations. Each structure underwent optimisation at the 
HF/3-21G*, DFT-B3LYP/3-21G* and HF/6-31G* levels. The MEP was then determined at the 
HF/6-31G* level. The polarisable continuum model was implemented for the POPE charge calculation 
case to prevent proton transfer from the lipid head group to the phosphate moiety. Upon successful 
optimisation at this level, the partial charges were then extracted using the standard RESP protocol. 
Charges were fitted using the two-stage procedure developed by Cornell et al.83-84 and final lipid 
partial charges taken as an average over the five fits for each lipid, similar to the procedure used by 
Jójárt et al.139 The resulting lipid parameters were termed GAFFlipid. Parameters are provided in full 
in Appendix I – GAFFlipid atom types and charges and in supplementary files. 
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Lipid bilayers of size 72 and 288 lipids, and a double bilayer consisting of two 288 bilayers stacked on 
top of one another, were simulated using the AMBER11 GPU code. The 72 models were run for 
250 ns, the 288 models for 100 ns and the 2 x 288 stacks for 50 ns. 
 
3.1.2 Membrane simulation protocol 
 
3.1.2.1 Initial configuration 
 
To create a starting configuration, a single lipid molecule was replicated along the x and y axes, and 
flipped along the z, until a square grid of 72 or 288 lipid molecules was obtained. A 20 Å layer of 
TIP3P water molecules was added above and below the bilayer using the LEAP module from the 
AMBER suite. Water molecules automatically placed below the carboxylic bonds were deleted. 
 
The 2x288 bilayer stacks were constructed by placing an equilibrated 288 bilayer on top of itself (with 
water removed) with separation so as to create a steric water thickness in line with the experimental 
value reported by Nagle et al.,35 then re-solvating the system with a 20 Å layer of TIP3P water 
molecules added above and below. As before, water molecules that were automatically placed below 
the carboxylic bonds were removed. 
 
3.1.2.2 Equilibration procedure 
 
The system was minimised with lipids constrained for 1000 steps, of which the first 250 steps used 
the steepest descent method and the remaining steps used the conjugate gradient method.162 Then 
minimisation was performed with no restraints for 5000 steps, of which the first 2500 were steepest 
descent and the remaining 2500 were conjugate gradient. The system was heated from 0K to 
303-323 K using Langevin dynamics90 within a 20 ps constant volume run, with weak restraints on the 
lipid (force constant 10 kcal/mol/Å2). Following this, the system was simulated in NPT using Langevin 
temperature control with a collision frequency of γ=1 ps-1, and anisotropic Berendsen control91 of the 
pressure at 1 atm by coupling the repeating box with a time constant of 0.5 ps for 50 ps. Finally the 
pressure relaxation time was reduced to 1 ps and the system left to equilibrate, again in NPT, for 
170 ps. Water was then removed from the top and bottom of the bilayers, and from below the 
carboxylic bonds, leaving a hydration level replicating experiment, with 31.3 waters/lipid (DLPC),32 
25.6 waters/lipid (DMPC),35 30.1 waters/lipid (DPPC),35 32.8 waters/lipid (DOPC),35 31 waters/lipid 
(POPC)163 or 32 waters/lipid (POPE). After water removal each system was equilibrated again using 
the same procedure. 
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3.1.2.3 Production runs 
 
Production NPT runs were performed on the 72 and 288 single bilayers and the 2x288 bilayer stacks 
of DOPC, DMPC, DPPC, DLPC, POPC and POPE for simulation times of 50 ns (2x288 bilayers), 100 ns 
(288 bilayers) or 250 ns (72 bilayers) using the AMBER 11 package.159 The CUDA implementation of 
the AMBER 11 code was used to run the simulations on in-house NVIDIA GPU cards.130-132, 159 Three 
dimensional periodic boundary conditions with the usual minimum image convention were 
employed. Bonds involving hydrogen were constrained using the SHAKE algorithm,85 allowing a 2 fs 
time-step. Structural data was recorded every 2 ps. PME was used to treat all electrostatic 
interactions beyond a cut-off of 10 Å.87 A long-range analytical dispersion correction was applied to 
energy and pressure. Simulations were performed at constant pressure of 1 atm and constant 
temperature of 303K (DOPC, DMPC, DLPC, POPC), 310K (POPE) or 323K (DPPC) in order to replicate 
experimental conditions. Temperature was controlled by the Langevin thermostat,90 with a collision 
frequency of γ=1 ps-1. Pressure was controlled anisotropically with the Berendsen method,91 with a 
pressure relaxation time of 2 ps, meaning the box dimensions were allowed to adjust freely and 
independently in all three directions. 
 
3.1.2.4 Data analysis 
 
The first 10ns of each simulation was disregarded as equilibration time, with the remaining 
simulation time then divided into two equal blocks, and sub averages over each block for each 
property used to compute standard errors. Results are thus reported as average ± standard error. 
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3.1.3 Membrane validation simulations with GAFFlipid 
 
3.1.3.1 Structural parameters 
 
Table 3.3 - Structural properties of bilayers calculated via molecular dynamics simulation using 
GAFFlipid and comparison to experiment and, where available, simulations using standard GAFF 
parameters, for three system sizes of six different phospholipid types. 
Lipid system Area per lipid  
AL (Å
2) 
Volume per 
lipid  
VL (Å
3) 
Area compressibility 
modulus  
KA (mNm
-1) 
Peak distance DHH 
(Å) 
DLPC 
72 
288 
2x288 
Experiment 
 
59.97±0.0007 
60.45±0.059 
62.4±0.42 
63.232 
 
1008.79±0.14 
1009.98±0.17 
1007.78±0.4 
   99132 
 
291±64 
336±7 
422±297 
- 
 
31.6 
30.6 
31.5±0.85 
30.832 
DMPC 
72 
288 
2x288 
GAFF 
Experiment 
 
59.95±0.15 
60.38±0.0039 
61.05±0.72 
55.8141 
60.6164 
 
1117.83±0.51 
1115.81±0.31 
1105.11±0.36 
1097.4141 
110132, 35 
 
299±75 
368±74 
150±150 
- 
234165 
 
33.6±1 
34.6 
37±1 
35.2141 
34.4,166 35.3164 
DPPC 
72 
288 
2x288 
Experiment 
 
61.24±0.4 
61.77±0.21 
61.75±0.012 
6331 
 
1265.46±0.8 
1264.51±0.63 
1267.24±0.29 
 123235 
 
274±22 
243±21 
713±143 
23135 
 
37.6±0.72 
37.6 
39 
38,31 38.335 
DOPC 
72 
288 
2x288 
GAFF 
Experiment 
 
66.79±0.069 
67.4±0.03 
67.17±0.061 
65141,62140 
67.4,31 72.535 
 
1327.41±0.38 
1328.9±0.11 
1326.35±0.11 
1333.8141 
130335 
 
314±39 
392±87 
1317±359 
- 
254,167 265,165 300168 
 
37.6±0.14 
37.6 
38 
38.4,141 40140 
35.3169, 36.7,31, 167 
36.9,35 37.1170 
POPC 
72 
288 
2x288 
GAFF 
Experiment 
 
63.74±0.22 
63.91±0.059 
64±0.058 
50.5139 
64.3,171 68.3163 
 
1277.31±0.16 
1279.97±0.15 
1276.91±0.29 
- 
  1256163 
 
391±81 
259±276 
1147±23 
- 
180-330172 
 
37.6 
37.6±0.71 
37.5±0.5 
- 
37163 
POPE 
72 
288 
2x288 
Experiment 
 
55.64±0.19 
55.33±0.11 
56.15±0.19 
56.6,173 59-60174 
 
1185.21±0.68 
1175.3±0.25 
1185.58±0.03 
  1180174 
 
484±34 
282±116 
847±244 
 
233173 
 
43.4±0.28 
43.6±0.41 
43 
39.5174 
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Area per lipid 
The area per lipid for each system was calculated using the dimensions of the simulation box 
according to: 
  =
       
      
 3.3 
where Lx is the x-dimension of the simulation box, Ly is the y-dimension of the simulation box and 
nlipid is the number of lipids in the system. 
 
It is seen that although agreement with experiment is not perfect for AL values, GAFFlipid results are 
much improved over available GAFF results and indicate that all bilayers are in the correct liquid 
crystalline phase. Little variation in AL results is observed between the different system sizes (see also 
Figure 3.3). Furthermore, there remains some uncertainty in evaluating experimental AL values, as 
such the area per lipid should be but one metric for bilayer simulations to compare with 
experiment.175 
 
Figure 3.3 - Time evolution of the area per lipid for each lipid type and system size (72 bilayers black, 
288 bilayers red, 2x288 bilayer stacks blue). Experimental values shown as a dotted line. 
Experimental AL values as listed in Table 3.3. Reproduced by permission of The Royal Society of 
Chemistry.155 
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Volume per lipid 
Likewise the volume per lipid was also calculated using the dimensions of the simulation box 
according to: 
   
         
      
 3.4 
where Vbox is the volume of the simulation box, nW is the number of waters and VW is the volume of 
each water molecule, which was previously determined to be 30.53 Å3 for TIP3P water molecules.141 
It should be noted that this is slightly higher than the volume of water determined via bilayer X-ray 
scattering (30 Å3),176 consequently experimentalists have suggested testing other water models 
which may be better suited to lipid simulation. The VL values are also reported in Table 3.3. 
Experimentally, the lipid volume shows lower fluctuation than AL and as such is better defined, 
providing a better quality experimental structural parameter with which to validate simulation 
results.35,143, 177 Although in most cases slightly overestimated, the GAFFlipid force field finds a high 
level of agreement with experiment for VL values, in all instances achieving a VL value within 2% of 
experiment. 
Isothermal area compressibility modulus 
The isothermal area compressibility modulus, KA, was then calculated from the fluctuation in the 
area per lipid via: 
   
        
        
  3.5 
where kB is Boltzmann’s constant, T is the temperature, <AL> is the mean area per lipid and σA
2 is the 
variance in the area per lipid. KA results for the 72 lipid systems fall closest to experiment, though 
experimental values do not always fall within the error range of the simulation values. In general 
values are seen to increase with system size, in particular results for the 2x288 bilayer stacks are seen 
to be particularly large due to the lower variance in the area per lipid. When validating the GROMOS 
G53A6L lipid force field, Poger et al. also found calculated KA values to be sensitive both to system 
size and sampling time.175 The unusually large KA values for the double bilayer stacks may be due to 
the fact that equation 3.5 is normally applied to simulations of a single bilayer within a periodic box. 
It is also noted that in the current work the Berendsen barostat was implemented for pressure 
regulation which is in fact the only available option in AMBER, however other pressure regulation 
algorithms such as the Nosé-Hoover178-179 or Langevin180 piston may yield different isothermal 
compressibility results, given that the Berendsen barostat has been found unsuitable for simulations 
in which volume fluctuations are important.149 
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3.1.3.2 Electron density profiles 
 
The electron density profiles (EDP) were calculated by assuming an electron charge equal to the 
atomic number minus the partial charge of that atom, located at the centre of each atom. The total 
EDPs for the 72 lipid bilayers of the six lipid types are shown in Figure 3.4, along with the 
decomposition into contributions from the following groups: water, choline (CHOL), phosphate (PO4), 
glycerol (GLY), carbonyl (COO), methylene (CH2), unsaturated CH=CH and terminal methyls (CH3).  
From Figure 3.4 it can be seen that for each lipid type, water penetrates up to the carbonyl groups 
whereas the terminal methyl groups remain dehydrated, in agreement with experimental findings.32, 
163, 181 
 
Figure 3.4 - The total and decomposed electron density profiles of the 72 lipid bilayer systems for 
each lipid type averaged over 250ns. Contributions are shown from water, choline (CHOL), phosphate 
(PO4), glycerol (GLY), carbonyl (COO), methylene (CH2), unsaturated CH=CH and terminal methyl 
(CH3) groups. Reproduced by permission of The Royal Society of Chemistry.
155 
From the electron density profiles, the thickness of the lipid bilayer (DHH) was computed using the 
peak-to-peak distance. These values are reported in Table 3.3. As with the AL and VL values, high 
agreement with experiment is observed for the calculated DHH values for each lipid type. GAFFlipid 
finds DHH values within 5% of experiment with the exception of the POPE model, which is within 10%.  
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However the best comparison with experiment for bilayer simulations is the scattering form factors, 
which may be computed from electron density profiles. Experimental scattering data requires no 
intermediate modelling, thus allowing a direct comparison with experimental raw data. The total 
EDPs for each 72 lipid bilayer system were converted into X-ray and neutron scattering form factors 
using the SIMtoEXP software developed by Kučerka et al.182  Resulting GAFFlipid X-ray scattering 
results are shown in Figure 3.5 which in most cases compare well with the experimental data, 
however profiles for DMPC, DPPC and POPC are seen to diverge from experiment at low values of q. 
There is also some disagreement with experiment for the third lobe of the scattering profiles for 
DPPC and DOPC. These results indicate that the structure of the simulated lipid bilayers do not quite 
replicate experimental findings. 
 
Figure 3.5 - X-ray form factors of the 72 lipid bilayer systems for each lipid type averaged over 250ns 
(solid black line). Comparison to experiment shown ( ) for DLPC,32,171 DMPC,32,171 DPPC,31,171 DOPC167 
and POPC.163,171 Reproduced by permission of The Royal Society of Chemistry.155 
 
3.1.3.3 Order parameters 
 
The order parameter SCD measures the relative orientation of the C-D bonds with respect to the 
bilayer normal and may be calculated according to equation 1.1 (see also Figure 1.9). 
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Figure 3.6 - Order parameters for the 72 systems averaged over 250ns (  sn-1,   sn-2) and 288 
systems averaged over 100ns (  sn-1,  sn-2) for each lipid type. Comparison to experiment shown 
(  sn-1,   and  sn-2) for DLPC,183-184 DMPC,183-184 DPPC,183-184 DOPC,185 POPC185-186 and POPE.187-188 
Reproduced by permission of The Royal Society of Chemistry.155 
The calculated NMR order parameters are in general seen to agree well with experimental results 
(Figure 3.6), displaying a similar profile with the distinctive drop in SCD at carbon-9 and -10 for the 
unsaturated chains of DOPC, POPC and POPE. It should be noted however that the profiles for the 
saturated lipids DLPC, DMPC and DPPC are a little high, indicating that these bilayers are slightly too 
ordered. The POPE sn-1 chain order profile is higher than experiment, suggesting this chain is 
artificially ordered as is reflected in the disagreement with experiment for POPE simulation AL and 
DHH values. 
 
3.1.3.4 Spontaneous bilayer assembly 
 
As a further test of the lipid parameters, the spontaneous assembly of a random DOPC/water 
mixture into a lamellar bilayer was simulated. To obtain a randomised lipid/water starting structure, 
a 72 DOPC bilayer at experimental hydration was simulated in the NVT ensemble at 1000K for 1 ns. 
This caused the bilayer to collapse and mix completely with the water molecules. Following this, the 
mixture was simulated using the same protocol as the GAFFlipid equilibration runs (heated from 0 to 
303 K with restraints in NVT, before moving into NPT for 250 ns). 
72 
 
 
Figure 3.7 – The self-assembly of a DOPC bilayer using GAFFlipid parameters. Reproduced by 
permission of The Royal Society of Chemistry.155 
The mixture was rapidly seen to form a bilayer-like structure, containing a water pore. The pore then 
slowly collapsed leaving a stable bilayer after approximately 50 ns of simulation time (see Figure 3.7). 
Analysis of the resulting structure revealed an area per lipid, volume per lipid and NMR order 
parameters in good agreement with results obtained from the GAFFlipid validation study. The 
assembly process observed is in accordance with united-atom results obtained my Marrink et al.,189 
who simulated a random DPPC/water mixture which first clusters into a lipid aggregate, before 
transitioning to a bilayer structure containing a water pore; as with the GAFFlipid results, this water 
pore remains stable for tens of ns before disappearing, leaving a bilayer configuration. A thorough 
literature search revealed a number of united-atom and coarse-grained lipid bilayer self-assembly 
simulations, however at the time of writing a study concerning all-atom spontaneous bilayer 
assembly had not been reported. 
 
3.1.4 GAFFlipid discussion 
 
By modifying the GAFF alkane L-J and torsion parameters to better replicate the experimental heat of 
vapourisation and density for pentadecane, resulting lipid bilayer simulations are seen to find better 
comparison with experiment for a range of observables, including the area per lipid, volume per 
lipid, isothermal area compressibility modulus, bilayer thickness, NMR order parameters and 
scattering form factors. The parameters yield results that in general do not show sensitivity to 
increasing system size (from 72 to 288 lipids) and complexity (single bilayer to stacked configuration) 
and remained stable for the simulation lengths tested (50 – 250 ns). Results are not perfect, 
suggesting further refinements are possible: for example, area per lipid values are in general slightly 
low, with resulting order parameters for the saturated lipids DLPC, DMPC and DPPC being higher 
than experiment (indicating the bilayer is slightly too ordered). Furthermore a number of the X-ray 
scattering profiles show unusual behaviour at low q values, in disagreement with experiment, 
indicating the bilayer structure does not compare perfectly with experiment. However GAFFlipid 
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results are substantially better than simulating bilayers with the standard GAFF parameters and the 
better agreement with experiment afforded by GAFFlipid indicates that bilayers are remaining in the 
correct liquid crystalline phase. 
 
All systems were seen to remain stable for simulation times of up to a quarter of a microsecond. As 
has been found in a previous study using two different simulation packages,152 increasing the system 
size in either the xy- or z-direction causes little variation in the observed structural properties. Given 
that there is little variation in the observed properties between a more experimentally realistic 2x288 
bilayer system and a 72 bilayer simulated using GAFFlipid, finite-size effects do not affect the quality 
of the results and as such simulations using smaller bilayer patches remain valid for test purposes, 
provided the simulations are of an adequate duration. Furthermore, the observation that a 
simulation of a random DOPC/water mixture spontaneously assembles into a stable bilayer structure 
at 303K in approximately 50 ns acts as further validation of the GAFFlipid parameters. 
 
It was hoped that with the development of the GAFFlipid parameters, a stable DOPC bilayer model 
remaining in the correct liquid crystalline phase and displaying structural properties in good 
comparison with experiment may then be used for the study of PET tracer-membrane interactions. 
 
3.2 Merging GAFFlipid and Lipid11 force fields 
 
3.2.1 The Lipid11 framework 
 
In parallel with the GAFFlipid work, the Walker MD lab at University California San Diego developed 
the AMBER Lipid11 framework, in collaboration with researchers at the University of Bergen, 
Norway.190 Lipids are split into ‘residues’, with for example the phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE) head groups, and the palmitoyl (PA) and oleoyl (OL) lipid tail groups 
existing as separate residues with resulting combinations allowing the modelling of numerous 
different lipid types.  
74 
 
 
Figure 3.8 - Lipid11 is a modular lipid force field. Reprinted with permission from The Journal of 
Physical Chemistry B.190 Copyright 2012 American Chemical Society. 
This is achieved via the calculation of partial charges with a capping procedure such that the overall 
charge on each individual head group or tail group sums to zero: 
 
 
Figure 3.9 - Structure and charges of Lipid11 head group and tail group caps. Adapted with 
permission from The Journal of Physical Chemistry B.190 Copyright 2012 American Chemical Society. 
Lipid tails are capped with an ester moiety during the RESP charge calculation whereas head groups 
are capped with a methyl (one in place of each lipid tail) during the charge calculation. 
However all bond, angle, torsion and vdWs parameters were taken directly from the GAFF and 
GLYCAM force fields, meaning that in order to achieve bilayer properties with good comparison to 
experiment the application of a surface tension was required (see Figure 3.10). 
Tail cap Head cap 
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Figure 3.10 - Area per lipid versus simulation time for three lipid types simulated with Lipid11 using 
different values for the surface tension and comparison to experiment. Reprinted with permission 
from The Journal of Physical Chemistry B.190 Copyright 2012 American Chemical Society. 
It was thus decided to merge the Lipid11 parameters with GAFFlipid, by using the GAFFlipid 
hydrocarbon torsion and vdWs parameters to create the updated AMBER lipid force field with the 
following attributes: 
 No surface tension term required for bilayer simulation 
o Use of a surface tension is not strictly scientifically valid as the surface tension of a 
flat bilayer is thought to be identically zero.138 
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o Although identification of the appropriate surface tension for a single component 
lipid bilayer is relatively straightforward by tuning γ until an experimental area per 
lipid value is achieved, problems arise when the membrane contains a mixture of 
lipid types, or when other components such as membrane proteins are present in 
the bilayer. 
 Modular 
o Different combinations of head and tail groups allows the simulation of a broad 
range of lipid types. 
o New lipid types may be introduced into the force field in a methodological manner. 
 Combination with other AMBER force fields 
o By applying the conventional AMBER RESP charge protocol a force field may be 
produced that can be combined with other AMBER protein and small molecule force 
fields. 
 Ease of bilayer set up 
o The Lipid11 framework may be directly combined with the CHARMM membrane 
builder GUI to construct single component or mixed bilayers which may then be 
directly imported into AMBER. Furthermore the GUI may also create bilayers 
containing a membrane protein. 
 
3.2.2 Initial runs with merged Lipid11/GAFFlipid parameters 
 
Bilayers of each of the six lipid systems used for the GAFFlipid work were set up, using the Lipid11 
atom types, charges and parameters, with the addition that the lipid tails were modelled with the 
modified GAFFlipid L-J and torsion parameters. The bilayers consisted of 128 lipids and were run with 
an identical procedure to the GAFFlipid validation runs. 
 
3.2.3 A bug in the code? 
 
Initial Lipid11/GAFFlipid validation runs seemed promising, giving similar bilayer properties as found 
during the GAFFlipid work. However it was noticed that restarting a bilayer run would cause a drop in 
both the area per lipid of a bilayer and the system energy, driving the bilayer into the gel phase (see 
Figure 3.11). 
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Figure 3.11 - The discontinuity in the area per lipid and system energy after restarting an MD bilayer 
run, which quickly causes the liquid phase DPPC bilayer to transition to the gel phase. 
This behaviour was found to be localised to the GPU code and not the CPU version of the AMBER 
code, as subsequent CPU runs gave area per lipid and potential energy values similar to a GPU run 
after a restart. Such sudden changes in bilayer runs had not been observed during the GAFFlipid 
work for the simple reason that all simulations were performed on GPU and no bilayer runs required 
restarting during the course of a production run. 
 
It was determined that a bug existed in the GPU code, since this behaviour was not observed when 
performing identical bilayer runs using the CPU AMBER code. Consequently bilayer simulation results 
using both GAFFlipid and the merged Lipid11/GAFFlipid parameters were not found to correctly 
model bilayers in the liquid phase – in reality bilayers, particularly those consisting of saturated lipids, 
become too ordered with area per lipid values lower than experiment. The previous agreement with 
experiment found for GAFFlipid results was thus fortuitous and a result of the GPU bug, which 
caused the system to maintain a higher potential energy than is realistic for the system. 
 
MD run restarted 
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3.2.4 Identification of AMBER GPU bug 
 
Hence the lipid parameters required further work in order to allow the proper simulation of 
membranes in the liquid phase, however in order to achieve this at a high throughput the bug in the 
GPU code had to first be identified. 
 
Two of the main authors of the AMBER GPU implementation, Scott Le Grande and Ross Walker,130-132 
were able to look through the code, finding that it was an issue related to the rapid collapse of the 
periodic box as occurs during the equilibration of a bilayer. When the size of the periodic cell changes 
the PME grid was not getting recalculated, causing higher energies than is the real case for the size of 
the periodic box. This issue is not as prevalent in the CPU code due to a difference in the way the 
PME grid is set up. The AMBER GPU code has to date predominantly been used for the simulation of 
proteins, these systems typically start close to equilibrium and will not exhibit such rapid changes in 
simulation cell size. 
 
The GPU code was thus updated and a patch released by Ross Walker. In hindsight, results from the 
GAFFlipid work should have been checked using simulations on CPUs. Despite the computational 
expense of these runs, even a relatively short bilayer simulation would have exhibited the differing 
behaviour between the uncorrected GPU results and CPU. Indeed, the GPU code comes with the 
caveat that it is experimental, having only been officially released in 2012.130-131 However bilayers are 
unusual systems for typical MD simulation, particularly when using code designed for proteins, given 
that they often start far from equilibrium, meaning the simulation cell contracts rapidly during the 
first 5-10 ns of simulation time. Indeed it is unlikely this bug would have been identified were it not 
for the present work. 
 
With the release of the fix for the GPU code, attention could turn back to improving the AMBER lipid 
parameters. It was decided to focus on partial charges, alkane parameters and the parameters 
representing the glycerol linkage and head group region, due to the success of the CHARMM and 
Slipids all-atom lipid force fields, which concentrated on such updates.122, 124 
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3.3 Updating Lipid11 parameters 
 
3.3.1 Parameter development strategy 
 
A similar parameterisation strategy was followed as in the GAFFlipid work, however with more 
emphasis on the CH2-CH2-CH2-CH2 torsion parameter. Transition of bilayers from the liquid to the gel 
phase is associated with a higher population of trans than gauche dihedrals along the lipid tail 
groups. Thus if the torsion is not optimal the ratio of trans/gauche may not be correct and this is 
likely the reason for the low area per lipid values experienced in previous AMBER lipid simulations. 
To perform a more thorough parameterisation of hydrocarbon parameters a method similar to that 
used by Davis et al. was followed.191 A number of torsion scans were performed on hexane and 
octane carbon chains, with the selection of chains used for the scans including local minima 
conformations of these chains. Furthermore, a better fit to QM may be achieved by increasing the 
periodicity of the torsion parameter, as GAFFlipid only used an n=1 to n=3 periodicity torsion as is 
present in GAFF. 
Torsion Fitting 
The hexane and octane QM cans were performed using a higher level of theory (CCSD(T)/pVQZ) via 
application of the Hybrid Method for Interaction Energies (HM-IE).192 
                  
                                                           
                                                   
               
where the small basis set (SBS) was cc-pVDZ and the large basis set (LBS) was cc-pVQZ. Consequently 
molecules were optimized at the MP2/cc-pVDZ level and single-point energy calculations then 
performed at the CCSD(T)/cc-pVDZ and MP2/cc-pVQZ levels. Torsion scans were again performed at 
15° intervals. 
 
On completion of the quantum chemical calculations, the CH2-CH2-CH2-CH2 alkane torsion was fitted 
using Paramfit. A multiple molecule weighted fit was performed using the genetic algorithm, 
meaning torsion scans on both hexane and octane were used as input to the program. The tgt local 
minima of hexane and tgttt local minima of octane were given a weighting of 10, the tgg, tgg-, gtg 
and gtg- local minima of hexane and the tggtt, tgg-tt, tgtgt and tgtg-t local minima of octane were 
given a weighting of 4 and cis conformers given a weighting of 0.1. These weighting values have 
previously given good results for alkane torsion fitting.191 
3.6 
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Paramfit seeks to minimise the AMBER sum of squares term (see equation 3.2). After each fit, the 
sum of squares value is reported, with a low value indicating good agreement with the QM input 
data. The original GAFF torsion parameters return a sum of squares value of over 100. Each iterative 
torsion fit returned lower and lower sum of squares values, until a minimum was reached at a value 
of about 30. Torsion fits were then tested for their ability to achieve the experimental trans/gauche 
fraction (35%),193 as this property was identified as the most important characteristic to prevent lipid 
bilayers from incorrectly transitioning to the gel phase. It was found that a torsion fit that did not 
perfectly reproduce the QM energy profile (with a sum of squares value close to 70) was actually 
best at reproducing the experimental trans/gauche fraction, with better QM fits returning too low a 
gauche fraction. The final torsion fit was thus selected on its ability to reproduce the experimental 
trans/gauche fraction; this process was similar to work by Murzyn et al. who recently developed new 
OPLS parameters for pentadecane, choosing a torsion fit that correctly reproduced the experimental 
melting point of pentadecane, with no QM input to the torsion fitting.194 
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Table 3.4 - Convergence of the CH2-CH2-CH2-CH2 torsion fitting with Paramfit and trans/gauche 
fraction of a box of 144 pentadecane chains run for 10 ns with resulting parameters. 
Fit # Sum Squares 
AMBER 
Standard 
Torsion % Gauche 
GAFF 100.59 c3-c3-c3-c3   1          0.20        180.0             1.                 3.58 
  c3-c3-c3-c3   1          0.25        180.0             2.          
  c3-c3-c3-c3   1          0.18            0.0              3.  
1 74.00 c3-c3-c3-c3   1          0.3112      180.0           1. 35.00 
  c3-c3-c3-c3   1         -0.1233      180.0           2.  
  c3-c3-c3-c3   1          0.1149        0.0              3.  
  c3-c3-c3-c3   1         -0.2199        0.0              4.  
  c3-c3-c3-c3   1          0.2170        0.0              5.  
2 43.93 c3-c3-c3-c3    1         0.1932       180.0           1. 31.00 
  c3-c3-c3-c3    1        -0.0571       180.0          2.  
  c3-c3-c3-c3    1         0.0833         0.0             3.  
  c3-c3-c3-c3    1        -0.0978         0.0             4.  
  c3-c3-c3-c3    1         0.1502         0.0             5.  
3 32.71 c3-c3-c3-c3    1         0.1126       180.0           1. 29.00 
  c3-c3-c3-c3    1        -0.0178       180.0          2.  
  c3-c3-c3-c3    1         0.0557         0.0             3.  
  c3-c3-c3-c3    1        -0.0114         0.0             4.  
  c3-c3-c3-c3    1         0.1071         0.0             5.  
4 29.99 c3-c3-c3-c3    1         0.0796       180.0          1. 28.00 
  c3-c3-c3-c3    1         0.0090       180.0          2.  
  c3-c3-c3-c3    1         0.0461         0.0             3.  
  c3-c3-c3-c3    1         0.0244         0.0             4.  
  c3-c3-c3-c3    1         0.0776         0.0             5.  
5 28.98 c3-c3-c3-c3    1         0.0481       180.0           1. 26.8 
  c3-c3-c3-c3    1         0.0436       180.0           2.  
  c3-c3-c3-c3    1         0.0313         0.0             3.  
  c3-c3-c3-c3    1         0.0590         0.0             4.  
  c3-c3-c3-c3    1         0.0448         0.0             5.  
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Figure 3.12 - The energy profile for rotating about the  CH2-CH2-CH2-CH2 torsion of an octane 
molecule. Energy evaluated using QM and the HM-IE method (filled triangle ), AMBER with 
standard GAFF parameters (dotted line), AMBER with updated Lipid11 parameters (dashed line) and 
AMBER with the best torsion fit achieved using Paramfit (dot-dash line). 
Whilst the torsion fitting was underway, the Lennard-Jones parameters were scaled from their GAFF 
values until agreement was found with experiment for the heat of vapourisation and density of a 
range of alkane chains. In contrast to the GAFFlipid work, parameters for the alkane carbon atom 
were kept the same as GAFF and only the hydrogen Lennard-Jones parameters were modified. 
  
83 
 
Table 3.5 - Modification of L-J and torsion parameters of alkane chains. 
 L-J parameters CH2-CH2-CH2-CH2 Torsion ∆Hvap 
(kJ mol-1) 
ρ (kg m-3) 
  Radius 
R (Å) 
Well-
depth ε 
(kcal/mol) 
Force 
constant PK 
(kcal/mol) 
Periodicity 
PN 
Phase 
(deg) 
  
Lipid11 cA 1.9080 0.1094 0.20 1 180   
 hA 1.4870 0.0157 0.25 2 180 105.88155 842.0155 
    0.18 3 0   
Updated cD 1.9080 0.1094 0.3112 1 180 74.99±0.39 
 
770.67±0.25 
 
 hL 1.4600 0.0100 -0.1233 2 180   
    0.1149 3 0   
    -0.2199 4 0   
    0.2170 5 0   
Experiment  76.77195 768.5195 
 
Lipid bilayer simulations conducted for 100 ns using the updated Lipid11 parameters were found to 
satisfactorily match experimental data using the corrected GPU code, with no artificial transition to 
the gel phase – see area per lipid values in Table 3.6. Further simulations on CPU replicated 
membrane structural properties from GPU simulations. 
Table 3.6 - Area per lipid values of lipid bilayers simulated for 100ns using updated Lipid11 
parameters. 
 DLPC DMPC DPPC DOPC POPC POPE 
Area per lipid 
simulation (Å2) 
63.0±0.2 
 
59.7±0.7 
 
62.0±0.3 
 
69.0±0.3 
 
65.6±0.5 
 
55.5±0.2 
 
Area per lipid 
experiment (Å2) 
63.2,3260.81
71 
60.6,3259.91
71 
63.1,17164.3
181 
67.4,31 
72.535 
64.3,171 
68.3196 
56.6,173 59-
60174 
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3.3.2 Underlying hydrocarbon parameters 
 
The use of a torsion fit that reproduces the experimental trans/gauche fraction of alkanes, although 
allowing improved lipid simulations, does not in reality provide a proper description of alkane chains. 
As can be seen from Figure 3.12, the QM energy profile for rotating about the central torsion of an 
octane chain is not correctly reproduced using updated parameters. An investigation into how to 
correct for this behaviour concluded that the underlying GAFF hydrocarbon parameters on which 
AMBER lipid parameters are based require further work. Comparison of hydrocarbon parameters 
with other all-atom force fields, such as CHARMM or OPLS (both of which have been optimised for 
hydrocarbons) revealed a number of differences in bond and angle parameters. In particular the 
CH2-CH2-CH2 angle parameter was found to have a large influence on the trans/gauche fraction. 
Hence to correctly model lipids in AMBER, a great deal of attention must be paid to hydrocarbon 
vdWs, bond, angle and torsion parameters. Hydrocarbon parameters which are able to reproduce 
correctly a range of experimental observables, including the trans/gauche fraction, in combination 
with a torsion that reproduces a quantum mechanical energy profile, make a better foundation for 
AMBER lipid simulation. 
Table 3.7 - Hydrocarbon parameters from a selection of all-atom force fields. 
Bonds C-C C-H  
 R(eq) kbond R(eq) kbond  
AMBER Parm9482 1.526 310 1.09 340 
AMBER GAFF133 1.535 303.1 1.092 337.3 
CHARMM C36*122 1.53 222.5 1.111 309 
OPLS197 1.529 268 1.09 340 
Angles C-C-C C-C-H H-C-H 
 θ(eq) kangle θ(eq) kangle θ(eq) kangle 
AMBER Parm94 109.5 40 109.5 50 109.5 35 
AMBER GAFF 110.63 63.21 110.05 46.37 108.35 39.43 
CHARMM C36* 113.6 58.35 110.1 26.5 109 35.5 
OPLS 112.7 58.35 110.7 37.5 107.8 33 
VDW C H  
 Radius R Well-depth ε Radius R Well-depth ε  
AMBER Parm94 1.908 0.1094 1.487 0.0157 
AMBER GAFF 1.908 0.1094 1.487 0.0157 
CHARMM C36* 2.01 0.056 1.34 0.028 
OPLS 1.9643 0.066 1.4031 0.03 
* CHARMM parameters also have additional Urey-Bradley and special 1-4 interaction terms. 
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3.4 Final Lipid14 parameters 
 
The correct simulation of all-atom lipid bilayers is known to be intimately dependent on appropriate 
hydrocarbon parameters. Although the derivation of previous all-atom lipid force fields, such as 
Berger lipid parameters and Slipids,124, 154 only required updating the CH2-CH2-CH2-CH2 torsion 
parameter, in this case this modification was not enough. Adapting GAFF with a better 
CH2-CH2-CH2-CH2 torsion fit did not allow proper simulation of lipid bilayers – membranes 
transitioned to the gel phase (GAFFlipid section 3.1), although this behaviour was initially hidden due 
to a bug in the GPU simulation code. Further attempts to identify a torsion fit that may allow better 
lipid simulation revealed that in fact a fit which do not fully reproduce the QM energy profile did 
allow improved lipid simulations, due to the reproduction of the correct trans/gauche ratio of long 
hydrocarbon chains (section 3.3). However this is not a suitable basis on which to build a force field; 
the energy of the molecule does not suitably match quantum mechanically derived data. These 
results indicate that other parameters require investigation, in particular the most striking 
differences between the GAFF and CHARMM or OPLS covalent parameters in Table 3.7 is the 
description of CH2-CH2-CH2 angle bending. Given that CHARMM has been optimised for linear 
hydrocarbons, it is likely that these parameters are superior to GAFF for modelling hydrocarbons. 
However a single angle parameter cannot merely be inserted into the parameter set, as this will 
affect the performance of the remaining parameters to describe a hydrocarbon chain. Rather a full 
study must be performed on all bond, angle and torsion parameters describing hydrocarbons. 
 
3.4.1 Revised Lipid14 hydrocarbon parameters 
 
3.4.1.1 Fitting parameters to quantum mechanical data 
 
To this end, a number of QM bond, angle and dihedral scans were performed on the small 
hydrocarbons ethane, 1-butene and pentane. All scans for methyl and methylene parameters were 
performed on ethane, with the exception of the CH2-CH2-CH2 angle scan which was performed on 
pentane. Using quantum mechanically optimised structures, the CH2-CH2-CH2 angle is found to be 
approximately 112° in propane, yet increases to approximately 113.5° in pentane.126 As this force 
field is intended for the modelling of long hydrocarbons, pentane was used for the CH2-CH2-CH2 angle 
scan. All scans concerning double bonded carbon atoms were performed on 1-butene. Each of these 
hydrocarbons are represented by a combination of four atom types in GAFF, as detailed in Figure 
3.13. 
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Figure 3.13 - The hydrocarbons ethane and 1-butene and General Amber Force Field atom types. 
Each bond, angle and torsion scan was performed at an estimation of the CCSD(T)/cc-pVQZ level 
using the HM-IE method (see section 3.3); AMBER parameters were then fitted to reproduced the 
QM energy profile using Paramfit and the genetic algorithm (see section 3.3.1). Resulting parameter 
fits are shown in Figure 3.14.
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Bonds 
The c2-c3 bond did not improve with fitting and was left as its GAFF value. 
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Angles 
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The ha-c2-c2 and ha-c2-c3 angles did not improve with fitting and were left at their GAFF values.
 
90 
 
The hc-c3-c2 and ha-c2-ha angles did not improve with fitting and were left at their GAFF values. 
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Dihedrals 
 
Figure 3.14 – Fitting of AMBER alkane bond, angle and dihedrals parameters to quantum mechanical 
energy profiles. In all plots, the quantum mechanical profile is shown as filled triangles ( ), the 
GAFF profile as a dotted line and the Lipid14 fit generated with Paramfit as a solid black line. In 
instances where fitting did not improve the MD profile, the GAFF scan only is shown. 
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For the most part, GAFF is seen to be able to reproduce the position of the minima in the QM bond, 
angle and dihedral scans, but does not always perform well at positions of deformation. This is in 
part due to the functions used by the covalent parameters: the parabolic function for bond 
stretching and angle bending is a simplification. However, the use of the Paramfit tool does allow 
parameters to be identified that not only locate the potential minima but also show a better match 
to the QM away from the minima. In particular, the CH2-CH2-CH2 angle bending term is better 
reproduced, as shown in Figure 3.14 and Figure 3.15. Not all hydrocarbon parameters were modified, 
many angle bending parameters involving hydrogen atoms were found to be suitable and were 
therefore left untouched. 
 
Figure 3.15 - Close-up view of the CH2-CH2-CH2 parameter fitting to QM data. 
During the hydrocarbon fitting, bond and angle force constants were in general reduced from their 
GAFF values in order to provide a better description of deformation, making the force field ‘softer’. 
Given that GAFF was parameterised to reproduce vibrational frequencies,133 this will be detrimental 
to the performance of the resulting force field to describe vibrational frequencies and infrared 
spectra. By comparing the normal mode frequencies of ethane and propane determined 
experimentally and using high level QM methods with those calculated using AMBER with GAFF and 
the current fitted hydrocarbon parameters, in general this is seen to be the case (Table 3.8). However 
the change is not catastrophic: GAFF matches experiment with RMS error 9.59% and QM with RMS 
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error 9.45% for the ethane vibrational frequencies in Table 3.8; this rises to 14.22% and 11.89% using 
the current fitted hydrocarbon parameters. For the propane vibrational frequencies, GAFF matches 
experiment with RMS error 6.12% and QM with RMS error 5.50%; this changes to 7.01% and 5.12% 
using the current fitted hydrocarbon parameters. Also, a proper description of spectroscopic 
properties requires a QM treatment of vibrational motion, which cannot be achieved using a classical 
MD method. 
 
Table 3.8 - Vibrational frequencies of ethane and propane from experiment, high-level QM and using 
AMBER with GAFF and current fitted hydrocarbon parameters. 
Molecule Vibrational mode Experimental 
frequency* 
(cm-1) 
Ab initio 
frequency† 
(cm-1) 
GAFF 
frequency 
(cm-1) 
Lipid14 
frequency 
(cm-1) 
Ethane CH3-CH3 torsion 283 330 306.607 306.456 
 CH3 asym rocking 822 832.88 915.054 798.163 
 CH3 asym rocking 822 832.88 915.612 798.163 
 C-C stretch 995 1032.33 915.612 814.865 
Propane CH3-CH2 torsion 217 223.01 229.425 225.406 
 CH3-CH2 torsion 265 288.65 270.198 256.956 
 C-C-C bend 379 369.7 409.094 348.299 
 CH2 rock + CH3 def 748 761.85 813.246 709.489 
 CH3 rock + sym C-C 
str/str 
868 900.76 843.74 741.847 
*Experimental values and assignment from Cornell et al.82 
†Ethane and propane were geometry optimised and vibrational frequencies calculated using QM at 
the MP2/6-311+G(d,p) level. 
 
3.4.2 Testing revised hydrocarbon parameters 
 
A thorough analysis of the new alkane parameters was then undertaken by calculating the heat of 
vapourisation, density, diffusion, 13C NMR T1 relaxation time and rotamer population for a selection 
of alkane chains of varying length: pentane, hexane, heptane, octane, decane, tridecane and 
pentadecane. The alkene parameters were also tested by calculating the heat of vapourisation and 
density of cis-2-hexene, cis-5-decene and cis-7-pentadecene. 
 
3.4.2.1 Density and heat of vapourisation 
 
The heat of vapourisation was calculated in an identical manner to the previous GAFFlipid work, with 
the only difference being that gas and liquid phase simulations were performed for 60 ns each, with 
the final 50 ns being used for block average sampling, using five blocks of 10 ns each. The density 
was calculated from the liquid phase simulations from the average volume of the simulation box. 
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These properties were calculated for the full range of saturated and unsaturated hydrocarbon chains 
under study. The liquid phase simulations used a box of 288 (pentane, hexane, cis-2-hexene and 
heptane) or 144 (octane, decane, cis-5-decene, tridecane, pentadecane and cis-7-pentadecene) 
molecules. Charges were first calculated using the RESP procedure by optimising a single chain at 
HF/3-21G*, B3LYP/3-21G* then HF/6-31G* levels in the gas phase, with the MEP then calculated at 
the HF/6-31G* level and the two-stage RESP procedure used to generate partial charges. A liquid 
simulation was performed for each alkane chain in NPT for 10 ns. At the end of this run fifty chains 
were extracted and charges determined using the usual RESP procedure with no QM optimisation 
being performed. Final charges were taken as an average over all fifty chains. 
 
Charge calculation of the alkane chains thus followed a similar methodology as that used by 
Slipids.124 Although a single RESP fit often resulted in hydrogen atoms with a negative charge, which 
is physically unrealistic, conformational averaging resulted in all hydrogens retaining a positive partial 
charge. It should however be noted that the correct modelling of the MEP along an alkane chain 
remains controversial. In an interesting study by D.E. Williams, it was found that partial charges from 
a single RESP fit are often no better at modelling the MEP than simply completely neglecting charges 
(all atoms have zero charge).198 Williams found that models with additional charge sites, located 
between hydrogen atoms, on a line bisecting the CH2 group, were much better at modelling the MEP. 
It was also found that CH2 groups display charge alternation along the chain. 
 
3.4.2.2 Alkane trans/gauche population 
 
To further assess the alkane parameters, the ability to reproduce the experimental balance of 
trans/gauche carbon-carbon bonds for the range of alkane chains under study was determined. The 
trans, gauche, end gauche (gt-), double gauche (-gg-) and kinked gtg’+gtg (-gtg-) conformer 
populations were evaluated from the 50 ns NPT runs by classifying torsion angles as either gauche 
plus (g+) 0-120°, trans (t) 120-240° or gauche minus (g-) 240-360°. If the alkane parameters are able 
to correctly reproduce the experimental trans/gauche fraction then it is likely that lipid bilayer 
simulations will not be driven into the gel phase due to a unrealistically high population of trans 
carbon-carbon bonds. 
 
3.4.2.3 Calculation of alkane diffusion 
 
In addition to thermodynamic properties, dynamic properties such as the alkane diffusion were also 
calculated. How well this property is reproduced in comparison to experiment will impact on lipid 
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diffusion results during resulting lipid bilayer simulations. The uncorrected diffusion DPBC was 
calculated for each alkane using the slope of a mean-square displacement (MSD) plot versus time of 
the centres of mass averaged over the trajectories of each molecule via the Einstein relation: 
           
        
    
  3.7 
where nf is the number of dimensions (in this instance nf=3) and ∆r(t)
2 is the distance that the 
molecule travels in time t. It is then possible to correct for the system size dependence of a diffusion 
coefficient calculated under periodic boundaries (DPBC) to yield the corrected diffusion coefficient 
Dcorr by adding the correction term derived by Yeh and Hummer:
199 
           
    
      
  3.8 
where kB is Boltzmann’s constant, T is the temperature, ε=2.837297, η is the viscosity and L is the 
length of the simulation box. 
 
It has been shown that dynamic properties are affected by temperature coupling algorithm such as 
the Langevin barostat, diffusion is therefore best calculated in a constant energy ensemble.200 
Consequently the diffusion was calculated by extending the 50 ns NPT runs into the microcanonical 
(NVE) ensemble for a further 100 ns using PME and a 10 Å cut-off, at a temperature of 298.15 K. To 
avoid energy and temperature drift, it was found to be necessary to remove the centre of mass 
motion every 500 steps (nscm=500), make both the shake tolerance and Ewald direct sum tolerance 
more stringent and reduce the time step to 1 fs. Diffusion values were then calculated by taking the 
slope of the linear 2-5 ns region of the MSD versus time curve and the correction calculated using 
experimental viscosity values. Diffusion results are reported with standard deviations calculated by 
block averaging, dividing the 100 ns run into five 20 ns blocks.  
 
3.4.2.4 T1 relaxation time 
 
The 13C NMR T1 relaxation time is a dynamic property measuring the local chain dynamics and 
another metric by which to assess the quality of the alkane parameters. 13C NMR T1 relaxation times 
were calculated from NPT alkane simulations using the following formula for dipolar relaxation from 
the reorientation correlation functions of the CH vectors:201 
 
   
                                
 
 
 3.9 
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which assumes motional narrowing and an effective C-H bond length of 1.117 Å,202 with N the 
number of protons bonded to the carbon and   the CH vector. The alkane simulations for the four 
chain lengths for which T1 relaxation times were calculated were repeated using the same NPT 
protocol at the experimentally relevant temperature of 312K, with production runs being extended 
out to 200 ns to improve sampling. 
3.4.3 Hydrocarbon results 
 
Table 3.9 - Thermodynamic and dynamic properties of a selection of alkane chains simulated using 
Lipid14 parameters and comparison to experiment. 
 ∆Hvap 
(kJ/mol) 
ρ (kg/m3) DPBC (10
-5 cm2/s) Dcorr (10
-5 cm2/s) 
Pentane 
Lipid14 
Expt. 
 
23.09±0.05 
26.43195 
 
592.87±0.07 
626.2195 
 
6.21±0.21 
 
6.86±0.21 
5.45203 
Hexane 
Lipid14 
Expt.  
 
28.46±0.05 
31.56195 
 
636.68±0.07 
656,204 660.6195 
 
4.37±0.24 
 
4.85±0.24 
4.21203 
Heptane 
Lipid14 
Expt. 
 
33.62±0.11 
36.57195 
 
667.42±0.05 
679.5195 
 
3.35±0.11 
 
3.73±0.11 
3.12203 
Octane 
Lipid14 
Expt. 
 
38.84±0.04 
41.49195 
 
690.92±0.09 
698.6195 
 
1.87±0.08 
 
2.23±0.08 
2.354205 
Decane 
Lipid14 
Expt. 
 
48.99±0.11 
51.42195 
 
724.01±0.09 
726.6195 
 
1.36±0.07 
 
1.56±0.07 
1.39205 
Tridecane 
Lipid14 
Expt. 
 
64.16±0.1 
66.68195 
 
755.44±0.06 
756.4195 
 
0.65±0.03 
 
0.74±0.03 
0.712205 
Pentadecane 
Lipid14 
Expt. 
 
74.23±0.11 
76.77195 
 
769.38±0.11 
768.5195 
 
0.45±0.03 
 
0.51±0.03 
0.461205 
All values at 298.15 K. 
 
The density and heat of vapourisation for the range of alkane chains is found to be in satisfactory 
agreement with experiment, with values increasing with the length of the carbon chains, following 
the experiment trend. The simulation values match experiment with an RMS error of 7.65%. The 
simulated densities are reproduced somewhat better than ΔHvap, with an RMS error of 2.56% when 
compared to experiment. In particular, results are seen to converge with experimental values for the 
longer chains. Diffusion results are likewise similar to experiment, though not quite so well 
reproduced – the RMS error between simulation and experiment remains significant at 15.14%. 
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Again, values find better agreement with experiment for the longer chains. This may reflect the fact 
that AMBER using a single atom type for methyl and methylene carbon atoms. Failure to distinguish 
between terminal and in-chain carbons will have greater effect on shorter hydrocarbon chains. 
 
Table 3.10 - Thermodynamic properties of a selection of alkene chains simulated using Lipid14 
parameters and, where available, comparison to experiment.  
 ∆Hvap 
(kJ mol-1) 
ρ (kg m-3) 
cis-2-Hexene 
Lipid14 
Expt. 
 
26.37±0.04 
32.19195 
 
656.11±0.1 
683204 
cis-5-Decene 
Lipid14 
Expt. 
 
45.71±0.07 
42.9195 
 
740.33±0.1 
744.5195 
cis-7-Pentadecene 
Lipid14 
Expt. 
 
69.79±0.21 
 
 
781.58±0.04 
775204 
 
Results for the unsaturated hydrocarbon chains are further from experiment than the saturated 
chain results; this is due to the difficulty in tuning the hydrogen L-J parameters to achieve 
experimental heat of vapourisation results due to the high charge about the carbon-carbon double 
bond, an issue which has been experienced before.125, 206 Consequently there is an RMS error of 
13.60% for ∆Hvap when compared to experiment, the density values are again better reproduced with 
an RMS error of 2.23%. 
 
As well as achieving heat of vapourisation, density and diffusion values in good agreement with 
experiment, assessment of the conformational population of the carbon chains reveals that the 
population of trans and gauche carbon-carbon bonds falls very close to the experimental estimate of 
35% gauche. (i.e. trans/gauche ratio of 1.86) 
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Table 3.11 - Average number of trans, gauche, end gauche (eg), double gauche (gg) and gtg’+gtg 
conformers per alkane molecule and comparison to experiment. 
 trans gauche t/g ratio eg gg gtg’+gtg 
Pentane 
Lipid14 
 
1.24 
 
0.76 
 
1.63 
 
0.51 
 
- 
 
- 
Hexane 
Lipid14 
 
1.88 
 
1.12 
 
1.68 
 
0.55 
 
- 
 
- 
Heptane 
Lipid14 
 
2.54 
 
1.46 
 
1.74 
 
0.55 
 
0.1 
 
- 
Octane 
Lipid14 
 
3.21 
 
1.79 
 
1.80 
 
0.54 
 
0.17 
 
0.09 
Decane 
Lipid14 
 
4.54 
 
2.46 
 
1.84 
 
0.54 
 
0.34 
 
0.27 
Tridecane 
Lipid14 
Expt.193 
 
6.54 
6.5 
 
3.46 
3.5 
 
1.89 
1.86 
 
0.54 
0.68 
 
0.57 
0.64 
 
0.54 
0.77 
Pentadecane 
Lipid14 
 
7.9 
 
4.1 
 
1.92 
 
0.54 
 
0.72 
 
0.71 
 
Experimental chain conformation data, estimated by Fourier transform IR, exists for tridecane 
only;193 however these parameters reproduce these results extremely well, although there is a slight 
underestimation of the end gauche, double gauche and kink conformations. 
 
The final comparison with experiment for the alkane results comes with the calculation of the 13C 
NMR T1 relaxation times, which depends on the rotation of the C-H vector. As with the other 
properties calculated, reasonable agreement with experiment is found for the T1 relaxation time 
results. In almost all instances the experimental trend is reproduced, although values are consistently 
2-4 s higher than experiment. The tridencane and pentadecane result does not follow the 
experimental trend at the carbon 2 position - this may possibly reflect the fact that the Lipid14 force 
field (and likewise other AMBER force fields) use a single torsion parameter for CH3-CH2-CH2-CH2, 
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CH3-CH2-CH2-CH3 and CH2-CH2-CH2-CH2 torsions, in contrast to other all-atom force fields such as 
CHARMM or Slipids, which differentiate between these torsions. 
 
Figure 3.16 – Calculated 13C NMR T1 relaxation times for selected alkane chains and comparison to 
experiment.207 Values at 312K.  
 
3.4.4 Lipid14 head group parameters 
 
To investigate the parameters modelling the head group region, and in particular the glycerol linkage 
region at the top of the lipid tail groups, the model compound methyl acetate was used. The density 
and heat of vapourisation of this molecule was calculated using GAFF parameters and the result for 
Hvap found to be significantly higher than experiment. To correct for this the Lennard-Jones 
parameters for the carbonyl carbon, oxygen and ester oxygen were scaled until better agreement 
with experiment was found. 
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Table 3.12 - Thermodynamic properties of methyl acetate simulated using GAFF/Lipid11 and Lipid14 
and comparison to experiment. 
 L-J parameters ∆Hvap 
(kJ/mol) 
ρ (kg/m3) 
  Radius R 
(Å) 
Well-depth ε 
(kcal/mol) 
  
Lipid11 oC 1.6612 0.210 39.11±0.04 928.38±0.09 
 oS 
cC 
1.6837 
1.9080 
0.170 
0.086 
  
Lipid14 oC 1.6500 0.140 33.0±0.07 925.8±0.05 
 oS 
cC 
1.6500 
1.9080 
0.120 
0.070 
  
Experiment    32.29195 934.2195 
All values at 298.15K. 
Two torsions involving the glycerol linkage region were also scanned using the HM-IE method (the 
oC-cC-cD-cD and oC-cC-cD-cD torsions – see Figure 3.17 and Figure 3.18) and torsion parameters 
fitted using Paramfit.  
 
Figure 3.17 - A capped lauroyl tail group residue was used to fit the oS-cC-cD-cD and oC-cC-cD-cD 
torsions. 
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Figure 3.18 - The energy profile for rotating about selected torsions of a capped lauroyl residue. 
Energy evaluated using QM and the HM-IE method (filled triangle ), AMBER with standard GAFF 
parameters (dotted line) and AMBER with Lipid14 parameters (black line). 
 
3.4.5 Lipid14 partial charges 
 
Partial charges were calculated using the same capping procedure as Lipid11, however in line with 
previous all-atom force fields a greater number of head group and tail group conformations were 
used for the charge calculation. Twenty-five head group and fifty tail groups were extracted from 
bilayer simulations in order to obtain representative structures, with the MEP being calculated 
directly from these structures in the gas phase at the HF/6-31G* level (no optimisation was 
performed) and partial charges extracted using the two stage RESP fitting procedure. This method 
introduces a temperature dependence, with resulting charges being intrinsically Boltzmann 
weighted.124, 127 Parameters are provided in full in Appendix II – Lipid14 atom types and charges and 
in supplementary files. 
 
3.4.6 Membrane simulation protocol 
 
In order to thoroughly validate the new lipid parameters, 128 bilayers of DLPC, DMPC, DPPC, DOPC, 
POPC and POPE were simulated at an experimentally relevant hydration and temperature (identical 
values to the GAFFlipid validation) for 125ns. These runs were repeated twice for each lipid system, 
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using a different initial random seed for the velocities and slightly different simulation times for the 
heating phase. The simulation protocol varied only slightly from that used in earlier GAFFlipid bilayer 
runs. 
 
3.4.6.1 Equilibration procedure.  
 
The full system was minimized for 10000 steps, of which the first 5000 steps used the steepest 
descent method and the remaining steps used the conjugate gradient method.162 The system was 
then heated from 0K to 100K using Langevin dynamics90 within a 5 ps constant volume run, with 
weak restraints on the lipid (force constant 10 kcal/mol/Å2).  
 
Following this, the volume was allowed to change freely and the temperature increased to 303-323 K 
with a Langevin collision frequency of γ=1 ps-1, and anisotropic Berendsen control91 of the pressure 
around 1 atm was applied by coupling the repeating box with a time constant of 2 ps for 100 ps. The 
same weak restraint of 10 kcal/mol/Å2 was maintained on the lipid molecules. 
 
3.4.6.2 Production runs.  
 
NPT runs were performed on the 128 bilayers using the AMBER 12 package.81 The CUDA 
implementation of the AMBER 12 code was used to run the simulations on NVIDIA GPU cards located 
either in-house, at the Imperial College London High Performance Computing Cluster or at the San 
Diego Supercomputing Centre, achieving approximately 30 ns per day for the 128 lipid bilayer 
systems.81, 130 All simulation settings for the production runs were identical to the GAFFlipid 
production runs. The first 5 ns of the NPT run consisted of restarting the run every 500 ps to allow 
the simulation cell to shrink and the PME grid to be recalculated with each restart. 
 
Each lipid type was simulated for 125 ns with a second repeat, with the first 25 ns of each run 
removed for equilibration. Results are reported as block averages over the two repeats ± standard 
error. 
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3.4.7 Membrane validation simulations with Lipid14 
 
3.4.7.1 Structural parameters 
 
Table 3.13 - Comparison between experimental and simulation membrane properties using the 
AMBER Lipid14 force field for six lipid types plus comparison to other all-atom lipid force fields. 
Lipid system Area per lipid 
AL (Å
2) 
Volume per 
lipid 
VL (Å
3) 
Isothermal area 
compressibility 
modulus 
KA (mNm
-1) 
Bilayer 
thickness 
DHH (Å) 
Bilayer 
Luzzati 
thickness DB 
(Å) 
ΔDB-H = 
(DB-DHH)/2 
(Å) 
Ratio r of 
terminal 
methyl to 
methylene 
volume 
DLPC  
Lipid14 
 
Experiment 
 
C36122 
 
Slipids124 
63.81±0.15 
 
63.2,3260.8171 
 
64.4±0.3 
 
62.4±0.4 
949.24±0.08 
 
99132 
 
 
 
951 
262±52 
 
- 
 
 
 
268±24 
30.25±0.25 
 
30.832 
 
 
 
30.1 
29.78±0.08 
 
31.432 
 
 
 
30.4 
-0.24±0.09 
 
0.8208 
 
-0.2 
 
0.15 
1.9 
 
1.8-2.1176 
DMPC  
Lipid14 
 
Experiment 
 
 
 
C36122 
 
Slipids124 
61.06±0.16 
 
60.6,3259.9171 
 
 
 
60.8±0.2 
 
60.8±0.5 
1052.9±0.12 
 
110132, 35 
 
 
 
 
 
1060 
208±32 
 
234165 
 
 
 
 
 
250±29 
34.13±0.13 
 
34.4,166 
35.3164 
 
 
 
 
34.5 
34.52±0.08 
 
36.3,32 
36.7,171 
36.9166 
 
 
 
35.3 
0.2±0.02 
 
0.8208 
 
 
 
0.2 
 
0.4 
1.97 
 
1.8-2.1176 
DPPC  
Lipid14 
 
Experiment 
 
C36122 
 
Slipids124 
63.43±0.07 
 
63.1,17164.3181 
 
62.9±0.3 
 
62.6±0.5 
1179.5±0.05 
 
123235 
 
 
 
1201 
334±15 
 
23135 
 
207±14 
 
238±35 
37 
 
38,31 38.335 
 
 
 
37.7 
37.21±0.04 
 
39.031, 171 
 
 
 
38.3 
0.11±0.02 
 
0.8208 
 
0.1 
 
0.3 
2.0 
 
1.8-2.1176 
DOPC  
Lipid14 
 
Experiment 
 
 
 
 
C36122 
 
Slipids125 
69.68±0.05 
 
67.4,31 72.535 
 
 
 
 
69±0.3 
 
68±0.5 
1249.1±0.04 
 
130335 
 
 
 
 
 
 
1262 
321±11 
 
265,165 300,168 
318209 
 
 
 
 
 
256±29 
36.75 
 
35.3,169 
36.7,31,167 
36.9,35 
37.1170 
 
 
 
36.6 
35.87±0.03 
 
35.9,35 
36.1,169,170 
38.731 
 
 
 
 
37.2 
-0.44±0.01 
 
1.0-1.7176 
 
 
 
 
-0.6 
 
0.3 
2.0 
 
1.8-2.1176 
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Lipid system Area per lipid 
AL (Å
2) 
Volume per 
lipid 
VL (Å
3) 
Isothermal area 
compressibility 
modulus 
KA (mNm
-1) 
Bilayer 
thickness 
DHH (Å) 
Bilayer 
Luzzati 
thickness DB 
(Å) 
ΔDB-H = 
(DB-DHH)/2 
(Å) 
Ratio r of 
terminal 
methyl to 
methylene 
volume 
POPC  
Lipid14 
 
Experiment 
 
 
C36122 
 
Slipids125 
66.03±0.23 
 
64.3,171 
68.3196 
 
64.7±0.2 
 
64.6±0.4 
1205.9±0.04 
 
1256196 
 
 
 
 
1213 
351±36 
 
180-330172 
 
 
 
 
298±30 
36.63±0.13 
 
37196 
 
 
 
 
36.5 
36.54±0.13 
 
36.8,196 
39.1171 
 
 
 
38.5 
-0.04 
 
0.8208 
 
 
 
 
1.0 
1.85 
 
1.8-2.1176 
POPE  
Lipid14 
 
Experiment 
 
 
C36122 
 
Slipids125 
56.02±0.08 
 
56.6,173 59-
60174 
 
59.2±0.3 
 
56.3±0.4 
1139.68 
 
1180174 
 
 
 
 
1153 
370±78 
 
233173 
 
 
 
 
282±29 
42.13±0.38 
 
39.5174 
 
 
 
 
41.1 
40.71±0.06 
 
- 
 
 
 
 
41.6 
-0.7±0.16 
 
- 
2.0 
 
1.8-2.1176 
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The same structural properties were calculated for Lipid14 as the GAFFlipid work, with a few 
additions. An alternative bilayer thickness, the Luzzati thickness DB, was calculated according to: 
              
    
     
 3.10 
where bz is the average z-dimension of the simulation box throughout the NPT simulation and ρW(z) 
is the probability distribution of water along the z-axis which is calculated from the time-averaged 
histogram of water distribution along the z-axis of thickness dz: 
      
       
  
 3.11 
where nW(z) is the time-averaged number of water molecules per slice and dV is the time-averaged 
volume of each slice. 
These results are shown in Table 3.13 as block averages over the two repeat 100 ns production runs 
± standard deviation. The area per lipid is found to come out in very good agreement with 
experiment, with the DOPC and POPC results falling closer to the more recent experimental 
estimates (67.4 Å2 and 64.3 Å2 respectively). Likewise the volume per lipid values VL, although 
systematically underestimated, falls close to experiment. It is hypothesised that this underestimation 
is due to the head group parameters, as the extensive work on the lipid carbon tail parameters 
makes it unlikely that the tail groups are the cause. Indeed by studying the lipid volume breakdown 
afforded by SIMtoEXP this was found to be the case, as the head group volume of DOPC was found to 
be 305.41 Å3, which is below the experimental estimate of 319-331 Å3, whilst the hydrocarbon chain 
volume of 965.88 Å3 is closer to the experimental range of 972-984 Å3.176 The SIMtoEXP volume 
breakdown was also used to calculate the ratio r of the terminal methyl to methylene volume, as this 
is well defined experimentally. All lipid systems report a value of r=1.85-2.0, which is within the 
experimental range of 1.8-2.1. 
 
The KA values are also well reproduced despite using a Berendsen barostat for the production runs. 
In most cases experimental values fall within the error range of the calculated values, though 
simulation values do retain a large standard deviation. 
 
The bilayer thickness values DHH and DB are also well reproduced, though in some instances the DB 
values are slightly underestimated, in particular for the saturated lipids DLPC, DMPC and DPPC. Given 
that DB is the distance between the points along the membrane normal at which the water density is 
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half of its bulk value, this indicates that water is penetrating slightly too far into the hydrophobic 
region of the bilayer, lowering the value of DB. 
 
3.4.7.2 Order parameters 
 
The lipid order parameters were calculated via the same routine as the earlier GAFFlipid work.  
Figure 3.19 – Simulation NMR order parameters for the six lipid systems and comparison to 
experiment.185,187,183-184, 188, 210-211 
Order parameters are shown in Figure 3.19 and match with experiment extremely well, with the only 
exceptions being the POPE sn-1 chain profile which is slightly high; and the level of carbon-2 splitting, 
which though observed does not occur to the same extent as experiment. The distinctive dip at 
carbons-9 and -10 positions is seen for the unsaturated lipid chains due to the carbon-carbon double 
bond (sn-1 and sn-2 in DOPC, sn-2 in POPC and POPE), also in accordance with Jambeck et al. varying 
behaviour is seen for the sn-1 and sn-2 chains about the double bond in DOPC.125 
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3.4.7.3 Electron density profiles 
 
EDPs were determined in the same manner as the previous GAFFlipid work, by assuming an electron 
charge equal to the atomic number minus the partial charge of that atom, located at the centre of 
each atom. Profiles are decomposed into contributions from the following groups: water, choline 
(CHOL), phosphate (PO4), glycerol (GLY), carbonyl (COO), methylene (CH2), unsaturated CH=CH and 
terminal methyls (CH3). As expected, profiles are symmetrical, with water penetrating up to the 
carbonyl groups leaving the terminal methyls dehydrated which is in agreement with experimental 
findings.32, 181, 196 
 
Figure 3.20 - The total and decomposed electron density profiles for each of the six lipid bilayer 
systems with contributions shown from water, choline (CHOL), phosphate (PO4), glycerol (GLY), 
carbonyl (COO), methylene (CH2), unsaturated CH=CH and terminal methyls (CH3). 
 
3.4.7.4 Scattering form factors 
 
The EDPs were then converted to X-ray and neutron scattering profiles using the SIMtoEXP 
software.182 As stated previously, scattering data is the most suitable comparison for bilayer 
simulations due the fact that no intermediate modelling is used to interpret the raw experimental 
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output. Results are shown in Figure 3.21, displaying good comparison with experiment for both the 
X-ray and neutron scattering profiles; Lipid14 results are also a marked improvement over the 
GAFFlipid work, which displayed unusual behaviour at low q values. 
 
Figure 3.21 – Simulation X-ray scattering form factors for the six lipid systems (black line) and 
comparison to experiment31-32, 167, 171, 196 (cyan circles) and, inset, simulation neutron scattering form 
factors at 100% D2O (black line), 70% D2O (red line) and 50% D2O (blue line) and comparsion to 
experiment171, 212 (black, red and blue circles respectively). 
Experimentalist John Nagle has emphasised that simulators should aim to replicate both X-ray and 
neutron scattering data, which Lipid14 is shown to do so. However he also points out an important 
relationship between bilayer thickness values and scattering results: the agreement with X-ray 
scattering is sensitive to peak-to-peak thickness DHH; whilst agreement with neutron scattering is 
sensitive to bilayer Luzzati thickness DB.
176, 208 Consequently simulations should aim to replicate both 
of these experimental thickness values in order to best replicate scattering data. Ability to replicate 
each thickness value may be analysed by calculating the difference ΔDB-H = (DB-DHH) / 2, which 
experimentally remains within the range 0.8-1.7 for a range of lipid types (and thus areas per lipid). 
These values were calculated for Lipid14 and are shown in Table 3.13. Calculated values do not fall 
within the experimental range, with ΔDB-H values falling lower than experiment. Analysis of ΔDB-H 
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results for other all-atom lipid force fields in fact reveals that this quantity is difficult to replicate 
using all-atom representation. Whilst the GROMOS united-atom force field does find good 
agreement with experiment for ΔDB-H results,
176, 208 neither CHARMM C36122 or Slipids124-125 AA force 
fields correctly reproduce this quantity. Figure 3.22 plots ΔDB-H results for Lipid14, CHARMM C36
208 
and Slipids.124-125 All show a decrease in ΔDB-H as area per lipid increases, though Slipids comes closest 
to the experimental ΔDB-H results in isolated cases. 
 
Figure 3.22 - Plot of ΔDB-H = (DB-DHH)/2 versus area per lipid AL for the three all-atom lipid force fields 
CHARMM36 (squares), Slipids (diamonds) and AMBER Lipid14 (circles). Values shown for DLPC 
(green), DMPC (magenta), DPPC (blue), DOPC (red) and POPC (orange). 
 
3.4.7.5 Lipid lateral diffusion 
 
To assess the ability of the Lipid14 parameters to reproduce dynamic lipid properties, the lipid lateral 
diffusion coefficient D(xy) was calculated using the Einstein relation (equation 3.7) with the number 
of degrees of freedom nf=2. Diffusion coefficients were calculated for each lipid from the two 
production runs and are presented as a block average over the two NPT runs. The mean-square-
displacement (MSD) curves were determined using window lengths spanning 20 ns and averaged 
over different time origins separated by 200 ps. The slope of this curve then yields the diffusion 
coefficient using equation 3.7, with the linear 10-20 ns region used to perform the fit. Prior to the 
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MSD calculation, the lipid coordinates were corrected to remove the artificial centre of mass drift of 
each monolayer.143 
Table 3.14 - Lipid lateral diffusion coefficients calculated from NPT runs, NVE runs and experimental 
values. 
Lipid system Calculated NPT D(xy)    
(10-8 cm2/s) 
Calculated NVE D(xy) 
(10-8 cm2/s) 
Experimental D(xy)         
(10-8 cm2/s) 
DLPC 11.03 11.24 8.5213 
DMPC 9.25 8.21 5.95,214 940, 215 
DPPC 13.15 15.45 12.5,36 15.2,216 18217 
DOPC 8.56 9.21 11.5,40 17,38 
POPC 7.77 9.40 10.740 
POPE 4.93 7.20 5.2218* 
*Cell cultured membrane containing 78% POPE at 305K. 
Results are of the same order of magnitude as experimental values; although in some cases they are 
underestimated, possibly due to size effects, given that unlike the bulk alkane work there is no 
correction term to account for collective motion which cannot be sampled using a periodic box of 
limited size. Also as highlighted by Poger at al there remains a wide spread in experimental lipid 
lateral diffusion values available in the literature, with a range of experimental techniques applied to 
the calculation of diffusion values.144 Even different groups applying the same experimental 
technique to determine lipid diffusion do not necessarily yield comparable diffusion coefficients. 
Calculated diffusion coefficients are however found to be in good agreement with other simulation 
values.124-125, 140, 144, 219-220 
 
Given that the production runs were performed in the NPT ensemble, and that temperature 
regulation methods such as Langevin dynamics, which randomizes particle velocities, may affect 
dynamic properties such as diffusion, the lipid lateral diffusion was also determined in the 
microcanonical ensemble (NVE). A single production run of each lipid system was extended into the 
NVE ensemble for 100 ns using the same simulation settings as used for the alkane diffusion runs. 
Resulting time averaged MSD curves are shown in Figure 3.23 and calculated diffusion values are 
reported in Table 3.14. It is observed that although similar to the D(xy) values determined from the 
NPT runs, diffusion coefficients from the NVE ensemble are in general slightly higher, with the result 
for DPPC and POPE showing the largest difference. These results support a recent study on the effect 
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of temperature control on dynamic properties by Basconi et al.,200 who found that diffusion 
coefficients calculated under Langevin dynamics approach those determined under NVE provided 
weak coupling is used for the temperature regulation. 
 
Figure 3.23 - Time averaged mean-square-displacement of the center of mass of the lipid molecules 
versus simulation time calculated from the NVE simulations.  
Lipid diffusion in the plane of the membrane is known to occur via two regimes: fast ‘rattling’ of the 
lipid in the local solvation cage221 and slower, long distance diffusion in the plane of the bilayer. The 
two regimes can clearly been seen in the MSD versus time curves (Figure 3.23) and are also reflected 
by computing the diffusion coefficients using different time ranges of the MSD curve. Figure 3.24 
plots the diffusion coefficient D(xy) against the starting time for fitting the MSD slope. Time windows 
were either 100 ps long (fit starts between 10 ps and 500 ps) or 500 ps long (fit starts between 
500 ps and 20 ns). D(xy) values are seen to decrease smoothly and converge at a value for the long 
time diffusion of lipids in the bilayer plane. 
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Figure 3.24 - Lipid diffusion coefficient as a function of starting time for fitting of the MSD curve. 
Between 10 and 500 ps windows were 100 ps long; thereafter windows were 500 ps long. 
 
3.4.8 Lipid14 discussion 
 
The Lipid11 force field released by Skjevik et al.190 was updated using experience gained during 
previous GAFFlipid work, with resulting lipid simulation properties found to match experiment for a 
range of observables. This was achieved by fitting hydrocarbon bond, angle and torsion parameters 
to QM scans; furthermore vdWs parameters in the glycerol linkage region were found to require 
updating. It was found to be extremely important to have hydrocarbon parameters which reproduce 
the experimentally observed trans/gauche fraction. The hydrocarbon parameters were also validated 
by calculating a range of properties for comparison to experiment for hydrocarbon chains of varying 
lengths, including ΔHvap, density, diffusion, and 
13C NMR T1 relaxation times. 
 
On reflection, the fundamental assumption that GAFF contained suitable hydrocarbon parameters on 
which to build a lipid force field complicated and slowed the progress of this work. Although suitable 
for small molecules, GAFF has not been specifically optimised for hydrocarbons, as identified at the 
start of the GAFFlipid work (see Figure 2.4). For this reason, fitting the CH2-CH2-CH2-CH2 torsion to 
QM data was not enough to allow the creation of suitable hydrocarbon parameters allowing lipid 
simulations, although this fact was initially hidden by a bug in the GPU code. Rather each individual 
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hydrocarbon covalent parameter had to first be studied at the QM level and parameters for MD 
simulated then fitted to this data. 
 
Partial charges were recalculated using the Lipid11 methodology, however using a greater number of 
head group and tail group conformations as input. In order to ensure these conformations were 
representative of those typically found in a bilayer structure, each head group and tail group 
conformation was extracted from previous bilayer simulations. 
 
The final Lipid14 parameters are found to reproduce a range of experimental membrane observables 
with high accuracy, including area per lipid, volume per lipid, isothermal area compressibility 
modulus, bilayer thickness DHH (and to an extent DB), NMR order parameters, X-ray and neutron 
scattering data and lipid lateral diffusion. Further work may involve refining the parameters to 
address shortfalls in comparison to experimental data, specifically the volume per lipid, carbon-2 
splitting in NMR order parameters and values for the bilayer Luzzati thickness DB.  
 
The Lipid14 parameters allow the accurate simulation of a range of lipids in the tensionless NPT 
ensemble and as such are a significant update to any previous AMBER lipid parameters. Thus they 
provide a suitable starting point for the simulation study of drug-membrane interactions. 
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4 Simulation of PET tracer-membrane systems 
 
The movement of ten well characterised PET radiotracers into the membrane, their behaviour within 
the membrane and the influence of varying concentrations of tracer on membrane structure is 
examined using molecular dynamics simulations. Bilayers are modelled using parameters developed 
in chapter 3, whereas tracers are parameterised using the General Amber Force Field. All tracers are 
found to preferentially partition just below the lipid head group region of the membrane. 
Furthermore, those PET tracers possessing higher non-specific binding values are found to impart 
higher ordering of the lipid tail groups, this effect becomes more evident with higher concentrations 
of PET tracer partitioned into the membrane. 
 
4.1 PET tracer data set 
 
Collecting experimental NSB data is a costly and time-consuming procedure, due to the requirement 
for multiple PET scans (see 1.1.3). Consequently, if the development of a new PET tracer is deemed 
unsuccessful due to high NSB, the tracer is abandoned and rarely well characterised. There is 
however a limited amount of NSB data available in the literature for ten frequently used PET tracers. 
These are the same ten PET tracers studied by Rosso et al. using quantum chemical methods, in an 
investigation into the relationship between NSB and the quantum mechanically calculated 
interaction energy between a PET tracer and lipid molecule.18 This set of PET tracers, detailed in 
Figure 4.1, are well characterised (for example, calculated and measured log P values are available) 
and have become known as the ‘Golden ten’ during the NSB project at Imperial College London. 
 
The Golden ten are all small, drug-like molecules, with molecular weight < 500 and adhering to all 
other of Lipinski’s guidelines. Their structures are shown in Figure 4.1 and molecular properties listed 
in Table 4.1; it is observed that the log P of the tracers does not follow the NSB trend (as also shown 
graphically in Figure 1.5). 
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Figure 4.1 - The names and structures of the ‘Golden ten’ set of PET tracers. 
Table 4.1 - Molecular properties of the Golden ten PET tracer set.* 
PET tracer Code NSB 
(mL/g) 
Measured 
Log P 
Calculated 
Log P 
Volume 
(Å3) 
TPSA 
(Å2) 
Heavy 
atom 
count 
Molecular 
weight 
(g/mol) 
H-bond 
acceptor 
count 
H-
bond 
donor 
count 
Rotatable 
bond 
count 
Flumazenil FLU 1 1.1 1.291 257.21 64.44 22 303.29 7 0 3 
Fallypride FAL 3.93 2 1.798 318.04 61.80 24 336.41 6 2 8 
Rolipram ROL 6 2.1 1.715 262.74 47.57 20 275.35 4 1 4 
Raclopride RAC 10.25 1.2 0.903 295.40 61.80 22 347.24 5 2 5 
Diprenorphine DIP 13.5 - 0.719 400.01 62.16 31 425.57 5 2 4 
WAY100635 WAY 13.83 3.1 3.69 414.14 48.91 31 422.57 6 0 7 
MDL100907 MDL 55.25 1.9 2.285 355.90 41.93 27 373.47 5 1 7 
NPA NPA 67 - 3.917 273.73 43.69 22 293.37 3 2 2 
DASB DAS 100.12 2.38 3.029 264.44 53.05 20 283.4 3 2 4 
Spiperone SPI 165.67 - 1.739 365.56 52.65 29 395.48 6 1 6 
*Lipophilicity and non-specific binding data from Rosso et al.,18 remaining data calculated with the 
Molinspiration Chemoinformatics Web Server.222 
116 
 
4.2 Single drug-bilayer runs 
 
In order to observe the unassisted entry process of each PET drug in the data set into a lipid bilayer, 
ten systems were constructed consisting of a 72-DOPC bilayer patch hydrated with 70 waters per 
lipid and one of each of the ten drugs in the data set inserted into the water phase above the bilayer. 
 
Simulation of these systems allowed the examination of the insertion process of each drug into the 
bilayer by calculating the following: orientation of the drug during and after membrane insertion, the 
favoured position of each drug in the bilayer, hydrogen bonding behaviour whilst in the bilayer and 
finally diffusion in the plane of the membrane.  
 
4.2.1 Methods 
 
4.2.1.1 Simulation set up 
 
The ten PET tracers (Figure 4.1) were modelled using GAFF, which has been designed for small 
molecules.133 Parameters were prepared using the Antechamber module of AmberTools,81 whilst 
partial charges were obtained using a RESP fit of the quantum mechanically calculated MEP in the 
gas phase at the HF/6-31G* level. The tracers were modelled as charge neutral in agreement with 
the assumption that only neutral solute species transverse the bilayer.223-224 Parameters are provided 
in full in Appendix III – Golden ten GAFF atom types and charges. 
 
A 72-DOPC bilayer was constructed using the CHARMM GUI membrane builder225 at hydration level 
70 waters per lipid. The higher level of hydration was required to provide a sufficiently thick water 
layer to accommodate the PET drugs. This bilayer was then simulated in the NPT ensemble for 90ns 
using Lipid14 parameters and identical settings to the Lipid14 production runs. After this period 
analysis of the area per lipid determined that the bilayer was well equilibrated. 
Ten systems were then constructed by inserting each one of the ten PET drugs into the water phase 
above the equilibrated DOPC bilayer, with separation 32 Å between the drug and bilayer centre of 
mass. The drugs were aligned such that their long axis of inertia was orientated along the z-axis (the 
bilayer normal). 
 
Each system was then heated and run for 100 ns NPT simulation (constant pressure of 1 atm and 
constant temperature of 303 K) using identical simulation settings and protocol as the Lipid14 NPT 
production runs, with the addition that the drug was restrained during the heating phase with a 
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weak force constant of 5 kcal/mol. During the 100 ns simulation, seven of the ten PET tracers were 
observed to enter the membrane interior, with the exception of DIP, FLU and WAY which required an 
additional 100 ns NPT simulation before insertion into the bilayer was observed. 
 
Following the insertion of the drugs into the bilayer during the NPT runs, each system was extended 
into the NVE ensemble for a further 100 ns of simulation time using identical settings to the Lipid14 
NVE runs. The extension into the NVE ensemble was performed in order to ensure the most accurate 
calculation of diffusion possible, due to the known influence of temperature regulation methods on 
dynamic properties.200 The NPT and NVE trajectories were then analysed for the following: electron 
density profile (providing preferred position within the bilayer of the drug), order parameter of the 
drug (providing orientation of the drug), hydrogen bonding between the drug and water molecules, 
hydrogen bonding between the drug and lipid molecules, internal hydrogen bonding of the drug, and 
diffusion of the drug in the 2-dimensional membrane plane and 3-dimensions. All simulations were 
run using the CUDA implementation of the AMBER 12 code81 on NVIDIA GPU cards, which were 
located either in-house, at the Imperial College London High Performance Computing Cluster, or at 
the San Diego Supercomputing Centre. 
 
4.2.1.2 Drug order parameter 
 
The order parameter of the drug was calculated at each frame of the simulation to quantify the 
orientation of the drug during the course of the simulation. This calculation was similar to the 
calculation of the order parameters of the lipid tails during the lipid parameter development, with 
the drug order parameter P2 taking the same form: 
   
 
 
           4.1 
However in this instance the angle θ is the angle between the ‘long’ principal axis of inertia of the 
drug and the z-axis (bilayer normal). In order to calculate the order parameter of the drug, a specific 
piece of code was written to analyse AMBER trajectory files, written in the C coding language. 
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4.2.1.3 Hydrogen bonding 
 
In this work a hydrogen bond took a definition which is similar to that used by AmberTools,81 
specifically that the distance between the donor and acceptor heavy atoms must be 3.5 Å or less and 
the angle between the three atoms involved in the hydrogen bond must be within the range 160-
200°. These conditions are shown pictorially in Figure 4.2. 
 
Figure 4.2 - Definition of a hydrogen bond used in this work. 
Although hydrogen bonding analysis is possible using the PTRAJ module of AmberTools, this is 
primarily designed for the analysis of protein trajectories, thus specific routines were included in the 
analysis code to count hydrogen bonds between the drug and water molecules, the drug and lipid 
molecules and intramolecular hydrogen bonding within the drug. 
 
For each frame, the number of hydrogen bonds a drug displays was counted. If a drug has a single 
hydrogen bond to water for a given MD frame 1 is counted; if it displays two hydrogen bonds to 
water 2 is counted, and so on. Finally the average value may be calculated over the trajectory. Values 
for hydrogen bonding of the drug while located inside the membrane obtained from the NVE 
simulations are reported using block averaging – five blocks of 20 ns ± standard error. 
 
4.2.1.4 Diffusion 
 
Diffusion was calculated from time averaged MSD curves as in the Lipid14 work. The MSD was 
calculated over 20 ns blocks from the 100 ns trajectories, using different time origins separated by 
200 ps. As with the pure lipid lateral diffusion, the artificial centre of mass drift of the monolayer was 
removed from the drug. If the drug resided in the upper monolayer then the COM drift of this 
monolayer was removed from the drug prior to calculation of the MSD; likewise if it resided in the 
lower monolayer then the COM drift of this monolayer was removed from the drug.  
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4.2.2 Single drug-bilayer results 
 
4.2.2.1 Drug entry into the membrane 
 
The entry process of each of the drugs into the membrane was examined from the 100 ns NPT runs – 
the orientation of the drug may be obtained from the order parameter of the drug, whilst changes in 
hydrogen bonding behaviour may be observed from examination of drug-water and drug-lipid 
hydrogen bonds. 
 
Figure 4.3 plots the separation between the drug and membrane centre of mass and the drug order 
parameter during the period that the drug enters the membrane. It is seen that in most cases, the 
drug aligns parallel to the membrane normal (z-axis) with P2≈1 upon approaching the water-
membrane interface. The drug then enters the membrane and aligns parallel to the membrane plane 
(P2≈ -0.5) once inserted into the membrane, though in some cases the drug remains parallel to the 
membrane normal after entry (DIP, NPA). Of the ten drugs, ROL, and to an extent DAS, are observed 
to be the only ones which enter the membrane whilst remaining completely parallel to the 
membrane plane. 
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Figure 4.3 - Separation between drug and membrane centre of mass (black, upper row) and order 
parameter of the drug (black, lower row) and moving average of the drug order parameter (red, 
lower row) calculated using 500 ps windows. 
Hydrogen bonding during the membrane insertion period was also examined (see Figure 4.4). In 
general, the number of hydrogen bonds the drug molecules make with water decreases upon entry 
into the membrane, however with the exception of FAL each of the ten drugs retains an average of 
1-2 hydrogen bonds with water, indicating that the drugs remain partially hydrated whilst in the 
membrane region, in agreement with previous simulation findings for other small molecules.226-227 
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Upon membrane entry, drugs that are able to form hydrogen bonds with lipid are seen to do so, with 
a select few (RAC, NPA, DAS) making such hydrogen bonds prior to full membrane insertion. If the 
drug then permeates further into the membrane interior during the NPT simulation, as is the case 
with SPI, the drug then loses these hydrogen bonds with lipid. This movement however is not 
detrimental to drug-water hydrogen bonds due to the existence of water wires that act to partially 
hydrate the drug, such as that shown in Figure 4.5 for SPI. 
 
Figure 4.4 - Separation between drug and membrane centre of mass (black), hydrogen bonding 
between water and drug (blue) and hydrogen bonding between lipid and drug (cyan). 
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Figure 4.5 - The PET tracer SPI (spiperone) remains hydrogen bonded to water by way of a water wire 
despite permeating almost to the centre of the membrane. 
When studying a set of peptidic small molecules, Jacobson et al. found that the intentional 
introduction of an intramolecular hydrogen bond donor-acceptor pair increased membrane 
permeability whilst allowing the retention of favourable drug-like properties.228 Small molecule 
solubility may be increased by the introduction of hydrophilic species, such as hydrogen bond donors 
or acceptors. However this often comes at the expense of membrane permeability. Jacobson et al. 
argue that adding a complementary hydrogen bond donor/acceptor to allow intramolecular 
hydrogen bonding reduces the desolvation penalty upon moving into the membrane environment. 
Similarly, in a separate study by Alex et al., the presence of intramolecular hydrogen bonds in drug 
molecules with molecular weight greater than 500 Da is found to correlate with improved membrane 
permeability.229 
 
It is therefore of interest to investigate intramolecular hydrogen bonding in the water and membrane 
phases of those tracers that are capable of forming these bonds due to the influence of 
intramolecular hydrogen bonding on membrane permeability. The intramolecular hydrogen bonding 
behaviour of FAL, RAC, DIP and DAS over the course of the 100 ns NPT run, during which time of the 
drugs transitioned from the water phase into the membrane interior, is shown in Figure 4.6, Figure 
4.9, Figure 4.12 and Figure 4.13. 
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Fallypride intramolecular hydrogen bonding 
 
Figure 4.6 - Separation between drug and membrane centre of mass (black, upper row) and drug 
intramolecular hydrogen bonding (black, lower row; membrane entry period highlighted in red) for 
the PET tracer FAL. 
FAL, which has the lowest NSB of the subset of tracers that are able to make intramolecular hydrogen 
bonds, is observed to consistently maintain an intramolecular hydrogen bond whilst in the water 
phase, during the insertion period, and also while partitioned into the membrane (see Figure 4.6). In 
order to form such a bond, FAL must adopt a conformation as shown in Figure 4.7. 
 
Figure 4.7 - Conformation of FAL which does not allow formation of an intramolecular hydrogen 
bond with θ≈±50° (left)  and the conformation that FAL predominantly adopts, allowing formation of 
an intramolecular hydrogen bond with θ≈±150° (right). 
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The population of the torsion angle θ was calculated over the 100 ns NPT simulation, for the periods 
during which FAL was in either the water or membrane phases (see Figure 4.8). It is seen that FAL 
adopts a conformation allowing the formation of an intramolecular hydrogen bond, with θ remaining 
almost exclusively on or near ±150°, both in the water and membrane phases. A slight peak at ±50° is 
observed while FAL is in water which leaves the hydroxyl group is exposed to water, allowing the 
formation of a hydrogen bond with a water molecule. The torsion angle population results also serve 
to support the observation that FAL retains an intramolecular hydrogen bond both in the water and 
membrane phases. 
 
Figure 4.8 – Population of the torsion angle determining whether FAL may form an intramolecular 
hydrogen bond whilst the drug is in the water and membrane phases. 
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Raclopride intramolecular hydrogen bonding 
 
Figure 4.9 - Separation between drug and membrane centre of mass (black, upper row) and drug 
intramolecular hydrogen bonding (black, lower row; membrane entry period highlighted in red) for 
the PET tracer RAC. 
RAC, which has higher NSB than FAL but lower than DIP or DAS, displays a lower tendency to form an 
intramolecular hydrogen bond while in the water and membrane phases than FAL during the 100 ns 
NPT simulation. Intramolecular hydrogen bonding levels are seen to remain relatively constant for 
RAC whilst in water and also when undergoing insertion into the membrane. Once partitioned into 
the membrane, RAC initially displays intramolecular hydrogen bonding however the signal quickly 
drops to zero; thereafter RAC displays little intramolecular hydrogen bonding tendency while in the 
membrane during the NPT run. Note however that this is a short sampling period and intramolecular 
hydrogen bonding of RAC increases during the subsequent 100 ns NVE run (see 4.2.2.3) during which 
time RAC remains inside the membrane. 
 
As with FAL, the intramolecular hydrogen bonding of RAC is dependent on a torsion angle, with 
θ≈±150° permitting intramolecular hydrogen bonding – see Figure 4.10. 
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Figure 4.10 - Conformation of RAC which does not allow formation of an intramolecular hydrogen 
bond with θ≈±50° (left)  and the conformation of RAC allowing formation of an intramolecular 
hydrogen bond with θ≈±150° (right). 
By plotting population of the torsion angle θ of RAC while it is in the water and membrane phases 
from the 100 ns NPT run (see Figure 4.11) it is observed that a significant peak is found at ±50° in the 
water phase leaving the hydroxyl group exposed to hydrogen bond with a water molecule, however 
the ±150° conformation is adopted more frequently allowing intramolecular hydrogen bonding. Once 
RAC is partitioned into the membrane the drug primarily adopts the ±150° conformation exclusively, 
allowing intramolecular hydrogen bonding. The hydrogen bond analysis results (Figure 4.9) show a 
long period during which no intramolecular hydrogen bond exists directly after RAC enters the 
membrane. As can be seen from the plot of the torsion population (Figure 4.11), RAC does not 
always adopt a conformation with the angle at ±150° when in the membrane – the drug rotates 
about this torsion, in some instances remaining near ±50° and picking up hydrogen bonds with water 
molecules in the membrane. In other instances it is observed that although the torsion θ is at ±150°, 
the hydroxyl group points away from the carbonyl group to form a hydrogen bond with a water 
molecule, preventing intramolecular hydrogen bonding. 
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Figure 4.11 - Population of the torsion angle determining whether RAC may form an intramolecular 
hydrogen bond whilst the drug is in the water and membrane phases. 
DIP intramolecular hydrogen bonding  
 
Figure 4.12 - Separation between drug and membrane centre of mass (black, upper row) and drug 
intramolecular hydrogen bonding (black, lower row; membrane entry highlighted in red) for the PET 
tracer DIP. 
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Although DIP has the capacity to form an intramolecular hydrogen bond, it chooses to do so for only 
a short period while in the water phase (Figure 4.12). Visual analysis of the trajectory reveals that 
instead it prefers a side-chain orientation allowing formation of hydrogen bonds with water 
molecules while in the water phase, replacing these with hydrogen bonds to lipid on movement into 
the membrane. 
 
DAS intramolecular hydrogen bonding 
 
Figure 4.13 - Separation between drug and membrane centre of mass (black) and drug 
intramolecular hydrogen bonding (black; membrane entry highlighted in red) for the PET tracer DAS. 
Finally DAS, which has the highest NSB of the tracer subset able to form intramolecular hydrogen 
bonds, shows some intramolecular hydrogen bonding tendency while in water, however the signal is 
not present whatsoever as DAS undergoes the main period of membrane insertion. This is because 
DAS undergoes a conformational change prior to membrane insertion which prevents any 
intramolecular hydrogen bonding. 
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Figure 4.14 - Conformation of DAS which does not allow formation of an intramolecular hydrogen 
bond (left)  and the conformation allowing formation of an intramolecular hydrogen bond (right). 
Once inside the membrane, DAS then changes conformation back to one that allows intramolecular 
hydrogen bonding, before the signal again drops to zero. This change corresponds to both a change 
in DAS orientation and conformation in the membrane. Analysis of the order parameter of the drug 
shows that at 80 ns of simulation time DAS goes from random orientation (P2≈0) to an orientation 
that is parallel to the membrane plane (P2≈ -0.5). At the same time, the drug transitions to a 
conformation that does not permit intramolecular hydrogen bonding. 
 
It has previously been found that the presence of an intramolecular hydrogen bond in a molecule 
may promote membrane permeation. In these simulations, it is seen that FAL, with the lowest NSB of 
the subset of tracers able to form intramolecular hydrogen bonds, retains an intramolecular 
hydrogen bond while in the membrane for a longer period than RAC, DIP or DAS. Furthermore, both 
FAL and RAC tend to retain an intramolecular hydrogen bond in both the water and membrane 
phases, whereas DAS and in particular DIP show lower tendency to form such bonds after 
transitioning from the water into the membrane phase. To further study intramolecular hydrogen 
bonding of these drugs while partitioned in the membrane the 100 ns NVE simulations were 
subjected to similar analysis – see 4.2.2.3. 
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4.2.2.2 Position of drug in membrane phase 
Figure 4.15 - The electron density profiles of the single drug-membrane systems while drug is in the 
membrane phase. Tracers are listed in order of increasing NSB. 
The electron density profiles of the systems were calculated over the full 100 ns NVE run during 
which time all drugs remained inside the membrane (Figure 4.15) using PTRAJ as per the lipid 
parameter development work. It is seen that all ten drugs predominantly reside just below the head 
group region, at the point where the lipid tails meet the head groups (i.e. the glycerol region). NPA 
and DAS sit slightly closer to the membrane centre than the remainder of the PET tracer set. During 
the course of the 100 ns NVE run the majority of the drugs remain at this position, however WAY and 
MDL are seen to sample regions closer to the membrane centre, with WAY in particular displaying a 
strong signal at the membrane centre. This may be related to the fact that WAY is unable to form 
hydrogen bonds with the DOPC lipid, having no hydrogen bond donors. 
 
4.2.2.3 Hydrogen bonding behaviour of drug in membrane phase 
 
Hydrogen bonding of the PET tracers to water while partitioned in the membrane was investigated 
by analysis of the 100 ns NVE runs. It has previously been reported that in some cases, the 
permeability of drugs through a membrane is directly linked to the number of drug-water hydrogen 
bonds formed by the drug (i.e. the more drug-water hydrogen bonds formed, the slower the 
membrane permeation).230 
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Figure 4.16 - Average hydrogen bonds per frame between drug and water molecules while drug is in 
the membrane phase. Tracers are listed in order of increasing NSB. 
Figure 4.16 plots the average number of hydrogen bonds to water whilst the drug is inside the 
membrane. The average number of hydrogen bonds to water ranges from 0.25-1.25 meaning that all 
drugs remain hydrated to some extent whilst inside the membrane. Certain drugs display large 
variations in the average number of hydrogen bonds to water – WAY in particular. This is due to 
movement of the drug deeper into the membrane, at which point it loses some hydrogen bonds to 
water. No clear trend is found in relation to NSB. 
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Figure 4.17 - Average hydrogen bonds per frame between drug and lipid while drug is in the 
membrane phase. Tracers are listed in order of increasing NSB. 
The average number of hydrogen bonds to lipid whilst the drug is inside the membrane is plotted in 
Figure 4.17. This value ranges from 0-0.25, given that some drugs do not have hydrogen bond donors 
and thus do not have the capacity to hydrogen bond to DOPC lipid molecules, as DOPC only 
possesses hydrogen bond acceptors. As with the water hydrogen bonding, some drugs display large 
variations in the average number of hydrogen bonds to lipid, due to movement of drugs deeper into 
the membrane and changes in drug orientation. Although tracers with higher NSB do in general 
display higher hydrogen bonding to lipid molecules whilst inside the membrane, no clear pattern is 
found in relation to NSB. 
 
The final piece of hydrogen bond analysis was to study intramolecular hydrogen bonding while 
tracers are inside the membrane, due to its possible influence on membrane permeability. 
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Figure 4.18 - Average intramolecular hydrogen bonds per frame while drug is in the membrane 
phase. Tracers are listed in order of increasing NSB. 
Figure 4.18 plots the average number of intramolecular hydrogen bonds – values exist only for FAL, 
RAC and DAS. DIP is also capable of forming an intramolecular hydrogen bond, however does not 
display any during the 100 ns NVE simulation. The average intramolecular hydrogen bonding is an 
order of magnitude lower than the water or lipid hydrogen bonding, indicating that intramolecular 
hydrogen bonds are relatively short lived over the course of the trajectory. 
 
Although only three of the ten PET tracers under study form an intramolecular hydrogen bond while 
in the membrane phase, it is interesting that the PET tracer with the lowest NSB exhibits a high 
degree of intramolecular hydrogen bonding while in the membrane interior, and the tracer with the 
highest NSB exhibits much lower intramolecular hydrogen bonding while in the membrane. 
Intramolecular hydrogen bonding has been linked to membrane permeability; the permeation of 
each of the ten PET tracers through a membrane is calculated computationally in chapter 6. 
 
4.2.2.4 Diffusion of drug in membrane phase 
 
The diffusion of the PET tracers while partitioned into the membrane was calculated from the 100 ns 
NVE runs, both in the 2-dimensional membrane plane (XY-plane) and 3-dimensions (XYZ). A review 
on drug-membrane interactions73 highlights that a limiting factor to PET tracers reaching membrane 
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bound targets may be diffusion of the PET tracer in the plane of the membrane, as it is possible that 
these drugs reach membrane bound targets via a 3D-2D reduction in dimensionality approach, 
whereby the tracer first diffuses in 3D (solution) before partitioning into the membrane, then 
diffusing to the membrane bound target in 2D (plane of the membrane). The NSB of PET tracers may 
thus potentially be linked to slower diffusion in the membrane. 
 
Figure 4.19 plots the time averaged MSD of each of the drug molecules in the membrane plane over 
a 20 ns period, calculated from the full 100 ns NVE runs using different time origins separated by 
200 ps. The centre of mass drift of the monolayer that the drug resided in was removed prior to the 
MSD calculation. 
 
Figure 4.19 - Mean square displacement of each of the ten PET tracers while inside the membrane. 
The 2D (XY-plane) and 3D (XYZ) diffusion coefficients were calculated by fitting appropriate MSD 
curves in the 10-20 ns region and are reported in Table 4.2. It is seen that in all cases the 3D diffusion 
of the drugs is lower than 2D diffusion, due to limited movement of the drug in the direction normal 
to the membrane after membrane insertion. Values for D(xy) are on the same order of magnitude as 
pure DOPC lateral diffusion which displays D(xy)= 9.21 cm2/s (see 3.4.7.5) – solutes have been shown 
computationally to exhibit the same mechanism of diffusion in the membrane plane as lipid 
molecules, via a short timescale rattling which contributes to long timescale net displacement.227, 231 
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Table 4.2 - Diffusion coefficients for movement of the PET drugs inside the membrane plane and in 
3-dimensions within the membrane, plus the experimental NSB values of the PET tracers. 
 D(xy) (10-8 cm2/s) D(xyz) (10-8 cm2/s) NSB (mL/g) 
FLU 17.01 11.03 1 
FAL 16.99 11.54 3.93 
ROL 5.84 3.80 6 
RAC 8.66 6.47 10.25 
DIP 9.69 8.09 13.5 
WAY 12.91 10.06 13.83 
MDL 7.56 5.52 55.25 
NPA 10.04 7.65 67 
DAS 14.93 9.14 100.12 
SPI 6.87 5.90 165.67 
 
By comparing lateral diffusion coefficients with the hydrogen bond analysis (section 4.2.2.3), it is 
seen that all radiotracers exhibiting D(xy)>10 cm2/s also have <0.5 hydrogen bonds to water per MD 
frame, whereas the remainder of the set have D(xy)<10 cm2/s and >0.5 hydrogen bonds to water, 
with the exception of FLU, which maintains D(xy)=17 cm2/s and an average of 0.9 hydrogen bonds to 
water per frame. A similar relationship does not appear to exist between diffusion and drug-lipid or 
intramolecular hydrogen bonding. Furthermore, no clear pattern is found in relation to NSB. 
 
4.3 Molar concentration simulations 
 
To assess the impact of differing concentrations of the PET drugs on bilayer structure, the clinically 
relevant 12mol% and 36mol% concentrations of each of the PET tracers were inserted into a 
128-DOPC bilayer, again with hydration level 70 waters per lipid, and the impact of the two 
concentrations of each drug on the membrane was then assessed using 100 ns NPT simulations. Due 
to the large simulation time that would be required to observe the spontaneous insertion of each of 
the drugs into the bilayer, the drugs were manually inserted just below the head group region, the 
preferred position of the drugs in the membrane in the previous single drug-bilayer simulations. An 
alternative, although more computationally expensive method to construct the mol% systems, would 
be to perform self-assembly simulations in a similar manner to Orsi et al., who started with a random 
136 
 
mixture of water, lipid and drug and allowed a bilayer to assemble, with the drug choosing to 
position inside the membrane.232 
 
4.3.1 Methods 
 
4.3.1.1 System set up 
 
As with the single drug simulations, an equilibrated bilayer was first obtained by running a 128-DOPC 
bilayer for 90 ns with hydration level 70 waters per lipid. The area per lipid of this system indicated 
that 90 ns was more than adequate to equilibrate the membrane. 
 
A rough calculation reveals that a 1μmol dose of drug (the upper bound of a PET drug dosage) results 
in roughly 4mol% of drug in a lipid membrane. The workings are as follows: 
 An average person weighs 70kg so the body has volume 70 Litres 
 Drug dose 1μmol 
Number of drug molecules = NA x 1 x 10
-6 x 70 
    = 4.2 x 1019 
 Conservative estimate of 1 trillion (1 x 1012) cells in the human body 
 There are therefore 4.2 x 1019 / 1 x 1012 drug molecules per cell 
= 4.2 x 1019 / 1 x 1012  
= 4.2 x 107 drugs per cell 
 There are an estimated 1 x 109 lipid molecules per cell51 
 This results in a drug : lipid ratio of 4.2 x 107 : 1 x 109  
= 4% 
A higher value was used to as a basis for the initial system (12mol%) whilst an exaggerated dose was 
also modelled (36mol%). Twenty systems were then set up, consisting of 12mol% and 36mol% of 
each of the ten PET drugs, by inserting either 18 or 72 drugs into the membrane (equally distributed 
between the two monolayers) at a position just below the head group region. The concentration is 
determined as: 
     
      
              
 4.2 
with nlipids=128. In order to avoid bad contacts and interdigitation of lipid and drug structures, a 
growing procedure was used to insert the PET tracers into the DOPC bilayer. All twenty systems were 
then simulated for 100 ns in the NPT ensemble on GPU cards, with identical settings and protocol to 
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the Lipid14 and single drug-bilayer NPT runs; as with the single-drugs simulations all drugs were 
restrained during the heating phase with a weak force constant of 5 kcal/mol. 
Membrane insertion of drugs using growing procedure 
To set up the systems, a square grid of each of the drugs was created which was then flipped along 
the z-axis. This was overlaid with the equilibrated 128-DOPC bilayer such that the PET tracers were 
just below the DOPC head group region, the preferred position in the bilayer as predicted by the 
previous single drug-bilayer simulations (section 4.2). 
 
In order to avoid bad contacts and lipid tail groups running through ring structures of the PET drugs, 
each drug was grown in from approximately 26% of their actual size. In a similar method to Orsi et 
al.103 the drug bond lengths, partial charges and vdWs parameters were incrementally increased 
during the MD simulation of the tracer-membrane system. Although the ideal protocol would be to 
grow drugs in from 1% (or less) of actual size, AMBER is unable to simulate such small molecules. 
Attempting to simulate any molecule with a bond length less than ≈0.3 Å causes massive instabilities 
in the simulation and results in an extremely distorted structure of the molecule, likely due to 
non-bonded forces in the molecule (despite the scaling of these forces). The growing procedure has 
received considerable attention within the Gould group in relation to protein mutagenesis, with no 
procedure identified allowing one to start with a molecule containing a bond length less than ≈0.3 Å. 
 
It was thus decided to start drugs off from 26% of actual size. The ParmEd module of AmberTools81 
was utilised to list all bonds, atom types, L-J parameters and partial charges in each of the drugs, 
which were then scaled to 26%. A minimisation of the drug-membrane system was performed for 
1000 steps, the first 500 of which were steepest descent and the remainder conjugate gradient, with 
SHAKE turned off. The system was then simulated in the NVT ensemble for 2 ps, with a 1 fs time step 
and SHAKE turned off, during which time the system was heated from 0 to 303 K. After this the drug 
parameters were increased by 2% (i.e. parameters became 28% of actual size) and the same 
minimisation and MD simulation performed. This process was repeated until the drugs reached 
actual size. Drugs were thus grown in over a simulation period of approximately 70 ps. It was found 
to be necessary to start DIP and SPI at 36% of actual size, and ROL at 40% of actual size, to avoid 
distortion of these drug structures. 
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Figure 4.20 - Growing the drug MDL into a DOPC membrane just below the head group region over a 
70 ps simulation period. 
This growing procedure was successful on the first attempt for the 12mol% systems. Initially, the 
same growing process was repeated for the 36mol% bilayers. However due to the 4-fold increase in 
the number of PET tracer structures in the membrane, and the requirement to start from 26% of 
drug actual size, there was a much higher likelihood of bad contacts or interdigitated lipid molecules 
and drug ring structures. To assist with the creation the 36mol% systems, the final DOPC bilayer 
structure from a successful growing run (the 36mol% MDL system) was used as a starting bilayer 
structure for the creation of the remaining nine 36mol% systems.  
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4.3.1.2 Electrostatic potential 
 
The membrane dipole potential may be calculated from the charge density along the bilayer normal, 
using atomic partial charges. Specifically, the simulation box is split into equal slabs along the 
z-direction (bilayer normal) and charge density for each slab determined in a time averaged fashion 
from the simulation trajectory and atomic partial charges. This quantity is then integrated twice with 
respect to distance z along the bilayer normal: 
       
 
  
    
 
            
  
 
 4.3 
This calculation was performed by outputting the partial charge density along the membrane normal 
using CPPTRAJ and the ‘density’ routine. 
 
In accordance with guidelines proposed by Gurtovenko et al.,233 who studied methodological issues 
in the calculation of membrane dipole potentials from molecular dynamics simulations, for each 
dipole potential calculation in this work the positions of all atoms in the simulation box were centred 
with respect to the membrane centre of mass for each step; furthermore all coordinates were scaled 
such that the size of the simulation box remained constant with values equal to the starting box size 
(NPT fluctuations are removed). Finally, prior to the integration steps to calculate the dipole 
potential, the charge density was symmetrised across both sides of the membrane. 
 
4.3.2 Molar concentration results 
 
4.3.2.1 Position of mol% drug in membrane phase 
 
The electron density profiles of the membranes containing 12mol% and 36mol% of each of the ten 
drugs are shown in Figure 4.21 and Figure 4.22. 
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Figure 4.21 - Electron density profiles for the DOPC+12mol% drug systems. Tracers are listed in order 
of increasing NSB. 
Figure 4.22 - Electron density profiles for the DOPC+36mol% drug systems. Tracers are listed in order 
of increasing NSB. 
It is seen that in all cases the drugs predominantly remain in the region of the membrane where the 
DOPC head and tail groups meet, in accordance with the single drug simulations (see also Figure 
4.23). 
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During the 12mol% runs a select number of tracers, FAL, RAC and WAY, are seen to explore the 
membrane core to some extent. However the EDP retains a peak just below the head group region. 
The 36mol% EDPs are in general similar to the 12mol% results, with the exception that the FAL, RAC 
and WAY profiles now display prominent density at the membrane core. This is likely due to the fact 
that a greater amount of drug is available to explore the membrane interior.  
 
During the single drug-bilayer simulations, these three drugs displayed the lowest hydrogen bonding 
to water while in the membrane phase (Figure 4.16) and little to no hydrogen bonds to lipid (Figure 
4.17) indicating that they remain more mobile to explore different membrane regions. FAL and RAC 
are able to form an intramolecular hydrogen bond, reducing the penalty due to loss of hydrogen 
bonds with water or lipid upon moving towards the membrane centre. WAY on the other hand 
possesses no hydrogen bond donors and consequently cannot form hydrogen bonds with the DOPC 
lipid molecules, meaning movement towards the membrane centre is not detrimental in this respect. 
 
The presence of increasing concentrations of drug inside the membrane is seen alter the DOPC 
electron density. Although the signal from the lipid remains unchanged on addition of 12mol% of 
drug, addition of 36mol% of drug is seen to increase the EDP of DOPC at the centre of the 
membrane. This indicates ordering of the lipid tails – the ends of the tails become more laterally 
packed and exhibit an electron density signal similar to the upper acyl chain region. Furthermore, the 
EDP peaks are slightly shifted in the 36mol% result, indicating that the bilayer thickness has 
increased, again a sign that the bilayer is more ordered - see also Table 4.3. However certain tracers, 
in particular FAL, RAC and WAY, do not cause an increase in the EDP at the membrane centre. This 
may be due to the fact that these tracers also occupy space in the centre of the membrane, in 
addition to the region just below the lipid head groups, meaning there is less tracer in the upper acyl 
chain region to induce ordering of the lipid tails. This membrane ordering effect is investigated 
further in the following section via calculation of the lipid order parameters. 
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Table 4.3 - Bilayer thicknesses for the DOPC+12mol% and DOPC+36mol% drug systems. Tracers are 
listed in order of increasing NSB. 
 DOPC+12mol% tracer 
bilayer thickness DHH 
(Å) 
DOPC+36mol% tracer 
bilayer thickness DHH 
(Å) 
Difference (Å) 
FLU 36.4 36.9 0.5 
FAL 37.4 39.4 2 
ROL 37.1 37.8 0.7 
RAC 37.3 38.7 1.4 
DIP 37.4 38.2 0.8 
WAY 37.6 38.1 0.5 
MDL 37.4 38 0.6 
NPA 37.6 38.7 1.1 
DAS 36.8 37.4 0.6 
SPI 36.6 37.6 1 
 
 
Figure 4.23 – A DOPC membrane containing 36mol% of the PET radiotracer NPA after 100 ns NPT 
simulation. Lipid head groups are shown with the choline nitrogen coloured blue, the phosphate 
phosphorus atom in orange and all oxygen atoms in red. Carbon atoms are coloured grey.  
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4.3.2.2 Membrane order parameters 
 
To study the effect of 12mol% and 36mol% of each of the ten PET tracers on the ordering of a DOPC 
lipid chains, the order parameter of DOPC was computed using PTRAJ as per the lipid parameter 
development work. Results are shown in Figure 4.24 and Figure 4.25. 
Figure 4.24 - Simulation order parameters of lipid chains for pure DOPC system and DOPC+12mol% 
drug systems. Tracers are listed in order of increasing NSB. 
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Figure 4.25 - Simulation order parameters of lipid chains for pure DOPC system and DOPC+36mol% 
drug systems. Tracers are listed in order of increasing NSB. 
It is seen that in general, 12mol% of a PET tracer acts to order the upper region of the DOPC lipid 
tails. This appears sensible, as the EDPs (section 4.3.2.1) show that all ten of the PET tracers 
preferentially remain in the bilayer at the point where the lipid head groups join the lipid tails. The 
PET drugs will occupy volume in this region and increase lateral packing of the lipid tails around the 
tracer. It is seen that there is a general, if slight, trend with increased membrane ordering as NSB of 
the PET tracer increases. This trend is far more evident in the 36mol% order parameter result (Figure 
4.25). 
 
A common cell membrane component, cholesterol, exerts a similar ordering effect on lipid bilayers. 
Cholesterol is composed of a four-membered fused ring structure, with a hydrophilic hydroxyl group 
on one end and a hydrophobic carbon chain on the other (see Figure 1.8). The addition of cholesterol 
to a lipid bilayer is known to reduce the bilayer surface area and increase the order of the lipid 
chains. A popular explanations of this behaviour is the “umbrella mechanism”, whereby cholesterol 
molecules sit beneath phospholipid head groups to remain screened from water, reducing 
movement of lipid tail groups and thereby increasing their order.234  
 
The PET tracers are observed to impart order only to the upper region of the lipid tail groups, 
whereas cholesterol orders the entire chain. This may be due to the fact that after membrane entry, 
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tracers are seen to align parallel to the membrane plane during the single drug-bilayer simulations 
(section 4.2.2.1), whereas cholesterol is known to align parallel to the membrane normal, albeit with 
a tilt angle.235 Of the PET tracers, NPA increases the lipid chain order the most, it is also seen to be 
the only tracer possessing a flat four-membered fused ring structure, although it is different from 
that of cholesterol. 
 
4.3.2.1 Diffusion of mol% drug in membrane phase 
 
Table 4.4 - Diffusion coefficients for movement of the PET drugs in the membrane plane for 
DOPC+12mol% drug and DOPC+36mol% drug systems, plus the experimental NSB values of the PET 
tracers. 
 DOPC+12mol% drug 
D(xy) (10-8 cm2/s) 
DOPC+36mol% drug 
D(xy) (10-8 cm2/s) 
NSB (mL/g) 
FLU 11.39 7.18 1 
FAL 14.97 14.94 3.93 
ROL 11.93 10.16 6 
RAC 16.04 13.16 10.25 
DIP 8.11 3.60 13.5 
WAY 8.10 5.73 13.83 
MDL 9.28 6.19 55.25 
NPA 6.28 4.60 67 
DAS 12.41 8.53 100.12 
SPI 8.93 5.28 165.67 
 
Lateral diffusion coefficients for movement of PET tracers in the membrane plane are reported for 
the 12mol% and 36mol% systems in Table 4.4. For the most part the 12mol% lateral diffusion 
coefficients are within 2 cm2/s of the singe drug results (Table 4.2), however there are notable 
exceptions: the FLU, WAY and NPA single drug values are almost twice that of the 12mol% results, 
while the RAC and ROL single drug values are almost half those of the 12mol% results. It is seen from 
the 12mol% results that those tracers with D(xy)>10 cm2/s all have low NSB values, with the 
exception of DAS, which maintains D(xy)=12.41 cm2/s in the 12mol% system. Increasing 
concentration of tracer from 12mol% to 36mol% is seen to reduce the lateral diffusion, in particular 
for those tracers with higher NSB, although FLU also displays a drop in lateral diffusion. It is possible 
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that this drop in lateral diffusion is related to the observed ordering of the membrane tails by the 
PET tracers (section 4.3.2.2), which appears to be more pronounced for tracers with higher NSB 
values. 
 
4.3.2.2 Membrane electrostatic potential 
 
The dipole potential of a 128-DOPC bilayer is shown in Figure 4.26. As determined by experimental 
measurements, the dipole potential is positive, coming to a maximum in the centre of the bilayer. 
Furthermore, the resulting profile takes a similar shape to previous calculations of the DOPC dipole 
potential using AMBER parameters to model lipids by Siu et al., however the present Lipid14 result 
finds a slightly higher maximum of 1.2V compared to 1V found by Siu et al.140 Both of these 
simulation results are considerably higher than the 100-500mV range estimated experimentally.43 
This may be due to the lack of MD simulations to account for polarisation effects,236 furthermore the 
average angle of the P-N dipole in the Lipid14 simulations is 90° from the membrane normal, 
whereas experimentally this is found to be closer to 70°.237 This orientation of the head group 
towards the water phase would contribute a negative component to the dipole potential. 
 
Figure 4.26 - The dipole potential of a 128-DOPC membrane hydrated with 70 waters per lipid and 
simulated for 100 ns at constant pressure. 
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The DOPC membrane dipole potential was then split into the separate water and lipid contributions 
(see Figure 4.27). As has been found previously by MD simulation, the water contributes a large, 
positive dipole potential, which is considerably offset by the negative lipid contribution.100 
 
Figure 4.27 - The lipid (orange) and water (blue) contributions to the overall DOPC membrane dipole 
potential. 
The dipole potentials of the DOPC membranes containing 12mol% and 36mol% of PET tracers were 
then computed. 
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Figure 4.28 - Dipole potential of pure DOPC system and DOPC+12mol% drug systems. Tracers are 
listed in order of increasing NSB. 
Figure 4.29 - Dipole potential of pure DOPC system and DOPC+36mol% drug systems. Tracers are 
listed in order of increasing NSB. 
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The electrical dipole of DOPC membranes containing 12mol% and 36mol% of the PET drugs are 
plotted in Figure 4.28 and Figure 4.29 with comparison to a pure DOPC membrane. It is seen that in 
all cases, the addition of PET tracer to the membrane causes a reduction in the dipole potential in 
comparison to a pure DOPC membrane, and that in general a higher concentration of tracer leads to 
greater reduction of the dipole potential, with the exception of ROL and SPI. A similar effect was 
found in simulations by Orsi et al. using the anti-microbial trichlocarban232 and experimentally by 
Ostroumova et al. using flavonoids (plant metabolites),238 whereby higher concentrations reduced 
the membrane dipole potential to a greater extent than low concentrations . Experimental work by 
Asawakarn et al.42 found a decrease in membrane dipole potential to correlate with a decrease in 
binding capacity of the membrane. It would therefore be interesting if a trend was observed in the 
current dipole potential results in relation to NSB, however no such relationship is clear. 
 
The dipole moments of the Golden ten are shown in Figure 4.30 – tracers are observed to possess 
relatively low dipole moments with a range of 0.74 – 5.76 D. These values are similar in magnitude to 
that of cholesterol (1.9 D),63 a predominantly hydrophobic molecule. Cholesterol aligns virtually 
parallel to the membrane normal when inside a bilayer, with a polar hydroxyl group pointing 
outwards towards the lipid head groups. The dipole moment of cholesterol is therefore orientated 
with the positive end pointed inward towards the bilayer and cholesterol acts to raise the dipole 
potential of a membrane.63 It is seen that although ROL has the highest dipole moment (5.76 D), 
partitioning of this tracer into a membrane has almost no effect on the membrane dipole potential. 
This is due to ROL aligning parallel to the membrane plane when inside a bilayer – the dipole 
moment of ROL lies along its long principal axis of inertia and will have no effect on the dipole 
potential of a membrane along the membrane normal. The remainder of the tracer set are seen to 
lower the dipole potential of a membrane. This is due to the tracers orientating themselves such that 
a greater number have their dipole moment pointing with the negative end inwards towards the 
bilayer. 
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Figure 4.30 - The dipole moments of the ten PET tracers (red arrow). In all figures, the long principal axis of inertia of the tracers is aligned with the z-axis.
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4.4 Discussion 
 
Using unbiased simulations, the insertion process of ten well characterised PET radiotracers into a 
DOPC bilayer was investigated, by combining GAFF with lipid parameters developed in chapter 3 
(termed Lipid14). It was found that in general, tracers align with their principal axis parallel to the 
bilayer normal when transitioning from the water phase into the membrane phase. Once inside the 
membrane, tracers then align to sit parallel to the membrane plane, positioning themselves just 
below the head group region of the bilayer, at the point where the lipid head groups and lipid tail 
groups join. However it should be noted that these results are based on a single simulation of a drug-
bilayer system with no repeats, making it difficult to obtain quantitative data on the insertion 
process. For example, attempting to correlate the simulation time required to observe a membrane 
entry event with a molecular property such as NSB would require multiple repeat simulations. 
 
The effect of increasing tracer concentration on the membrane structure was then examined using a 
DOPC membrane containing 12mol% and 36mol% of each of the ten PET tracers. For each system, 
tracers were inserted at the region of the bilayer where the lipid head groups and lipid tail groups 
meet, the same point found to be favourable for tracer partitioning in the single drug simulations. 
During the course of 100 ns simulations, tracers remained in this region of the bilayer, although a 
select few sampled regions closer to the membrane core, possibly due to the lower penalty of 
sacrificing drug-water or drug-lipid hydrogen bonds for these structures. A large number of other 
small molecules have been found to preferentially partition polar/aplor interface region of the 
membrane.55, 226, 232, 239-241 The reason for this preferential accumulation at this position in the bilayer 
is thought to be due to the lateral pressure profile of the membrane (section 1.2) – at the 
polar/apolar interface the lateral pressure has a large negative, attractive trough due to the 
hydrophobic effect, which acts to contract the lipid chains and minimise their exposure to water, this 
will hence attract and stabilise solutes.227 Furthermore, it has been proposed that solute partitioning 
strongly depends on the free energy of cavity formation; this work is proportional to the lateral 
pressure surrounding the solute.242 At the polar/apolar interface the lateral pressure is negative, 
meaning that the free energy of cavity formation is negative and this region of the bilayer is most 
favourable for solute accumulation. Furthermore, at the polar/apolar interface region the 
amphiphilic drug molecules will be able to maintain hydrogen bonds with both lipid head groups and 
water molecules. 
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The calculation of the membrane lateral pressure profile is possible via molecular dynamics 
simulation and has received considerable attention in the literature, with a number of different 
methods proposed.243-245 The most recent method for calculation of the local stress by Vanegas et al. 
highlights the importance of the force decomposition step to obtain a symmetrical stress tensor, 
revealing the reason for some unphysical results of previous methods.245 Thus there are a number of 
different techniques available to perform pressure profile calculations, with new methods 
sporadically appearing in the literature, in some cases reporting conflicting results. To compound the 
issue, the lateral pressure profile of a membrane is not currently accessible experimentally, meaning 
no given method can be deemed as ‘correct’ via comparison to experiment. Given that no single 
method has come to prominence as the accepted way in which to calculate the membrane pressure 
profile, and the absence of any of these methods in the AMBER simulation code, it was decided not 
to pursue this analysis. It would however be an interesting addition for further work. 
 
While partitioned at the polar/apolar interface within the bilayer, calculation of lipid order 
parameters reveals that the PET tracers act to order the surrounding lipid chains in the region in 
which they reside. This phenomenon is more prominent with increasing concentrations of PET tracer; 
furthermore the ordering effect is seen to be more pronounced for those tracers in the data set 
possessing higher NSB. This effect is also seen to lead to a decrease in the lateral diffusion of these 
PET tracers. It is possible that PET tracers having higher NSB act to order the membrane in which 
they reside, possibly acting to ‘trap’ tracer in the membrane. The condensing effect of the membrane 
may also act to lower membrane permeability, in a similar manner to cholesterol – increased 
concentrations of cholesterol in a lipid bilayer leads to increased ordering of lipid chains and a 
reduction in membrane permeability.27 
 
To quantify the lipid ordering observation, the average order parameter values of the 36mol% 
systems were calculated for the upper four carbons only (corresponding to the region in which the 
tracer sits) and are plotted against tracer NSB values in Figure 4.31. The trend remains general; it is 
also interesting that the sn-2 order parameter result exhibits far higher correlation with NSB, 
although this is predominantly due to the low SPI sn-1 result. 
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Figure 4.31 - Average order parameter values of the upper four carbon atoms of the lipid tails in the 
36mol% membrane systems versus non-specific binding. 
The choice to select the upper four carbons of the lipid chains for the calculation of the average 
order parameter was arbitrary and based on the order parameter plots – the drugs are observed to 
sit in this region and the ordering effect is most evident for these carbons. However further analysis 
on including either just the upper carbon atom in the chain or all carbon atoms up the DOPC double 
bond reveals that although the correlation between the average order parameter of the lipid tail and 
NSB decreases, it continues to hold – see Table 4.5. Also reported are p-values which measure the 
statistical significance of a result; in all cases p-values are below 0.05 predicting a strong presumption 
against the null hypothesis i.e. that this result is statistically significant. All p-values were calculated 
assuming a two-tailed distribution and two-sample unequal variance. 
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Table 4.5 - Correlation between NSB versus average order parameter data using increasing numbers 
of carbon atoms for the average order parameter calculation. 
No. of upper DOPC 
carbon chain 
atoms included in 
average |SCD| 
calculation 
Statistical correlation between 
average  sn-1 chain |SCD| and NSB 
Statistical correlation between 
average  sn-2 chain |SCD| and NSB 
Pearson 
correlation 
coefficient (R) 
p-value Pearson 
correlation 
coefficient (R) 
p-value 
1 0.4881 0.0322 0.9034 0.0318 
2 0.5470 0.0321 0.9354 0.0319 
3 0.5367 0.0321 0.8859 0.0320 
4 0.5002 0.0321 0.8248 0.0320 
5 0.4747 0.0321 0.7665 0.0320 
6 0.4459 0.0321 0.7107 0.0320 
7 0.4274 0.0320 0.6783 0.0320 
8 0.4057 0.0320 0.6468 0.0319 
In addition to cholesterol, a number of other small molecules act to induce ordering of lipid tails on 
introduction into the bilayer. The neutral form of the local anaesthetic articaine was found to order 
the lipid chains of a DMPC bilayer using MD simulation.246 Articaine consists of a single thiophene 
ring onto which are attached substituents including an amide and ester. As with the PET tracers, 
articaine preferentially positions just below the lipid head groups, inducing order in only the upper 
region of the lipid tails. This ordering of lipid chains by articaine has also been observed by NMR.247 
However unlike the present work, articaine was found to increase the dipole potential of a 
membrane, whereas all ten PET tracers acted to decrease the membrane dipole potential. The 
general anaesthetic propofol, which has a 2,6-diisopropylphenol structure, has also been found to 
order lipid chains.248 
 
The antipsychotic drugs chlorpromazine and thioridazine, which share a rigid, tricyclic phenothiazine 
skeleton, have both been found to order lipid tails in the region of the bilayer that they reside.55, 249 
This ordering behaviour agrees with experimental results obtained for similar phenothiazine 
derivatives.250 Curcumin, a plant extract with antioxidant, anticarcinogenic and anti-inflammatory 
properties is another molecule that has been observed to order lipid chains, on examination with 
solid-state NMR.251 Unlike cholesterol or phenothiazine derivatives it contains no fused rings; it 
consists instead of two aromatic rings connected by a diene chain. 
 
The ordering effect of the tracers on lipid chains, in the position of the membrane in which the PET 
tracers preferentially position, it not limited to this class of imaging agents, rather local anaesthetics, 
general anaesthetics and plant extracts have also been found to exert a similar effect on membranes, 
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both via MD simulation and experimental NMR studies. The degree of lipid chain ordering by the 
radiotracers is found to generally increase with NSB of the PET tracers, with increasing 
concentrations inducing higher chain ordering. As the lipid chain order increases the lateral diffusion 
of the tracers in the membrane plane is simultaneously found to decrease. These simulations 
indicate that those tracers with higher NSB are may be more likely to become ‘trapped’ in a 
membrane structure in vivo, the condensing effect of the membrane may also lower membrane 
permeability. 
 
Earlier computational work on the interaction between PET radiotracers and lipid molecules found 
correlation R=0.74 between in vivo NSB and the quantum mechanically calculated energy of 
interaction between a single radiotracer and single lipid molecule in the gas phase for the Golden ten 
set of tracers.18 It would be interesting if the position of the tracer in relation to the lipid from the 
QM optimised tracer-lipid complex also shows a preference for the polar/apolar lipid region as found 
during the MD simulations. 
 
Figure 4.32 - A raclopride-DOPC system after quantum mechanical optimisation in the gas phase. 
However on investigation of the final energy minimised structures from the work by Rosso et al.,18 it 
is seen that tracers move towards the head group region in order to optimise electrostatic 
interactions (see Figure 4.32); tracers are not seen to position preferentially in the upper region of 
the lipid chains.  
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5 Simulation of drug-membrane permeability: theory and 
applications 
 
Unbiased simulations may only provide a limited picture of drug-membrane interactions as it is 
unlikely that the drug of interest will sample all possible regions of the membrane, such as the 
membrane core. In order to overcome this, biased simulations may be performed, which constrain a 
drug at numerous points in the water and membrane regions in order to model the complete 
permeation of drugs through a membrane. The theory underlying such biased simulations is outlined 
and successful application to a range of small molecules is discussed. 
 
5.1 Potential of mean force technique 
 
Marrink et al.252 and Roux253 introduced the z-constraint potential of mean force (PMF) technique 
which allows the calculation of the free energy of transfer profile for the passive permeation of a 
small molecule across a lipid membrane. Using this method, local diffusion and resistance 
coefficients along the membrane normal may also be calculated, resulting in an overall estimation of 
the permeability coefficient. This method is based on the inhomogeneous solubility-diffusion model 
proposed by Diamond et al.254 to describe the permeation of solutes through a membrane, which 
addresses the heterogeneity of lipid bilayers and its impact on partitioning and transport through a 
membrane which is neglected by the bulk solubility diffusion-model. The PMF z-constraint method 
involves constraining the centre of mass of a small molecule of interest at a defined distance from 
the bilayer centre and recording the force required to satisfy this constraint. The distance along the 
bilayer normal is taken as the reaction coordinate and it is assumed that solute permeation depends 
only on translation through the bilayer i.e. that this is the only slow degree of freedom. A number of 
windows are simulated, with the small molecule constrained at different depths from the bilayer 
centre and the free energy of transfer profile constructed from the average constraint force for each 
window. This method has proven to be a popular way to study the interaction between small 
molecules and membranes via computational simulation – many such applications are reviewed 
below. 
 
Specifically, the z-constraint PMF method operates as follows.107 At each step, the separation 
between the solute and lipid bilayer centre of mass is held fixed by a constraint force in the direction 
along the bilayer normal only (z-axis). By performing a number of simulation steps the average force 
required to constrain a solute at a certain depth within a bilayer may be obtained. In order to 
calculate a free energy of transfer profile, the solute is constrained at a range of depths from the 
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bilayer centre, with these ‘windows’  covering solute depths from the centre of the bilayer out to the 
water phase. The free energy profile is then calculated by integrating the average constraint forces 
over distance z along the bilayer normal: 
                  
 
       
 5.1 
It is also possible to calculate local diffusion coefficients D(z) along the z-axis using the following 
formula: 
     
     
                    
 
 
 5.2 
where the denominator is the integral of the force fluctuation time autocorrelation function, in 
which: 
                       5.3 
The force fluctuation time autocorrelation function (ACF) involves a slowly decaying exponential tail, 
depending on sampling time it may be required to perform a non-linear least squares fit to a double 
exponential function: 
            
 
  
          
 
  
  5.4 
The use of a double exponential for this fit is due to the fact that the force fluctuation ACF displays 
solute motion inside the bilayer with two distinct timescales, τ1 and τ2. Motions with a short decay 
time τshort are due to the immediate response of the solute to its local environment; whilst motions 
with a long decay time τlong are related to the overall mechanism of diffusion through the membrane, 
generally thought to occur via a hopping mechanism. 
 
From the D(z) values it is also possible to obtain local resistances R(z) using: 
      
               
     
 5.5 
Finally by integrating R(z) an overall resistance to permeation, R, may be obtained and hence the 
permeability coefficient P, which is the inverse of R, calculated: 
           
 
       
 
 
 
 5.6 
Another related method to calculate free energy of transfer profiles is that of umbrella sampling, 
which restrains (not constrains) a solute at different bilayer depths using a force constant. The 
z-constraint method is essentially umbrella sampling with an infinite force constant. 
 
The umbrella sampling method involves the addition of a biasing potential (the force constant) to 
restrain a given coordinate such that it samples a point along a reaction path. Performing a series of 
windows with the biasing potential located at different points along the reaction path (e.g. with the 
solute at different depths along the bilayer normal) allows determination of the potential of mean 
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force. The primary disadvantage of the umbrella method is that the magnitude of the biasing 
potential to apply is not known a priori. 
 
5.1.1 Applications of the PMF method: Literature background 
 
The z-constraint PMF method was applied by Bemporad et al. to study the permeation of a number 
of small molecules across a DPPC bilayer.107 The set of molecules studied was chosen to represent 
common chemical functionalities as may be found in pharmaceutical compounds and contained 
water, ethane, methanol, benzene, acetic acid, acetamide, methylamine and methylacetate. Free 
energy profiles and permeability coefficients were computed, and although permeability coefficients 
were in general an order of magnitude higher than experimental values, crucially the rank ordering 
was correct. 
 
The transbilayer permeation of more clinically relevant drugs has also been studied computationally 
using the PMF method. The movement of valproic acid, an anticonvulsant and mood-stabilising drug, 
across a DPPC bilayer was studied computationally with the PMF method by Ulander et al.224 In order 
to investigate pH dependence, both the neutral valproic acid and its water-soluble anionic conjugate 
base valproate were studied, with the neutral form found to have a much lower barrier to 
permeation. The authors suggested the drug may approach the bilayer in charged form, become 
protonated upon membrane insertion to allow an easier path across the bilayer, and become 
charged again on leaving the bilayer. A similar study was undertaken by Karlsson et al. on the 
interaction between the anticoagulant drug warfarin and a DOPC bilayer, who also found a lower 
barrier to membrane permeation for the neutral form of the drug.110 
 
A detailed study on the interaction of photosensitive drugs with lipid membranes has been 
undertaken by Eriksson et al.108 The free energy of transfer profile for five psoralen derivatives was 
calculated, from these runs the diffusion coefficient along the normal, local resistance coefficients 
and overall permeability coefficients were also extracted. In addition, unbiased runs were also 
performed to determine lateral diffusion coefficients and the most favourable position within the 
bilayer for each drug. It was found that the more polar compounds had a higher barrier to bilayer 
permeation and were thus expected to reside in the bilayer for a longer period of time. This 
correlates with experimental findings that the more polar drugs are observed to cause more 
photodamage to membranes upon exposure to UV radiation due to higher accumulation in 
membranes. Another class of photosensitive drugs, hypericin and its derivatives, were also 
investigated by Eriksson et al. The effect of bromination on bilayer permeation was elucidated, 
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causing deeper penetration of hypericin into the membrane;255 whilst the addition of cholesterol to 
the membrane was seen reduce permeation coefficients.256 
 
The interaction of adamantanes, a class of compounds that have found use in the treatment of 
influenza A and Parkinson’s disease, with lipid bilayers was studied by Chew et al., due to the 
knowledge that the mode of action of these drugs involves blocking the channels of membrane 
bound receptors.257 The preferred location in the bilayer for the three drugs in the adamantane class 
of compounds was located, and free energy of transfer profiles revealed that the neutral form of 
each drug had a lower barrier to bilayer permeation. 
 
The interaction of nonsteriodal anti-inflammatory drugs (NSAIDs) with membranes has received 
considerable attention using computational techniques. Unbiased runs were used to study the 
partitioning of the NSAIDs naproxen and Relafen, at varying concentrations, into a DMPC bilayer. 
Metrics such as the electrostatic potential and order parameters were computed to study the effect 
of the drugs on the membrane; whilst diffusion coefficients, hydrogen bond formation and hydration 
of the drugs within the membrane were computed for both the charged and uncharged forms.258 A 
more in depth study on the permeation of the NSAIDs aspirin and ibuprofen through a DPPC bilayer 
was performed by Boggara et al.,231 who calculated the free energy of transfer profiles for both the 
charged and neutral forms of these drugs. The neutral forms were found to have a much lower 
barrier to bilayer permeation. Furthermore the charged forms were seen to permeate fully hydrated, 
whilst the neutral forms permeate unhydrated. The partition coefficient for the partitioning of the 
drugs into a membrane were found to have the same rank order as those found by experiment. 
 
The PMF method has also been applied to more general studies, such as the functional group 
dependence of solute partitioning in a bilayer,239 the effect of solvents such as DMSO on bilayer 
permeability,259 the effect of lipid hydrocarbon chain length on membrane permeability,260 the effect 
of lipid type and cholesterol content on solute partitioning into a bilayer,261 the partitioning of amino 
acid side chains into bilayers,262and further studies on the impact of cholesterol in a membrane on 
transbilayer permeability of a drug.263  
 
By performing PMF calculations at different temperatures, MacCallum et al.264 were able to 
determine the entropic and enthalpic contributions to the overall free energy of transfer profile of 
hexane through a lipid membrane, finding a delicate balance between the two components. The free 
energy minimum within the bilayer centre is entropically driven as expected, however interestingly 
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the near-zero free energy within the head group region is due to a balance of a large negative 
entropy component arising from the high packing of the lipids in this region and a large positive 
enthalpy component due to the higher number of favourable vdWs interactions that are possible in 
this region. Further references on the general application of the PMF method are available in an 
excellent review by MacCallum and Tieleman.241 
 
The studies reported above typically combine unbiased all-atom simulations of either a single drug 
molecule, or a range of different concentrations of a drug, with a DMPC, DPPC, DOPC or POPC 
bilayer, using all-atom z-constraint simulations. The unbiased simulations provide the preferential 
position and orientation of a drug within a bilayer and may also reveal the effect of specific drug 
concentrations on a membrane. More detailed insight is provided by biased runs, which reveal free 
energy of transfer profiles and an overall estimation of the permeation coefficient. In most cases, the 
biased simulations used window lengths on the 10-30 ns timescale due to the computational 
expense of these all-atom simulations. 
 
5.1.2 Methodological and convergence considerations with the PMF method 
 
Recently there have been a number of studies on the statistical convergence of PMF results. Neale et 
al.265 inserted leucine and arginine side-chains into a DOPC bilayer, at distances from -32 Å to 32 Å 
from the bilayer centre and separated at 1 Å intervals. Umbrella sampling simulations were 
performed with a window length of 205 ns in order to construct the free energy of transfer profiles. 
The convergence of the free energy profiles was found to be much slower for the charged solutes. 
Furthermore the insertion procedure was seen to introduce membrane defects, with membrane 
reorganisation occurring on a long timescale, in some cases longer than the 205 ns sampling 
windows used. In order to accelerate the convergence of umbrella sampling results, a random walk 
method has been proposed to overcome hidden sampling barriers.266 
 
A broader study on the PMF method has been performed by Paloncyovà et al.,109 who investigated 
the effect of the solute charge derivation method, insertion procedure into the membrane and PMF 
method used (umbrella sampling or z-constraint) for the permeation of the organic compound 
coumarin through a DOPC bilayer.  Solute charges derived using the RESP procedure were found to 
give the best results, whilst starting windows extracted from unbiased drug-bilayer simulations 
avoided the introduction of membrane defects. Finally the z-constraint method allowed for faster 
convergence of free energy profiles in comparison to the umbrella sampling method. Windows were 
in general 30 ns in length, though some were extended to 50-100 ns. 
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Comer et al. combined the adaptive biasing force method with Bayesian statistics to calculate the 
permeability of water molecules through a POPC bilayer.267 The adaptive biasing force method 
applies an estimated instantaneous biasing force to restrain a molecule along a reaction coordinate; 
this biasing force improves with simulation duration. As with other PMF methods, the average force 
at different positions along a reaction coordinate may then be integrated to yield the free energy of 
transfer. Comer et al combine this method with a Bayesian interference algorithm to improve 
precision and spatial resolution. In their study, the influence of force field parameters, non-bonded 
cut-off distance, system size, thermostat and timescale on permeability results were examined. Force 
field parameters are found to exert a large influence on results, with the TIP3P and TIP4P-ew water 
models giving markedly different permeation coefficients. 
 
The influence of solute polarisation on membrane partitioning has also been studied by Jämbeck et 
al.268 Atomic charges were computed in the water and hexane phases for a range of small molecules. 
PMF calculations were then performed using the umbrella sampling method, using charges derived 
in water for windows in the water and lipid head group regions, whilst charges derived in hexane 
were used for windows in the lipid tail group region and a polarisation correction term employed to 
account for the change in polarisation energy. The implicit inclusion of polarisation was seen to have 
an influence on computed free energy of transfer profiles and allowed better agreement with 
experiment for computed free energies of transferring solutes from water to n-hexadecane. 
 
There has also been substantial work on multiscale models to study the permeation of small 
molecules through a membrane, allowing access to longer timescales and ensuring better 
convergence. Orsi et al. developed a coarse-grained lipid force field, which has been combined with 
all-atom representations of small molecules to compute free energy of transfer profiles using the 
z-constraint method.103 This dual resolution approach results in force fluctuation ACFs that do not 
require fitting to a double exponential function (equation 5.4), as is normally needed in all-atom z-
constraint simulations. This technique has been used to study the membrane interactions of 
antimicrobials,232 β-blockers and hormones.227  
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5.2 Summary 
 
The publications reviewed in this chapter indicate that the computational simulation of drug-
membrane systems and the use of the PMF technique may rationalise experimental results, suggest 
a mode of action of drug molecules and match experimental rank ordering of permeation 
coefficients for a set of compounds. A guide of best practice has been proposed, suggesting PMF 
windows should be prepared using unbiased simulations and also that the z-constraint method 
affords faster convergence of results than umbrella sampling. The PMF method may also be 
implemented to account for atomic polarisation; while the use of multiscale models allows faster 
simulation times. 
  
Due to the fact that all-atom simulation speeds are continuing to increase, the virtual screening of a 
small set of compounds to predict drug permeability through a lipid membrane is becoming 
tractable. There has thus been some interest from the pharmaceutical industry in the PMF method 
due to the importance of pharmaceutical ADMET (adsorption, distribution, metabolism, excretion 
and toxicological) properties, many of which are influenced by the ability of a drug to passively 
diffuse across a membrane.53, 269-270  
 
In chapter 4 unbiased simulations of tracer-membrane simulations revealed the preferred location of 
tracers in the membrane, hydrogen bonding behaviour of tracers, diffusion of tracers in the plane of 
the membrane and the effect of differing concentrations of tracer on the membrane structure. 
However very few tracers were observed to sample the membrane core region, with no complete 
membrane permeation events observed. In order to study the membrane permeation of the PET 
tracers it is proposed to perform z-constraint simulations of each of the ten PET tracers in the data 
set under study through a hydrated DOPC bilayer. Such simulations have proven insightful for other 
classes of small molecules and allow calculation of the permeation coefficient. As the AMBER code 
does not currently support such simulations, the possibility of inserting the z-constraint method into 
AMBER must first be investigated, or at least the possibility of performing such simulations using 
AMBER parameters in combination with an alternative MD engine. 
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6 PET tracer-membrane permeation simulations 
 
The permeation of each of the ten PET radiotracers through a DOPC membrane is determined using 
potential of mean force calculations, allowing a prediction of the overall permeability coefficient. 
These simulations also allow the study of the local resistance, orientation, hydrogen bonding and 
diffusion at different positions along the membrane normal. Resulting permeation coefficients 
indicate that non-specific binding is not linked to membrane permeation, at least not through a 
homogeneous DOPC membrane. 
 
6.1 Z-constraint PMF method in GROMACS with AMBER parameters 
 
As outlined in chapter 0, the z-constraint PMF method is the ideal choice to study the permeation of 
a molecule through a bilayer using molecular dynamics simulation. However the AMBER code does 
not support such simulations. Although umbrella sampling runs are possible using the SANDER 
module, this implementation is designed for angle or torsion scans; it is not possible to perform 
umbrella sampling using the distance from a bilayer centre as the reaction coordinate as would be 
required to study molecular permeation. Furthermore, the SANDER code does not allow the 
simulation times achievable with the efficiently parallelized PMEMD CPU or PMEMD CUDA codes. 
 
For this reason, a preliminary version of the z-constraint PMF method was inserted into the AMBER 
MD code. The original implementation by Marrink and Berendsen252 and Roux,253 which resets the 
constrained molecules position along the z-axis with each step, was added into the AMBER source 
code (SANDER, PMEMD and PMEMD.MPI routines). The modified code was then passed to the 
Walker MD lab, UCSD, who looked into updating the code to implement a revised z-constraint 
method,103, 271 which resets the constrained molecules velocity and force along the z-axis with each 
step and thus conserves detail balance. However, complications regarding the implication of this 
method arose and it became clear that suitable code would not be available to perform PMF 
calculations using the AMBER package in a reasonable timeframe. 
 
The GROMACS simulation package272 was instead used for all work in this chapter, as it contains the 
z-constraint PMF method, furthermore it is possible to perform molecular simulations in GROMACS 
using AMBER parameters. The PMF method was first validated against previous z-constraint results 
available in the literature, then applied to the study of the permeation of the Golden ten set of PET 
radiotracers through a DOPC membrane, in order to investigate any potential link between 
membrane permeation and NSB. 
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6.1.1 Converting AMBER parameter files into GROMACS format 
 
In order to perform z-constraint PMF simulations, the AMBER topology and coordinate files were 
converted into GROMACS format and simulated using the GROMACS v4.5 package.272 The ACPYPE 
python wrapper was used for all conversions.273 The ACPYPE tool correctly converts AMBER bond, 
angle, electrostatic, Lennard-Jones and torsion parameters into GROMACS format.  
 
In order to validate that GROMACS is capable of supporting the AMBER force field, a comparison 
between AMBER and GROMACS single-point energies of a simple pentadecane chain was performed. 
The AMBER topology and coordinates for pentadecane with standard GAFF parameters were first 
generated. These were then converted into GROMACS format (with Fourier rather than Ryckaert-
Belleman type dihedrals). Visual inspection of the resulting GROMACS topology file confirmed that it 
contained the correct AMBER parameters (bond, angle, charge, L-J and dihedrals). Then a single 
point energy calculation was performed using the GROMACS package. The same structure was post-
processed using AMBER to obtain the corresponding AMBER energies (AMBER performs a single step 
of minimization prior to reporting energies; this would thus alter the structure and the resulting 
energies would not be for the same structure as used for the GROMACS single point energy 
calculation). Results of the energy comparison are reported in Table 6.1 - values are observed to be 
extremely similar, in most cases agreeing to the third decimal place, confirming that GROMACS is 
able to correctly support the AMBER force field. 
Table 6.1 - Comparison between single point energies of a pentadecane chain, modelled using 
AMBER GAFF parameters, calculated with the AMBER and GROMACS simulation packages. 
 AMBER (kJ/mol) GROMACS (kJ/mol) |ERROR|% 
BOND 24.98140880 24.98120000 0.000835829 
ANGLE 6.59523920 6.59507000 0.002565553 
DIHED 20.13173440 20.13190000 -0.000822575 
1-4 NB 27.51607600 27.51560000 0.001729928 
1-4 EEL -0.97194320 -0.97185700 0.008869618 
VDWAALS -7.48517600 -7.48531000 -0.001790173 
EELEC 1.43720400 1.43703000 0.012108307 
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6.1.2 The GROMACS PMF algorithm 
 
GROMACS uses the SHAKE algorithm to constrain the distance between the centre of mass of two 
molecular groups, for example a lipid bilayer and small molecule, reporting the force required to 
satisfy this constraint. The SHAKE algorithm is detailed in the theory chapter (section 2.2.4). 
Specifically, this work used the ‘pull=constraint; pull_geometry=distance’ settings of the GROMACS 
pull code in one dimension to apply a distance constraint between the centre-of-masses of a small 
molecule and a DOPC bilayer along the z-axis (i.e. the z-axis is taken to be the reaction coordinate). 
 
6.2 PMF validation simulations 
 
In order to validate both the GROMACS implementation of the z-constraint PMF method and the 
AMBER parameters, the permeation of a number of small molecules was calculated and compared to 
other simulation values available in the literature. Although exact comparison is not expected, due to 
differences in the simulation code, parameters and resolution (for example all-atom versus coarse-
grained simulation), the results should be expected to match the ranking of permeates and obtain 
free energy of transfer profiles and permeation coefficients which are generally similar, provided 
adequate sampling has been obtained. 
 
The following molecules were chosen for the validation study, in order to ensure the test set had a 
polar, non-polar and amphiphilic solute: 
 Water 
 Benzene 
 Methanol 
 
6.2.1 System setup and simulation settings 
 
The 72-DOPC membrane patch with hydration level 70 waters per lipid equilibrated for 90ns in the 
single drug-bilayer runs (section 4.2) was used as a starting point to construct systems for validation 
of the z-constraint PMF method.  
 
The small molecules water, benzene and methanol were inserted at depths 0 Å, 2 Å, 4 Å, … , 3  Å 
from the bilayer centre of mass, creating 17 windows per solute and ensuring that all environments 
from the hydrophobic core of the membrane out to the water phase are sampled. The free energy of 
transfer through the entire bilayer is then accessible given that both leaflets are assumed to be 
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symmetrically identical. All systems then underwent a short minimization using the steepest descent 
method to remove bad contacts. 
 
When performing PMF simulations using the GROMACS code, simulation conditions and protocol 
were identical to the Lipid14 membrane validation runs with a few exceptions due to differences in 
the GROMACS and AMBER code: heating in NVT used the velocity-rescaling thermostat274 with the 
constrained molecule, bilayer and water all coupled to separate thermostats. NPT simulations used 
the Nose-Hoover thermostat,275-276 again with three separate heat baths, and the Parrinello-Rahman 
barostat277 for semi-isotropic pressure scaling. The centre of mass of the constrained molecule was 
fixed at a certain depth from the bilayer centre of mass and the constraint force recorded at every 
step. The centre of mass motion of the system was removed at every step. 
 
All other settings remained the same as previous AMBER membrane simulations: a 10 Å cut-off was 
used for electrostatic and vdW interactions, PME treated electrostatics beyond the cut-off, an 
analytical dispersion correction was used to correct for the vdW component of the energy and 
pressure beyond the cut-off, bonds involving hydrogen were constrained allowing a 2 fs timestep, 
coordinates were written every 10 ps. Each window of the small molecule PMF validation simulations 
was 30 ns in length, with the first 5 ns removed for equilibration. All simulations were run in parallel 
on the Imperial High Performance Computing cluster using 12-core nodes, achieving approximately 
15 ns per day. 
 
6.2.2 Checking convergence 
 
A number of recent z-constraint PMF simulations in the literature used a window length of 30 ns,109, 
278 spurring the choice of 30 ns windows for the small molecule PMF validation simulations. As 
observed by Orsi et al.,103 the constraint force fluctuates on the tens of ns timescale (Figure 6.1), thus 
windows spanning 20-30 ns at a minimum are required to obtain converged results. 
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Figure 6.1 - Fluctuation of the z-constraint force to constrain a water molecule at the centre (z=0 Å) 
of a DOPC bilayer. The constraint force is plotted as a moving average using window length 1 ns. 
Convergence may be examined by calculating the free energy profile using increasingly longer PMF 
windows. For this reason, after discarding the first 5 ns of each window for equilibration, the free 
energy of transfer profile of a water molecule through the DOPC bilayer was computed using the first 
5 ns, 10 ns, 15 ns and 20 ns of each window; then finally the full remainder of the window (25 ns). 
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Figure 6.2 - Free energy of transfer profile for movement of a water molecule through a DOPC bilayer 
computed using increasing window lengths. 
As can be seen from Figure 6.2 all profiles are of a similar shape, however in general the free energy 
maximum (in this instance at the centre of the bilayer) decreases as window length increases. The 
profiles for 10 ns and 15 ns windows are very similar, with results for 20 ns and 25 ns windows 
virtually identical, indicating that by this point the free energy profile has converged. 
 
From the ACF of the constraint force fluctuation it is then possible to calculate local diffusion values, 
local resistances and finally an overall permeation coefficient for movement of a molecule through a 
membrane (equations 5.2-5.6 in chapter 0). Consequently it is of interest to study resulting 
constraint force fluctuation ACFs and compare results to those available in the literature. The 
constraint force fluctuation ACF for a water molecule in different regions of a DOPC bilayer is shown 
in Figure 6.3 (computed from 25 ns windows). Specifically, the water is constrained in an area of low 
tail group density (centre of the membrane, z=0 Å), high tail group density (z=8 Å), high head group 
density (z=14 Å) and finally in the water phase (z=32 Å). 
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Figure 6.3 - The constraint force fluctuation autocorrelation function for a water molecule 
constrained in different regions of a DOPC bilayer. 
It is seen from Figure 6.3 that despite using a 25 ns sampling PMF window, the force fluctuation ACF 
does not always go to zero during the 0.5 ps ACF plot. For this reason, the force fluctuation ACF was 
fitted to a double exponential function (equation 5.4), with the coefficients τshort being related to the 
immediate response of the solute to the environment and τlong being related to the hopping 
mechanism of the diffusion of the solute through membrane. Similar behaviour of the constraint 
force fluctuation ACF for water is observed to that reported by Bemporad et al., using an all-atom 
DPPC model.107 Moving outwards from the bilayer centre, the force fluctuation ACF at t=0 tends to 
increase and the decay time τshort to decrease. 
 
In practice, the force fluctuation ACF was best fitted using a window length of 2 ps, a typical example 
is shown in Figure 6.4. 
170 
 
 
Figure 6.4 - The force fluctuation ACF for constraining a water molecule at the centre of a DOPC 
bilayer (z=0 Å) and a non-linear least squares fit to the double exponential function. 
The PMF of water, benzene and methanol was calculated using GAFF parameters for the solutes 
(water had TIP3P parameters), Lipid14 parameters for DOPC and the GROMACS molecular simulation 
engine. Results are reported as block averages using two blocks of 12.5 ns, and standard error of the 
mean. The free energy profile is calculated by integrating the average constraint force as a function 
of the distance z from the bilayer centre of mass (equation 5.1), with the water phase used as the 
zero for integration. 
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6.2.3 PMF validation results 
 
6.2.3.1 Free energy of transfer 
 
The free energy of transfer profile of water, benzene and methanol through a DOPC bilayer is shown 
in Figure 6.5. 
 
Figure 6.5 - Free energy of transfer for water, benzene and methanol as a function of distance 
between solute centre-of-mass and DOPC bilayer centre. 
Water free energy. The free energy result for water displays a maximum in the hydrophobic centre of 
the membrane, as should be expected for a polar molecule. The maximum value of 
27.13±1.36 kJ/mol compares well to previous all-atom results of 26±2 kJ/mol by Marrink and 
Berendsen252 using a DPPC membrane at 350 K, though it is slightly higher than the 22.9±1.9 kJ/mol 
result by Bemporad et al.,107 who used a DPPC membrane at 323K. The maximum ΔG value is in 
excellent agreement with 28.1±0.7 kJ/mol obtained by Orsi et al.103 using a coarse-grained DOPC 
membrane at 303 K (i.e. the same lipid system and simulation temperature as the present work) and 
the SSD potential for water. 
 
Benzene free energy. The free energy of transfer profile for benzene is observed to display a small 
barrier of 0.61±0.19 kJ/mol on approaching the head group region of the bilayer (z=24 Å) before 
dropping to a global minimum of -11±0.47 kJ/mol at the top of the lipid chains/just below the 
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glycerol region (z=12 Å). The ΔG then increases slightly and levels off at -9.1±0.95 kJ/mol in the 
bilayer core. This result compares reasonably well with the literature value for the free energy of 
transfer of benzene into hexadecane (-12.3 kJ/mol),279 it should however be noted that hexadecane 
may not fully represent the hydrophobic core of a membrane, due to differences in lateral packing. 
The present results differ from those reported by Bemporad et al. and Orsi et al., since the all-atom 
result by Bemporad et al. saw the benzene ΔG reach a minimum of just -4.8±2.1 kJ/mol in the centre 
of the membrane, whereas the multiscale result by Orsi et al. actually saw the benzene ΔG increase 
to a positive value in the centre of the membrane. It is possible that the Bemporad all-atom result 
requires further sampling, as PMF window lengths were 2 ns. However the multiscale result by Orsi 
et al. used extremely long PMF windows (80 ns), consequently it can only be assumed that the 
different benzene PMF result is due to the multiscale membrane model used. 
 
Figure 6.6 - A benzene molecule constrained at the centre of a DOPC membrane. Lipid head groups 
are shown with the choline nitrogen coloured blue, the phosphate phosphorus atom in orange and 
all oxygen atoms in red. Carbon atoms are coloured grey. 
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Methanol free energy. The methanol free energy of transfer profile is observed to increase to a local 
maximum of 1.51 kJ/mol on moving from the water phase into the head group region of the 
membrane. The ΔG profile then decreases slightly to a global minimum of -0.3 kJ/mol at a distance of 
14 Å from the bilayer centre, before rising to a global maximum of 13.77 kJ/mol in the centre of the 
membrane core. These results are consistent with those reported by Orsi et al., who found a similar 
free energy profile (small barrier in the head group region, dropping to a global minimum in the 
glycerol region and rising to a barrier of approximately 14 kJ/mol in the membrane core) and also all-
atom results by Patra et al.,280 who used unbiased simulations to show that methanol preferentially 
accumulates in the glycerol region (14 Å from the membrane centre). Furthermore, the maximum in 
the membrane core of 13.77 kJ/mol is close to the experimental free energy of transfer of methanol 
from water into hexadecane of 15.9 kJ/mol.279 The free energy curve for methanol is however 
different from the all-atom result by Bemporad et al., who observe the ΔG profile to monotonically 
increase on entering the bilayer to a maximum of about 20 kJ/mol in the membrane core, thus 
predicting methanol to preferentially accumulate in the water phase. 
 
6.2.3.2 Local diffusion coefficients 
 
As previously outlined, the constraint force fluctuation ACF may then be used to calculate local 
diffusion and resistance coefficients along the bilayer normal. The diffusion and resistance 
coefficients for water, benzene and methanol are shown in Figure 6.7 and Figure 6.8. 
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Figure 6.7 - Local diffusion profiles for water, benzene and methanol as a function of distance 
between solute centre-of-mass and DOPC bilayer centre. 
Water diffusion. The local diffusion profile for water follows those reported by Bemporad et al. and 
Orsi et al., with the bulk water value of 3.2x10-5 cm2/s, which is close to the experimental value of 
(2.3±1.5%)x10-5 cm2/s for the self-diffusion of water measured using the proton spin echo method.281 
As also found by Bemporad et al. and Orsi et al., diffusion then decreases moving into the membrane 
until rising to a peak in the membrane core, with D(z) being 1.22x10-5 cm2/s at the membrane centre. 
These results are however inconsistent with previous findings by Marrink and Berendsen252 and 
Shinoda et al.,282 who both found water to diffuse faster (more than twice as fast) in the membrane 
core than in bulk solution. This behaviour is ascribed to the hopping mechanism by which water, a 
small solute, diffuses; with the membrane core having the lowest density than any other region in 
the system. The different results may be due to different membrane models. 
 
Benzene diffusion. The benzene diffusion profile is again similar to those reported by Bemporad et 
al. and Orsi et al., with D(z) being about 0.5x10-5 cm2/s throughout the hydrophobic membrane 
region, rising to 2.5x10-5 cm2/s in bulk solution. Furthermore, the diffusion coefficient in the 
membrane core is 0.55 x10-5 cm2/s, which compares favourably with previous the theoretical result 
of 0.46 x10-5 cm2/s found by Stouch et al.283 
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Methanol diffusion. The diffusion result for methanol is very similar to the all-atom result by 
Bemporad et al., with the diffusion coefficient D(z) being 3.7x10-5 cm2/s in solution, before quickly 
dropping to approximately 0.5x10-5 cm2/s inside the membrane. D(z) then rises again to a local 
maximum of 0.86x10-5 cm2/s  in the centre of the membrane, in good agreement with Bemporad et 
al. These results are also consistent with the multiscale values reported by Orsi et al., with the 
exception of the D(z) values in the solution phase, which come out lower in the multiscale model 
(D(z) for methanol is approximately 1x10-5 cm2/s in water). However, overall both the shape of the 
local diffusion profile and D(z) values are in reasonable agreement with previous results. 
 
6.2.3.3 Local resistance coefficients 
 
 
Figure 6.8 - Local resistance profiles for water, benzene and methanol as a function of distance 
between solute centre-of-mass and DOPC bilayer centre. 
Water resistance. The local resistance profile for water is very similar in shape to those reported by 
Bemporad et al. and Orsi et al., however actual R(z) values are somewhat different. In the all-atom 
result by Bemporad et al., R(z) rises to about 500x106 s/cm2 near the membrane core, then displays a 
local minima at the membrane centre. The multiscale results by Orsi et al. display much larger R(z) 
values, with local resistance rising to 10000x106 s/cm2  at the membrane centre. The present results 
are thus closer to those reported by Orsi et al., which used a DOPC membrane and longer sampling 
than Bemporad et al. Given that the present water free energy result is closer to the Orsi et al. result, 
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it is not surprising that the local resistance result is also comparable, given that the two quantities 
are related via equation 5.5, with R(z) having an exponential dependence on ΔG.  
 
Benzene resistance. The local resistance result for benzene is very similar to the all-atom result by 
Bemporad et al., displaying exactly the same shape, however R(z) values are a little lower: Bemporad 
et al. reported a maximum of 0.5x106 s/cm2 at z=20 Å, whilst the present results reach a maximum of 
0.3x106 s/cm2 at z=22 Å. This is likely due to the different free energy of transfer result, given that 
diffusion profiles are very similar. 
 
Methanol resistance. The methanol local resistances are far lower than the all-atom result by 
Bemporad et al., which reached a peak of approximately 700x106 s/cm2 in the membrane core, 
presumably due to the different free energy result. The peak local resistance of 52x106 s/cm2 in the 
present work is however close to the multiscale result by Orsi et al., which rose to a maximum of 
approximately 100x106 s/cm2in the membrane centre. 
 
6.2.3.4 Permeability coefficients 
 
Finally, the resistance profiles were integrated according to equation 5.6 in order to obtain an overall 
value for the permeation coefficient through a DOPC membrane. The PMF results for both water and 
methanol are for the most part similar to the multiscale results obtained by Orsi et al., thus the 
water and methanol permeability coefficients in the present work are also expected to be similar. 
However, the benzene PMF result displays discrepancies with both the all-atom result by Bemporad 
et al. and the multiscale result by Orsi et al., meaning the overall permeability coefficient for benzene 
is likely to be different from previous results. 
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Table 6.2 - Calculated permeability coefficients (cm/s) and comparison to literature simulation and 
experimental results. 
Solute Present work Literature 
simulation 
Reference Literature 
experiment 
Reference 
Water 5.2 (±1.6) x10-3 1.33 (±0.28) x10-2 a 
1.4 (±0.28) x10-3 b 
3.2 (±0.6) x10-3 c 
7.0 (±3.0)x10-2 d 
6.8 x10-2 e 
4 x10-2 f 
1.6 x10-2 a 
107 
103 
278 
252 
260 
260 
282 
15.8 x10-3 † 
15 x10-3† 
13.6 x10-3‡ 
284 
285 
286 
Benzene 56.67 (±6.9) 9.91 (±1.11) a 
7.8 (±2.6) b 
29 (±3)g 
107 
103 
287 
  
Methanol 7.76 (±0.38) x10-1 1.94 (±0.44) x10-2 a 
1.8 (±0.2) x10-1 b 
107 
103 
  
aDPPC at 323K. bDOPC coarse-grained at 303K. cDOPC with 20mol% cholesterol at 303K.  
dDPPC at 350K. eDMPC at 320K. fDPPC at 320K. gDMPC coarse-grained at 303K. 
†DOPC at 303K. ‡POPC at 308K. 
The permeation coefficient for water through a DOPC membrane is found to be on the same order of 
magnitude as the multiscale result by Orsi et al., though roughly 4x times higher (5.2x10-3 c.f. 
1.4x10-3 cm/s), bringing it closer to the experimental values of 15x10-3 and 15.8x10-3 cm/s, both 
obtained using a DOPC bilayer at 303 K. Furthermore, the present result of 5.2x10-3 cm/s is 
moderately higher than the 3.2 x10-3 cm/s obtained by Jämbeck et al.,278 which also used the 
GROMACS z-constraint code, however with a DOPC bilayer containing 20mol% cholesterol at 303 K. 
Given that cholesterol is known to have a condensing effect on a membrane, ordering the lipid tails 
and thereby introducing a resistance to permeation, this is physically reasonable. The simulation 
result thus underestimates the permeability of water through a membrane, a conclusion also 
reached by Jämbeck et al. 
 
As with the result for water, the permeability coefficient for benzene is in general 4-5x higher than 
previous simulation results, however this is due to benzene finding a lower ΔG in the membrane 
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interior in the present work, which as previously stated is close to the experimental 
ΔG(water→hexadecane) value. However as yet there are no experimental values with which to 
compare the present results. The permeation of benzene through a DPPC bilayer was calculated to 
be 29 cm/s using multiscale methods by Orsi,287 it seems physically reasonable that the value of 
57 cm/s in the present work is higher than the DPPC value given that DOPC membranes have a 
higher area per lipid and hence present a lower barrier to solute permeation. The permeability 
coefficient for methanol is far higher than the previous all-atom result, likely due to the lower ΔG 
maximum at the membrane centre, and approximately 4x higher than the multiscale result for 
methanol permeation through a DOPC membrane. This is likely due to the lower resistance 
coefficients displayed by methanol in the present work in comparison to the multiscale results. 
 
6.3 Free energy of transfer of the Golden ten PET tracers 
 
6.3.1 System setup 
 
The free energy of transfer for the data set of ten PET radiotracers studied using unbiased 
simulations in chapter 4 was then calculated. The initial coordinates for each of the PMF windows for 
the Golden ten were extracted from the previous unbiased simulations of the PET tracer-DOPC 
bilayer systems (section 4.2), ensuring that the tracer was positioned 0 Å, 2 Å, 4 Å, … , 3  Å from the 
bilayer centre. In instances where the drug did not permeate all the way to the centre of the bilayer 
during the course of the unbiased simulation, the growing procedure (section 4.3) was used to create 
these windows, using the bilayer structure from the unbiased window that was closest to the bilayer 
centre. 
 
Windows for the PET tracer PMF runs were simulated in GROMACS with identical settings to the 
previous PMF validation runs, with the exception that each window was 45 ns in length to gain more 
sampling. The first 5 ns are removed for equilibration; results are reported as block averages ± 
standard error, achieved by splitting the remaining production time into two blocks of 20 ns. As with 
the PMF validation study, all simulations were run in parallel on the Imperial High Performance 
Computing cluster using 12-core nodes, achieving approximately 15 ns per day. 
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6.3.2 Golden ten PMF results 
 
6.3.2.1 Free energy of transfer 
 
The free energy of transfer profiles from the water phase through a DOPC membrane for the ten PET 
radiotracers under study are shown in Figure 6.9. 
 
 
Figure 6.9 - Free energy of transfer for the ten PET radiotracers as a function of distance between 
tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in order of increasing NSB, tracer 
NSB values are also given in the legend. 
It is seen that all PET tracers possess a free energy profile with a shape typical of that for other 
amphiphilic molecules,103, 224, 227, 231-232 with ΔG showing a slight increase on approaching the lipid 
head groups for FLU and SPI only, before rapidly dropping to a minimum just below the head group 
region for all ten radiotracers, at the polar/apolar interface. On moving towards the membrane 
centre, the ΔG then rises again.  
 
These results are in accordance with the previous unbiased simulations, which found all ten tracers 
to preferentially position just below the lipid head group region of the membrane, given that all ten 
tracers display a ΔG minimum at this position (10-12 Å from the bilayer centre), with FLU displaying a 
minimum of -10 kJ/mol and the remainder of the set have a minimum lying roughly between 
-30 kJ/mol and -40 kJ/mol. On moving to the membrane centre, the ΔG rises yet remains negative for 
180 
 
all tracers other than FLU, which displays a rapid increase in ΔG to 10 kJ/mol. It is interesting that the 
partitioning of FLU into the membrane is least favourable of the ten PET radiotracers, given that it 
also has the lowest NSB value. However beyond this observation there is no clear relationship 
between the free energy profiles of the PET tracers and their experimental NSB values, for example 
SPI which has the highest NSB value of the data set possesses a very similar free energy of transfer 
profile to ROL, which has one of the lowest NSB values in the set. 
 
The free energy curves may essentially be interpreted as follows (Figure 6.10): movement of the 
tracers from the water phase into membrane to the polar/apolar interface comes with a favourable 
change in free energy, ΔGwat; to extract the tracers from this region back into water therefore 
requires movement back across a free energy barrier of height ΔGwat. Due to the rise in the free 
energy profile on moving towards the membrane core, for the tracers to fully permeate the 
membrane they face a barrier of height ΔGpen then a further barrier of height ΔGwat on the opposite 
side of the membrane.  
 
Figure 6.10 - The free energy landscape for the permeation of the PET tracers through a membrane 
may be characterised by two barriers of height ΔGwat and ΔGpen. 
The values of each of these free energy barriers are given in Table 6.3, as may be deduced from the 
free energy curves no particular trend is observed that correlates with in vivo NSB. 
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Table 6.3 - The free energy barriers faced by radiotracers permeating a DOPC membrane. 
 ΔGwat (kJ/mol) ΔGpen (kJ/mol) NSB (mL/g) 
FLU -11.60±2.53 23.20±3.90 1 
FAL -34.46±2.22 13.33±5.16 3.93 
ROL -29.51±1.45 20.43±5.77 6 
RAC -41.22±3.03 5.59±7.21 10.25 
DIP -37.20±0.61 24.22±4.11 13.5 
WAY -39.85±4.77 15.92±7.57 13.83 
MDL -43.81±0.71 18.17±0.90 55.25 
NPA -41.89±2.37 12.92±5.94 67 
DAS -35.60±1.80 13.38±2.89 100.12 
SPI -30.94±0.51 17.38±0.57 165.67 
 
6.3.2.2 Local diffusion coefficients 
 
The local diffusion coefficients in the direction parallel to the membrane normal are shown as a 
function of distance from the membrane centre in Figure 6.11. 
 
Figure 6.11 - Local diffusion D(z) along the membrane normal for the ten PET radiotracers as a 
function of distance between tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in 
order of increasing NSB. 
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It is seen that local diffusion of all tracers is approximately 1x10-5 cm2/s in the bulk water phase, with 
D(z) decreasing approaching the lipid head groups, then dropping to a value of approximately 
0.25x10-5 cm2/s within the membrane. D(z) remains roughly at this value for all regions inside the 
bilayer, though it drops to approximately 0.1x10-5 cm2/s at the very centre of the membrane. This 
shows that these molecules are too large to display the enhanced diffusion at the membrane centre 
which some smaller solutes experience, for example the water result in section 6.2.3.2. These results 
are in agreement with other simulation results, which found D(z) to remain relatively constant 
regardless of position within the bilayer.227, 231 Furthermore, the D(z) value of 0.25x10-5 cm2/s inside 
the membrane is close to the experimental result of ≈0.23x10-5 cm2/s for the diffusion of the small 
molecule aspirin in a lecithin bilayer.288 
 
The diffusion of the tracers in the membrane plane was also calculated as a function of distance from 
the membrane centre via mean-square-displacement of the PET tracers in the same manner to 
section 4.2.1.4, results are plotted in Figure 6.12. 
 
Figure 6.12 - Lateral diffusion D(xy) in the membrane plane for the ten PET radiotracers as a function 
of distance between tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in order of 
increasing NSB. 
It is seen from Figure 6.12 that although the lateral diffusion takes a similar value to the diffusion 
coefficients along the z-direction in the water phase, D(xy) values rapidly drop on moving into the 
membrane, remaining at ≈0.01x10-5 cm2/s (or 10 x10-8 cm2/s), which is similar to the diffusion 
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coefficient values found for the unbiased single drug-bilayer and mol% simulations in chapter 4, in 
which tracers remained in the bilayer region just below the head group. Such a difference in D(z) and 
D(xy) values has previously been found in PMF simulations for hormomes permeating a DOPC 
membrane227 and may be explained due to the “free-volume” mechanism by which the drugs diffuse 
in the bilayer. The lipid molecules are orientated along the membrane normal, thus many more 
pockets of free-volume will exist in this direction, allowing higher rates of diffusion in this direction. 
 
6.3.2.3 Local resistance coefficients 
 
The local resistance profiles for the ten PET radiotracers are plotted in Figure 6.13. 
 
Figure 6.13 - Local resistance profiles for the ten PET radiotracers as a function of distance between 
tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in order of increasing NSB. 
It can be seen that the resistance profiles display a similar shape and rank ordering as the free energy 
profiles for the PET tracers, which is unsurprising given the exponential relationship between R(z) 
and ΔG. By far the highest R(z) value is displayed by FLU at the membrane centre, this is due to the 
positive ΔG value for FLU at this point. The remainder of the set show lower values of R(z) at the 
centre of the membrane (10-1000 s/cm2) with the lowest local resistances found at the polar/aploar 
interface of the membrane (0.1-10 s/cm2), the same position as the ΔG minimum. 
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6.3.2.4 Permeation coefficients 
 
The permeation coefficients for the ten PET tracers across a DOPC membrane were then calculated. 
Table 6.4 - Calculated permeability coefficients for ten PET radiotracers and their experimental NSB. 
 Permeability coefficient (cm/s) NSB (mL/g) 
FLU 0.59±0.32 1 
FAL 65.86±22.04 3.93 
ROL 60.35±5.29 6 
RAC 98.12±12.26 10.25 
DIP 44.77±3.46 13.5 
WAY 68.71±24.8 13.83 
MDL 67.02±14.17 55.25 
NPA 134.81±13.07 67 
DAS 70.01±5.28 100.12 
SPI 36.91±4.08 165.67 
It is seen from Table 6.4 that FLU has a low permeation coefficient due to its positive ΔG value at the 
membrane centre. The remainder of the data set have negative ΔG values at the membrane core 
resulting in permeation coefficients falling in the range ≈30-130 cm/s. The radiotracers that are 
predicted to passively diffuse through a membrane at the fasted rate from the current simulations 
are RAC (98 cm/s) and NPA (134 cm/s). On examination of their free energy of transfer profiles it can 
be seen that both of these tracers have almost the deepest minima of the set at the polar/apolar 
interface region (with only MDL having a more negative ΔG at this point) and importantly, retain a 
large negative ΔG value at the membrane centre (-36 kJ/mol for RAC and -30 kJ/mol for NPA, the 
lowest values in the set at this position in the membrane). The ≈30-130 cm/s range of values are of 
the same order of magnitude found via MD PMF simulations for the permeation of the small 
molecules ibuprofen (92 cm/s) and aspirin (244 cm/s) by Boggara et al.231 As concluded from the free 
energy of transfer profiles, although it is interesting that FLU has both the lowest NSB value and 
lowest permeation coefficient, any trend relating NSB and membrane permeability of the tracer set 
is not evident from the current results. Indeed, one would intuitively expect that if a link existed 
between membrane permeation and NSB, it would be that tracers with high NSB would have the 
lowest permeability coefficients, thereby remaining in the membrane for longer periods of time than 
tracers with low NSB. However no such trend is found in Table 6.4. 
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6.3.2.5 Tracer orientation in the membrane 
 
The orientation of the PET tracers at different positions along the membrane normal may be 
quantified from the PMF windows by calculating the drug order parameter in the same manner as 
section 4.2.1.2, this data is plotted in Figure 6.14. 
 
Figure 6.14 – Average order parameter P2 for the ten PET radiotracers as a function of distance 
between tracer centre-of-mass and DOPC bilayer centre. To aid interpretation the data set has been 
roughly split into two halves: the upper panel shows order parameters for PET tracers with in vivo 
non-specific binding below 50mL/g; the lower panel plots tracers with NSB above 50mL/g. Tracers 
are also listed in order of increasing NSB. 
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Figure 6.14 indicates that in water, tracers adopt a roughly random orientation (P2→0), however on 
moving into the membrane head group region tracers orientate themselves approximately along the 
membrane normal with P2→1. This change in orientation on reaching the head group region of the 
membrane is far more evident for those tracers with NSB lower than 50mL/g (tracer orientations are 
shown in Figure 6.15), with the exception of ROL, which remains parallel to the membrane plane 
during bilayer entry, as also observed in the unbiased single drug-bilayer simulations (section 
4.2.2.1). This may indicate that tracers with low NSB must adopt a certain orientation to partition 
into the membrane, with this requirement being less stringent for high NSB tracers (P2 closer to zero 
i.e. these tracers may partition into the membrane with almost random orientation).  
 
Figure 6.14 shows DAS to adopt a random orientation at the head group region, in good comparison 
with the previous unbiased simulations, however from the PMF simulations MDL, NPA and SPI 
maintain P2≈0.25, which is lower than the result from the unbiased simulations (P2=0.5-1). This may 
due to the limited sampling for the unbiased work, which used a single simulation of membrane 
entry for the ten PET tracers (therefore tracers spent very little time in the lipid head group region). 
 
The observed requirement for the majority of tracers with low NSB to align with the bilayer normal in 
order to undergo successful membrane entry make act as a barrier for movement of these tracers 
from the water phase into the membrane phase. If the tracer orientation has a low probability of 
being aligned to the membrane normal immediately before the membrane head group region, then 
the probability of a successful membrane entry event will likewise be diminished. To study this, the 
histograms of the drug order parameter in the region 22-28 Å from the bilayer centre (i.e. the water 
region just above the membrane head groups) during the unbiased single drug-membrane NPT 
simulations performed in chapter 4 are plotted in Figure 6.16. The tracer MDL spent little time in the 
water region directly above the head groups, quickly partitioning into the membrane, therefore 
adequate sampling is not available for MDL which displays a peak with P2=0.5-1. It is seen that for all 
other tracers, in the region just above the head groups the orientation parallel to the membrane 
plane is most frequently occupied. Furthermore, the occupancy of tracer orientation with P2→1 is 
lower than P2=0 in all instances, with the exception of NPA. Therefore those tracers with lower NSB 
are less likely to adopt a suitable orientation for membrane entry when approaching the head group 
region, making a successful membrane entry event less likely. The requirement to be aligned parallel 
to the membrane normal may act as a barrier to membrane entry for those tracers with low NSB. 
This may be the reason that additional unbiased NPT simulation was required for DIP, FLU and WAY in 
order to observe partitioning into the membrane phase in chapter 4. 
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Figure 6.15 - Orientation of the five PET radiotracers showing a strong tendency to align to the membrane normal when 
crossing the head group region. 
188 
 
Figure 6.16 - Histogram of the drug order parameter occupancy in the water region just above the 
membrane head groups from the unbiased single drug-membrane NPT simulations performed in 
chapter 4. 
 
On moving further into the membrane, at the polar/apolar interface where the drugs preferentially 
reside, it is seen from Figure 6.14 that most tracers align almost parallel to the membrane plane with 
P2→ -0.5, although DIP and NPA appear to prefer an orientation that is closer to being parallel to the 
membrane normal (as also observed in the unbiased simulations). This may however be due to their 
molecular shape, as both DIP and NPA have a skeleton containing a four-membered fused ring 
structure; their long principal axis of inertia will therefore be similar to the other principal axis of 
inertia lying in the plane of the fused rings.  
 
Finally on moving towards the membrane core ROL and NPA in particular adopt an orientation 
aligned with the membrane normal, whereas other tracers adopt a random orientation, with the 
exception of DIP and WAY which orientate in the membrane plane. 
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6.3.2.6 Tracer hydrogen bonding behaviour 
 
Finally the hydrogen bonding behaviour of the PET tracers at different points from the water into the 
membrane phase was examined. Hydrogen bonding analysis was performed in the same manner as 
section 4.2.1.3. 
 
Figure 6.17 - Average hydrogen bonds to water per MD frame for the ten PET radiotracers as a 
function of distance between tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in 
order of increasing NSB. 
The average hydrogen bonds to water for the ten PET tracers as a function of distance from the 
bilayer centre are shown in Figure 6.17, as is expected on moving from the water phase into the 
membrane all tracers lose some water hydrogen bonds. However not all hydrogen bonds are 
sacrificed, most tracers retain some water hydrogen bonds up to the membrane core, as was also 
observed in the single drug-bilayer simulations. This may be explained by tracers remaining partially 
solvated by way of a water wire. It is also seen that FLU displays the highest number of hydrogen 
bonds to water in the water phase, yet is unable to form any such hydrogen bonds at the membrane 
centre. This predicts FLU to be the most water soluble of the tracers and indeed as shown in Table 
4.1, FLU has the lowest measured log P value of the set. This may explain why it is the only tracer to 
have a positive ΔG value at the membrane core and also why it has the lowest permeation 
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coefficient, as it sacrifices the greatest number of hydrogen bonds on movement through the 
membrane in comparison to the other tracers in the set. 
  
Figure 6.18 - Average hydrogen bonds to lipid per MD frame for the ten PET radiotracers as a 
function of distance between tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in 
order of increasing NSB. 
The hydrogen bonding between PET tracers and lipid molecules was also calculated and is displayed 
in Figure 6.18. On entering the membrane most tracers that are able to pick up hydrogen bonds with 
lipid do so, for the most part these then disappear as the tracer gets close to the centre of the 
membrane. The tracer that makes the most hydrogen bonds with lipid is by far NPA, this tracer also 
possesses the highest membrane permeation coefficient. At a distance of 8 Å from the bilayer centre, 
the hydrogen bonds to lipid plot displays particularly large error bars for NPA. This is due to using the 
block averaging method – during the first 20 ns block, NPA forms few hydrogen bonds to lipid, 
preferring instead to hydrogen bond to water. During the second 20 ns block, NPA displays far higher 
hydrogen bonding to lipids, many of which exist for reasonably long timescales, such as that shown 
in Figure 6.19. This does however indicate that further simulation time is required to obtain 
converged hydrogen bonding results. 
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Partitioning of amphiphiles into the membrane at the polar/apolar interface is thought to be 
predominantly an enthalpically driven process via favourable interactions with the lipid head groups, 
given that the solute loses translational entropy and possibly other degrees of freedom, furthermore 
the highly packed upper acyl chain region of the membrane may impose an entropic penalty to 
solute partitioning.226 It will thus depend on the enthalpy and entropy change of the system on 
solute partitioning into the membrane which will depend on solute structure, partitioning is also 
thought to depend on solute size.231 The ability of NPA to make the most hydrogen bonds with lipid 
will result in a lower enthalpic penalty due to loss of hydrogen bonds with water on partitioning into 
the membrane, furthermore it is the most rigid drug in the set, meaning that it has the lowest 
entropy loss in terms of rotation about internal molecular degrees of freedom. On moving into the 
centre of the membrane NPA loses these lipid hydrogen bonds, however it can be seen from Figure 
6.17 that NPA maintains the highest number hydrogen bonds to water at the membrane centre. 
These factors may combine to result in NPA having the highest permeation coefficient. 
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Figure 6.19 - Hydrogen bonding of NPA to lipid while position 8 Å from the DOPC bilayer centre. 
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Certain tracers, such as DIP, display hydrogen bonding with lipid molecules even when constrained at 
the bilayer centre. This seems unusual due to the distance between the membrane core and lipid 
head group region, which contains the only polar lipid atoms capable of forming hydrogen bonds. On 
visualisation of the DIP trajectory, it is seen that a DOPC lipid moves inwards in order to satisfy a 
hydrogen bond with the drug. 
 
Figure 6.20 - A hydrogen bond between DIP and a DOPC lipid while the drug is restrained at the 
membrane centre. 
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Figure 6.21 - Average intramolecular hydrogen bonds per MD frame for the ten PET radiotracers as a 
function of distance between tracer centre-of-mass and DOPC bilayer centre. Tracers are listed in 
order of increasing NSB. 
The intramolecular hydrogen bonding during each window of the PMF simulations for the ten PET 
tracers was also examined (see Figure 6.21). As was observed in the unbiased single drug-bilayer 
simulations (section 4.2.2.3) DIP displays intramolecular hydrogen bonding in the water phase only, 
choosing to form hydrogen bonds with lipid or water while in the membrane. FAL displays more 
intramolecular hydrogen bonding than RAC; however both maintain a relatively constant value in the 
water phase which increases only slightly in the membrane phase. This does not however translate 
to FAL having a higher permeation coefficient than RAC (see Table 6.2). 
 
DAS however shows large fluctuations in intramolecular hydrogen bonding, displaying a large signal 
in the water phase; this then drops inside the membrane at which point DAS makes hydrogen bonds 
to lipid. DAS intramolecular hydrogen bonding then rises again at the centre of the membrane, 
correlating with the loss of hydrogen bonds to lipid and water experienced by DAS at this position in 
the membrane.  
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6.4 Discussion 
 
The permeation of the Golden ten set of PET radiotracers through a DOPC lipid membrane has been 
investigated using z-constraint PMF calculations, yielding the free energy of transfer profile and an 
estimation of the permeation coefficient for each drug in the set. This method has previously been 
shown to correctly rank small molecules in order of membrane permeability and has provided insight 
on the membrane interactions of a range of other drug-like compounds. In addition, this method 
provides data on the local diffusion and resistance at successive positions into the membrane, and 
the orientation and hydrogen bonding behaviour of the drug at each point may also be determined. 
Although ideally these calculations should be performed using the molecular dynamics engine with 
which the force field was derived, the absence of the z-constraint method in the AMBER code led to 
the use of the GROMACS MD package for the current work, which has been shown to correctly 
support the AMBER force field. The GROMACS z-constraint method and AMBER lipid force field 
parameters were first validated by calculating the free energy of transfer for a number of small 
molecules, finding satisfactory comparison to other simulation and experimental results. This 
method was then applied to the set of ten PET radiotracers in order to investigate any potential link 
between membrane permeation and in vivo NSB of the radiotracers, as to date experimental values 
for the permeation coefficient of this set of PET tracers across a membrane are not available. 
 
Values for the permeation coefficient are of the same order of magnitude calculated for other small 
molecules, yet simulation PMF results are known to be far higher than experimental results. This is 
due to the differing set up between simulation and experiment – simulations use a single lipid 
bilayer, yet experimental systems consist of either layers of cells (Caco-2 cell assays) or layers of lipid 
membranes (PAMPA), both of which are far thicker than a single bilayer. No connection was 
identified between the membrane permeation of the PET radiotracers and in vivo NSB, in fact the 
two tracers with the slowest permeation coefficients of the set were on either end of the NSB scale 
(FLU has NSB 1 mL/g and permeation coefficient 0.6 cm/s; SPI has NSB 165.67 mL/g and permeation 
coefficient 37 cm/s). If NSB is indeed connected to membrane permeation one would intuitively 
predict that those tracers with the highest NSB would permeate the membrane at the slowest rate, 
thus remaining in the membrane for a longer period of time, however no such trend is observed. 
 
Results from PMF calculations are known to be affected by convergence.109, 265 In this work, initial 
configurations for each of the PMF windows were extracted from unbiased simulations in order to 
speed up convergence of the results,109 furthermore windows of 45 ns in length were used in an 
attempt to obtain reasonable statistics while maintaining acceptable throughput (a total of 170 
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simulations lasting 72 hours each were required to calculate the free energy profiles of the ten 
tracers using 17 PMF windows per tracer). Despite this, the free energy profiles display noticeable 
standard errors, in particular at the hydrophobic membrane core region. Furthermore the 
requirement to fit the force fluctuation ACF to an analytical function indicates that present results 
are not suitably converged; this fitting has however been required in countless other all-atom 
potential of mean force studies reported in the literature.107-108, 231, 278 The limited convergence then 
translates to significant standard errors on some of the calculated permeation coefficients of the 
tracers. A further intrinsic limitation of the PMF method is the assumption that the position of the 
drug along the bilayer normal is the only reaction coordinate determining membrane permeation; 
this may not always be the case, with a recent study finding that other degrees of freedom may also 
influence the free energy of transfer profile, such as rotation about molecular torsions determining 
the formation of intramolecular hydrogen bonds.289 However in the present work those drugs that 
have the ability form intramolecular hydrogen bonds are seen to do so both in the water and 
membrane phases, furthermore the overall picture indicates that there is not a connection between 
membrane permeation and NSB, it therefore seems unlikely that further convergence of results, or 
the addition of extra degrees of freedom to the free energy landscape, would change the rank order 
of the tracers to the extent that a trend emerges. 
 
The outcome of PMF calculations using molecular dynamics will also depend on the force field used 
to model the system. The current work used GAFF which has been designed for small molecules in 
combination with RESP charges, as is the AMBER standard, to describe the set of PET radiotracers, 
while lipids were modelled with the Lipid14 force field derived in chapter 3. This set of lipid 
parameters was found to model lipids with numerous membrane properties in good comparison to 
experiment, such as area per lipid, volume per lipid, NMR order parameters, lipid lateral diffusion 
and X-ray scattering profile. However it remains a new force field and as such is not as rigorously 
tested as other available lipid force fields. 
 
The inherent lack of fixed charge force fields to account for molecular polarisation may be an issue. 
Attempts have been made to address this by using partial charges derived in the water phase when 
the solute is constrained in a polar environment, switching to partial charges derived in a lipophilic 
medium as the solute transitions into the hydrocarbon membrane core.268 This was found to result in 
improved comparison to experiment; such a method was not employed in the current work. As 
polarisable force fields present many theoretical and practical challenges they are currently at the 
developmental stage, future PMF calculations may potentially be able to implement such force fields.  
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7 Conclusions and outlook 
 
Position emission tomography scanning is a useful and versatile technique to study disease and drug 
action in the body, yet the development of imaging agents required for this method is hampered by 
the complicated and detrimental issue of in vivo NSB of PET radiotracers. The phenomenon of NSB 
remains poorly understood, however it is thought to arise at least in part from tracers adhering to 
membrane structures in vivo. Recent experimental work has identified a mechanism by which some 
tracers interact with lipids while crossing a lipid membrane,70-72 whereas computational quantum 
mechanical calculations identified a link between the energy of interaction between a single lipid and 
PET tracer and NSB.18, 74 These results indicate that some connection may indeed exist between the 
interaction of PET tracers with membranes and the lipid molecules that constitute the majority of 
such membranes, and NSB. 
 
In this work the molecular basis of NSB was investigated using molecular dynamics, which allows the 
modelling of a fully hydrated lipid membrane, in combination with a data set of ten well 
characterised PET radiotracers. To perform this work, a lipid force field for the AMBER molecular 
dynamics package had to first be developed, such that drug-membrane interactions may be studied 
at the all-atom level by combing the resulting lipid force field (termed Lipid14)156 with GAFF, which is 
designed for small molecules. Unbiased simulations were used to observe the entry process of a 
single PET tracer into a DOPC membrane and also the effect of 12mol% and 36mol% of PET tracer on 
a membrane structure. The permeation of each of the Golden ten set of PET radiotracers through a 
fully hydrated DOPC membrane was also investigated using biased simulations. The main findings 
predicted by these simulations may be summarised as follows: 
 All ten of the PET tracers display a favourable free energy change on transitioning from the 
water phase to the polar/apolar interface region of the membrane. This position in the 
membrane is also predicted to the preferred location for the tracers from unbiased 
simulations. In general tracers sit with an orientation parallel to the membrane plane when 
located at the polar/apolar interface region of the membrane. 
 Further movement across the hydrophobic core of the membrane results in an unfavourable 
increase in free energy. 
 The permeation of the PET tracers across a hydrated DOPC membrane does not appear to 
correlate with in vivo NSB of the tracers. 
 The majority of tracers with low NSB appear to require an orientation parallel to the 
membrane normal in order to enter the membrane, whereas tracers with higher NSB may 
enter with a more random orientation. This requirement may act as a barrier to membrane 
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entry for tracers with low NSB. 
 On partitioning into a membrane, the PET tracers act to increase the order of the lipid tails in 
the region in which they are positioned. This ordering effect increases with higher 
concentration of tracer; furthermore the effect is also more evident for tracers with higher 
NSB. A resulting decrease in lateral diffusion of tracers in the membrane is also observed. 
 It is therefore possible that NSB of PET tracers is related to membrane ordering. Tracers 
displaying higher NSB have a molecular structure that induces higher ordering of 
surrounding lipid tails when partitioned into the membrane. This effect may therefore act to 
‘trap’ tracer in the membrane and reduce the permeability of the membrane. 
 
These conclusions of course come with a number of caveats. In this work a small data set of ten PET 
tracers was studied, for a number of reasons: few PET tracers are as well characterised as those used 
in the current work, due to the time and expense involved in collecting NSB data, furthermore 
membrane systems are relatively large making their simulation at the all-atom level reasonably 
computationally expensive. The hypothesis that higher NSB of PET tracers is linked to increased 
ordering of lipid tails thus requires rigorous testing on a larger data set of PET tracers both 
computationally, and more importantly experimentally using NMR methods. A larger set of twenty-
two PET tracers with NSB data has in fact been made available by GlaxoSmithKline, these were 
employed in a previous QM study.74 It would therefore be interesting to study the effect of differing 
concentrations of this additional set of tracers on a membrane via MD simulations. Results for the 
free energy profiles calculated using molecular dynamics are known to strongly depend on the 
convergence of results and also the number of degrees of freedom of the free energy landscape 
taken into consideration. Finally, in terms of the unbiased simulations, it would be beneficial to 
investigate other molar concentrations of tracer, as well as larger system sizes, longer simulation 
timescales and perform repeat simulations in order to gain further statistics. An additional 
membrane property that was not calculated during the present work is the lateral pressure profile of 
the membrane, an important and fundamental membrane property that is known to influence drug-
membrane interactions. The effect of introducing PET tracers into a membrane on the lateral 
pressure would therefore be an interesting addition to this work. 
 
The proposed effect of membrane ordering by the PET tracers on membrane permeability would be 
interesting and possible to study using the methods in the current work. Specifically, PMF 
calculations could be performed on DOPC membranes containing 36mol% of each of the PET tracers 
in order to investigate whether those drugs with higher NSB reduce membrane permeab 
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ility to a larger extent than tracers with low NSB. It would be particularly interesting if the 
permeability of a PET tracer through a membrane doped with 36mol% of the same tracer alters the 
permeability rank ordering such that a trend emerges in relation to NSB. 
 
An inherent assumption made in the current work is that only the neutral form of the drug interacts 
with and permeates into the membrane; no other protonation states were considered. This 
conclusion has been reached experimentally223 and using simulations224 for other small molecules, 
however including other protonation states in the PMF simulations would determine whether this 
assumption is valid for the PET tracers. In particular, the PET tracers spiperone and raclopride are 
known to be protonated at physiological pH.72, 290 The protonated secondary/tertiary nitrogen atoms 
on these drugs play a crucial role in the degradative transport process in which they have been found 
to cross membranes – the drugs catalyse the hydrolysis of bilayer lipids into mono-chain PCs and 
fatty acids.70-72 This process therefore requires these drugs to be in a protonated state at the 
membrane/water interface, what is not clear from this experimental work however is the 
protonation state of the drugs while inside the membrane. Furthermore, this degradative transport 
process has only been observed for a small number of the Golden ten PET tracer set. 
 
A further fundamental assumption made in this work is that a hydrated lipid bilayer patch composed 
of a single lipid species (DOPC) may be used as a model for an in vivo cell membrane. In reality, the 
picture is far more complicated, with the presence of countless different lipid types and membrane 
proteins. Furthermore, many cell membranes are known to be asymmetric, with the outer 
(extracellular) monolayer having a different lipid composition to the inner (cytosol exposed) layer; for 
example it is known that the human red blood cell membrane contains predominantly 
phosphatidylcholine and sphingomyelin lipids in the outer layer, and phosphatidylserine and 
phosphatidylethanolamine lipids in the inner monolayer. The use of a homogenous lipid bilayer is 
therefore a severe assumption, which although also made experimentally when study drug 
permeation using PAMPA, has been overcome with the introduction of Caco-2 cell permeation 
assays. The construction of a more realistic computational cell membrane system is possible via the 
introduction of different lipid types into the two sides of the membrane, however each species must 
first be validated independently prior to mixing. Currently Lipid14 supports phosphatidylcholine and 
phosphatidylethanolamine lipids, however it is intended to extend this force field to numerous other 
lipid species, including phosphatidylserine, phosphatidylglycerol, sphingomyelin and cholesterol, 
with a prospective aim to also include glycolipids. This will allow the investigation of drug-membrane 
interactions using a more realistic cell membrane model. 
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Appendix I – GAFFlipid atom types and charges 
 
DLPC 
 
 
  
216 
 
Name Type Charge Name Type Charge Name Type Charge 
C20 a3 0.080314 O5 os -0.43404 H51 hl -0.00673 
H37 hl -0.00909 P1 p4 1.085275 C27 b3 0.02615 
H38 hl -0.00909 O6 o -0.72691 H52 hl -0.01045 
C19 a3 -0.00809 O8 o -0.72691 H53 hl -0.01045 
H35 hl 0.005046 O7 os -0.40264 C28 b3 0.022081 
H36 hl 0.005046 C6 c3 0.169293 H54 hl -0.01042 
C18 a3 -0.01611 H6 hc 0.042234 H55 hl -0.01042 
H33 hl 0.000516 H7 hc 0.042234 C29 b3 0.003037 
H34 hl 0.000516 C7 c3 0.045158 H56 hl -0.00617 
C17 a3 0.007571 H8 hc 0.056736 H57 hl -0.00617 
H31 hl -0.00352 H9 hc 0.056736 C30 b3 0.004534 
H32 hl -0.00352 N1 n4 0.012316 H58 hl -0.00049 
C16 a3 0.011731 C8 c3 -0.16168 H59 hl -0.00049 
H29 hl -0.00425 H10 hc 0.117176 C31 b3 0.066338 
H30 hl -0.00425 H11 hc 0.117176 H60 hl -0.00942 
C15 a3 0.009947 H12 hc 0.117176 H61 hl -0.00942 
H27 hl -0.00145 C9 c3 -0.16168 C32 b3 -0.12472 
H28 hl -0.00145 H13 hc 0.117176 H62 hl 0.025941 
C14 a3 -0.01032 H14 hc 0.117176 H63 hl 0.025941 
H25 hl -0.00337 H15 hc 0.117176 H64 hl 0.025941 
H26 hl -0.00337 C10 c3 -0.16168 C21 a3 -0.15003 
C13 a3 -0.00462 H16 hc 0.117176 H39 hl 0.031811 
H23 hl 0.012983 H17 hc 0.117176 H40 hl 0.031811 
H24 hl 0.012983 H18 hc 0.117176 H41 hl 0.031811 
C12 a3 0.019156 O4 os -0.50751    
H21 hl 0.004713 C4 c 0.775678    
H22 hl 0.004713 O3 o -0.58433    
C11 a3 -0.12468 C22 b3 -0.04909    
H19 hl 0.052552 H42 hl 0.025767    
H20 hl 0.052552 H43 hl 0.025767    
C1 c 0.636392 C23 b3 -0.00459    
O1 O -0.53084 H44 hl 0.00586    
O2 os -0.37352 H45 hl 0.00586    
C2 g1 0.012538 C24 b3 -0.00552    
H1 hc 0.113642 H46 hl 0.007891    
H2 hc 0.113642 H47 hl 0.007891    
C3 g2 0.131093 C25 b3 0.011518    
H3 hc 0.137758 H48 hl -0.00352    
C5 g3 0.028727 H49 hl -0.00352    
H4 hc 0.107429 C26 b3 0.012096    
H5 hc 0.107429 H50 hl -0.00673    
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DMPC 
 
  
218 
 
Name Tyep Charge Name Tyep Charge Name Tyep Charge 
C22 a3 -0.13943 C9 g1 -0.01542 H51 Hl 0.007371 
H42 hl 0.029884 H14 hc 0.120993 C27 b3 0.017463 
H43 hl 0.029884 H15 hc 0.120993 H52 Hl -4.36E-05 
H44 hl 0.029884 C10 g2 0.087406 H53 Hl -4.36E-05 
C21 a3 0.066877 H16 hc 0.144396 C28 b3 -0.01348 
H40 hl -0.00646 C11 g3 0.044154 H54 Hl 0.000613 
H41 hl -0.00646 H17 hc 0.092393 H55 Hl 0.000613 
C20 a3 -0.00062 H18 hc 0.092393 C29 b3 0.012539 
H38 hl 0.002479 O3 os -0.41455 H56 Hl -0.00471 
H39 hl 0.002479 P1 p4 1.109949 H57 Hl -0.00471 
C19 a3 -0.00664 O4 o -0.7226 C30 b3 0.000625 
H36 hl -0.00406 O5 o -0.7226 H58 Hl -0.00049 
H37 hl -0.00406 O6 os -0.44469 H59 Hl -0.00049 
C18 a3 0.022612 C12 c3 0.168041 C31 b3 0.007386 
H34 hl -0.00936 H19 hc 0.039679 H60 Hl -0.00176 
H35 hl -0.00936 H20 hc 0.039679 H61 Hl -0.00176 
C17 a3 0.02337 C13 c3 0.009524 C32 b3 0.004726 
H32 hl -0.00901 H21 hc 0.080485 H62 Hl -0.00142 
H33 hl -0.00901 H22 hc 0.080485 H63 Hl -0.00142 
C1 a3 0.006657 N1 n4 0.021802 C33 b3 -0.01026 
H1 hl -0.00713 C14 c3 -0.15338 H64 Hl -0.00026 
H2 hl -0.00713 H23 hc 0.11381 H65 Hl -0.00026 
C2 a3 0.038691 H24 hc 0.11381 C34 b3 -0.00287 
H3 hl -0.01276 H25 hc 0.11381 H66 Hl 0.002298 
H4 hl -0.01276 C15 c3 -0.15338 H67 Hl 0.002298 
C3 a3 0.013952 H26 hc 0.11381 C35 b3 0.069637 
H5 hl -0.00986 H27 hc 0.11381 H68 Hl -0.00771 
H6 hl -0.00986 H28 hc 0.11381 H69 Hl -0.00771 
C4 a3 0.007998 C16 c3 -0.15338 C36 b3 -0.13612 
H7 hl -0.00636 H29 hc 0.11381 H70 Hl 0.029142 
H8 hl -0.00636 H30 hc 0.11381 H71 Hl 0.029142 
C5 a3 -0.0079 H31 hc 0.11381 H72 Hl 0.029142 
H9 hl 0.006894 O7 os -0.41785    
H10 hl 0.006894 C23 c 0.718704    
C6 a3 0.051298 O8 o -0.58227    
H11 hl 0.010186 C24 b3 -0.08952    
H12 hl 0.010186 H46 hl 0.045575    
C7 a3 -0.1626 H47 hl 0.045575    
H13 hl 0.04393 C25 b3 0.003511    
H45 hl 0.04393 H48 hl 0.004379    
C8 c 0.75978 H49 hl 0.004379    
O1 o -0.60062 C26 b3 -0.00985    
O2 os -0.40425 H50 hl 0.007371    
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DPPC 
 
  
220 
 
Name Tyep Charge Name Tyep Charge Name Tyep Charge 
C23 a3 0.011053 H2 hc 0.115663 H57 hl -0.00338 
H43 hl -7.30E-05 C3 g2 0.043792 C30 b3 0.00482 
H44 hl -7.30E-05 H3 hc 0.151315 H58 hl -0.00897 
C22 a3 -0.00628 C5 g3 0.038535 H59 hl -0.00897 
H41 hl -0.00585 H4 hc 0.098733 C31 b3 0.030704 
H42 hl -0.00585 H5 hc 0.098733 H60 hl -0.01355 
C21 a3 0.029365 O5 os -0.41372 H61 hl -0.01355 
H39 hl -0.01097 P1 p4 1.09722 C32 b3 0.029241 
H40 hl -0.01097 O6 o -0.72048 H62 hl -0.01183 
C20 a3 0.011198 O8 o -0.72048 H63 hl -0.01183 
H37 hl -0.0053 O7 os -0.46394 C33 b3 0.021517 
H38 hl -0.0053 C6 c3 0.285482 H64 hl -0.01325 
C19 a3 0.018479 H6 hc 0.014201 H65 hl -0.01325 
H35 hl -0.00626 H7 hc 0.014201 C34 b3 0.019405 
H36 hl -0.00626 C7 c3 0.02128 H66 hl -0.01159 
C18 a3 -0.00383 H8 hc 0.041019 H67 hl -0.01159 
H33 hl -0.00407 H9 hc 0.041019 C35 b3 0.037245 
H34 hl -0.00407 N1 n4 0.055017 H68 hl -0.01442 
C17 a3 0.032267 C8 c3 -0.09738 H69 hl -0.01442 
H31 hl -0.00891 H10 hc 0.094534 C36 b3 0.020266 
H32 hl -0.00891 H11 hc 0.094534 H70 hl -0.01133 
C16 a3 -0.00442 H12 hc 0.094534 H71 hl -0.01133 
H29 hl -0.00325 C9 c3 -0.09738 C37 b3 0.008811 
H30 hl -0.00325 H13 hc 0.094534 H72 hl -0.01123 
C15 a3 0.016457 H14 hc 0.094534 H73 hl -0.01123 
H27 hl -0.0045 H15 hc 0.094534 C38 b3 0.002328 
H28 hl -0.0045 C10 c3 -0.09738 H74 hl -0.00031 
C14 a3 -0.00498 H16 hc 0.094534 H75 hl -0.00031 
H25 hl 0.001204 H17 hc 0.094534 C39 b3 0.084996 
H26 hl 0.001204 H18 hc 0.094534 H76 hl -0.0123 
C13 a3 -0.00818 O4 os -0.42256 H77 hl -0.0123 
H23 hl 0.009148 C4 c 0.772046 C40 b3 -0.1461 
H24 hl 0.009148 O3 o -0.60003 H78 hl 0.030144 
C12 a3 -0.01014 C26 b3 -0.08457 H79 hl 0.030144 
H21 hl 0.014958 H50 hl 0.031059 H80 hl 0.030144 
H22 hl 0.014958 H51 hl 0.031059 C24 a3 0.064269 
C11 a3 -0.0742 C27 b3 0.022721 H45 hl -0.00749 
H19 hl 0.031168 H52 hl -0.00326 H46 hl -0.00749 
H20 hl 0.031168 H53 hl -0.00326 C25 a3 -0.13222 
C1 c 0.727106 C28 b3 0.015214 H47 hl 0.028289 
O1 o -0.58459 H54 hl 0.001033 H48 hl 0.028289 
O2 os -0.41756 H55 hl 0.001033 H49 hl 0.028289 
C2 g1 0.026457 C29 b3 0.013506    
H1 hc 0.115663 H56 hl -0.00338    
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DOPC 
 
  
222 
 
Name Type Charge Name Type Charge Name Type Charge 
C33 a3 -0.13506 C32 a3 -0.06855 C14 b3 -0.0249 
H61 hl 0.027797 H59 hl 0.02545 H25 hl 0.008108 
H62 hl 0.027797 H60 hl 0.02545 H26 hl 0.008108 
H63 hl 0.027797 C35 c 0.70891 C10 b3 -0.00403 
C25 a3 0.084367 O1 o -0.56898 H17 hl 0.001853 
H45 hl -0.01113 O3 os -0.39093 H18 hl 0.001853 
H46 hl -0.01113 C37 g1 -0.03749 C9 b3 0.009933 
C23 a3 -0.0125 H67 hc 0.126461 H15 hl 0.000202 
H42 hl 0.006459 H68 hc 0.126461 H16 hl 0.000202 
H43 hl 0.006459 C38 g2 0.079998 C8 b3 -0.02661 
C21 a3 -0.03367 H69 hc 0.136169 H13 hl 0.013481 
H39 hl 0.00963 C39 g3 0.01006 H14 hl 0.013481 
H40 hl 0.00963 H70 hc 0.107655 C7 b3 0.044251 
C19 a3 -0.01693 H71 hc 0.107655 H11 hl 0.035453 
H35 hl 0.006705 O5 os -0.40744 H12 hl 0.035453 
H36 hl 0.006705 P1 p4 1.06745 C6 c2 -0.26316 
C17 a3 -0.00389 O6 o -0.71298 H10 hc 0.131941 
H31 hl 0.001535 O7 o -0.71298 C5 c2 -0.17236 
H32 hl 0.001535 O8 os -0.40414 H9 hc 0.109585 
C18 a3 0.0072 C40 c3 0.142683 C4 b3 -0.00395 
H33 hl 0.007316 H72 hc 0.057749 H7 hl 0.029747 
H34 hl 0.007316 H73 hc 0.057749 H8 hl 0.029747 
C20 a3 0.04484 C41 c3 -0.01483 C3 b3 -0.02355 
H37 hl 0.027339 H74 hc 0.073563 H5 hl 0.015218 
H38 hl 0.027339 H75 hc 0.073563 H6 hl 0.015218 
C22 c2 -0.23488 N1 n4 0.019315 C2 b3 0.019429 
H41 hc 0.115649 C42 c3 -0.14067 H3 hl 0.006465 
C24 c2 -0.2079 H76 hc 0.110461 H4 hl 0.006465 
H44 hc 0.117152 H77 hc 0.110461 C1 b3 -0.03152 
C26 a3 0.027135 H78 hc 0.110461 H1 hl 0.008452 
H47 hl 0.028662 C43 c3 -0.14067 H2 hl 0.008452 
H48 hl 0.028662 H79 hc 0.110461 C11 b3 -0.02629 
C27 a3 -0.00621 H80 hc 0.110461 H19 hl 0.006927 
H49 hl 0.006144 H81 hc 0.110461 H20 hl 0.006927 
H50 hl 0.006144 C44 c3 -0.14067 C12 b3 0.002474 
C28 a3 0.00319 H82 hc 0.110461 H21 hl 0.000429 
H51 hl 0.001425 H83 hc 0.110461 H22 hl 0.000429 
H52 hl 0.001425 H84 hc 0.110461 C13 b3 0.083887 
C29 a3 -0.01841 O4 os -0.42262 H23 hl -0.01214 
H53 hl 0.005691 C36 c 0.746096 H24 hl -0.01214 
H54 hl 0.005691 O2 o -0.58309 C34 b3 -0.13565 
C30 a3 0.011864 C16 b3 -0.00459 H64 hl 0.027621 
H55 hl 0.005074 H29 hl 0.007325 H65 hl 0.027621 
223 
 
H56 hl 0.005074 H30 hl 0.007325 H66 hl 0.027621 
C31 a3 0.016422 C15 b3 -0.00432    
H57 hl 0.000663 H27 hl 0.010081    
H58 hl 0.000663 H28 hl 0.010081    
 
  
224 
 
POPC 
 
Name Type Charge Name Type Charge Name Type Charge 
C24 a3 0.085155 H4 hc 0.086808 C36 b3 -0.00524 
H45 hl -0.00835 H5 hc 0.086808 H68 hl 0.008765 
H46 hl -0.00835 O5 os -0.40086 H69 hl 0.008765 
C23 a3 -0.01459 P1 p4 1.065607 C37 b3 -0.00641 
H43 hl 0.006652 O6 o -0.72112 H70 hl 0.002893 
H44 hl 0.006652 O8 o -0.72112 H71 hl 0.002893 
225 
 
C22 a3 -0.03565 O7 os -0.4101 C38 b3 0.028045 
H41 hl 0.009043 C6 c3 0.204228 H72 hl -0.00825 
H42 hl 0.009043 H6 hc 0.038859 H73 hl -0.00825 
C21 a3 0.001865 H7 hc 0.038859 C39 b3 -0.00468 
H39 hl 0.000135 C7 c3 -0.0012 H74 hl -0.00545 
H40 hl 0.000135 H8 hc 0.061629 H75 hl -0.00545 
C20 a3 -0.00408 H9 hc 0.061629 C40 b3 0.012184 
H37 hl 0.003338 N1 n4 0.039962 H76 hl -0.00322 
H38 hl 0.003338 O4 os -0.29866 H77 hl -0.00322 
C17 a3 0.034836 C4 c 0.599571 C41 b3 0.07304 
H31 hl -0.01146 O3 o -0.56022 H78 hl -0.01252 
H32 hl -0.01146 C26 b3 -0.06771 H79 hl -0.01252 
C16 a3 0.012557 H50 hl 0.035157 C42 b3 -0.11185 
H29 hl -0.00821 H51 hl 0.035157 H80 hl 0.02185 
H30 hl -0.00821 C27 b3 -0.00316 H81 hl 0.02185 
C15 a3 0.008775 H52 hl 0.00613 H82 hl 0.02185 
H27 hl -0.00729 H53 hl 0.00613 C8 c3 -0.14247 
H28 hl -0.00729 C28 b3 0.011064 H10 hc 0.110303 
C14 a3 0.025596 H54 hl 0.010444 H11 hc 0.110303 
H25 hl -0.00435 H55 hl 0.010444 H12 hc 0.110303 
H26 hl -0.00435 C29 b3 -0.04101 C9 c3 -0.14247 
C13 a3 -0.01667 H56 hl 0.015613 H13 hc 0.110303 
H23 hl 0.009738 H57 hl 0.015613 H14 hc 0.110303 
H24 hl 0.009738 C30 b3 -0.02854 H15 hc 0.110303 
C12 a3 0.007922 H58 hl 0.009944 C10 c3 -0.14247 
H21 hl 0.003758 H59 hl 0.009944 H16 hc 0.110303 
H22 hl 0.003758 C31 b3 -0.00611 H17 hc 0.110303 
C11 a3 -0.10509 H60 hl 0.012268 H18 hc 0.110303 
H19 hl 0.045089 H61 hl 0.012268 C25 a3 -0.15677 
H20 hl 0.045089 C32 b3 0.03974 H47 hl 0.033342 
C1 c 0.705221 H62 hl 0.031876 H48 hl 0.033342 
O1 o -0.55615 H63 hl 0.031876 H49 hl 0.033342 
O2 os -0.38208 C33 c2 -0.24681 C18 a3 -0.00184 
C2 g1 -0.04173 H64 hc 0.13018 H33 hl -0.00459 
H1 hc 0.118845 C34 c2 -0.21727 H34 hl -0.00459 
H2 hc 0.118845 H65 hc 0.116853 C19 a3 0.005808 
C3 g2 0.019264 C35 b3 0.040954 H35 hl -0.00054 
H3 hc 0.177318 H66 hl 0.023286 H36 hl -0.00054 
C5 g3 0.057992 H67 hl 0.023286    
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POPE 
 
  
227 
 
Name Type Charge Name Type Charge Name Type Charge 
C21 a3 0.068212 H3 hc 0.126275 H59 hc 0.111239 
H39 hl -0.00581 C5 g3 -0.01117 C32 b3 0.026943 
H40 hl -0.00581 H4 hc 0.11539 H60 hl 0.027134 
C20 a3 -0.00229 H5 hc 0.11539 H61 hl 0.027134 
H37 hl 0.00211 O5 os -0.41802 C33 b3 -0.02653 
H38 hl 0.00211 P1 p4 1.106888 H62 hl 0.009424 
C19 a3 -0.01816 O6 o -0.74652 H63 hl 0.009424 
H35 hl 0.003707 O8 o -0.74652 C34 b3 0.013513 
H36 hl 0.003707 O7 os -0.43418 H64 hl 0.005807 
C18 a3 -0.00203 C6 c3 0.116518 H65 hl 0.005807 
H33 hl -0.003 H6 hc 0.081046 C35 b3 -0.02174 
H34 hl -0.003 H7 hc 0.081046 H66 hl 0.006199 
C17 a3 0.026188 C7 c3 -0.05255 H67 hl 0.006199 
H31 hl -0.00319 H8 hc 0.096704 C36 b3 -0.01859 
H32 hl -0.00319 H9 hc 0.096704 H68 hl 0.005803 
C14 a3 0.000409 N1 n4 -0.18841 H69 hl 0.005803 
H25 hl 0.003092 O4 os -0.44335 C37 b3 -0.01164 
H26 hl 0.003092 C4 c 0.759345 H70 hl 0.005805 
C13 a3 -0.02069 O3 o -0.59449 H71 hl 0.005805 
H23 hl 0.008719 C23 b3 -0.07689 C38 b3 0.074161 
H24 hl 0.008719 H44 hl 0.033063 H72 hl -0.00952 
C12 a3 -0.01513 H45 hl 0.033063 H73 hl -0.00952 
H21 hl 0.006161 C24 b3 0.004715 C39 b3 -0.13151 
H22 hl 0.006161 H46 hl 0.010477 H74 hl 0.027117 
C11 a3 -0.01524 H47 hl 0.010477 H75 hl 0.027117 
H19 hl 0.012753 C25 b3 -0.00538 H76 hl 0.027117 
H20 hl 0.012753 H48 hl 0.006393 H10 hn 0.271742 
C10 a3 -0.01161 H49 hl 0.006393 H11 hn 0.271742 
H17 hl 0.005064 C26 b3 -0.03601 H12 hn 0.271742 
H18 hl 0.005064 H50 hl 0.014117 C15 a3 -0.00916 
C9 a3 0.033841 H51 hl 0.014117 H27 hl 0.004357 
H15 hl -0.00196 C27 b3 0.004332 H28 hl 0.004357 
H16 hl -0.00196 H52 hl 0.001935 C16 a3 -0.01841 
C8 a3 -0.11115 H53 hl 0.001935 H29 hl 0.00417 
H13 hl 0.035876 C28 b3 0.002666 H30 hl 0.00417 
H14 hl 0.035876 H54 hl 0.010517 C22 a3 -0.13812 
C1 c 0.814082 H55 hl 0.010517 H41 hl 0.029442 
O1 o -0.61169 C29 b3 0.013752 H42 hl 0.029442 
O2 os -0.45103 H56 hl 0.032774 H43 hl 0.029442 
C2 g1 -0.00951 H57 hl 0.032774    
H1 hc 0.121089 C30 c2 -0.24112    
H2 hc 0.121089 H58 hc 0.123854    
C3 g2 0.115804 C31 c2 -0.18126    
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Appendix II – Lipid14 atom types and charges 
 
Lipid14 phosphatidylcholine head group (PC) 
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Lipid14 phosphatidylethanolamine head group (PE) 
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Lipid14 oleoyl tail group (OL) 
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Lipid14 lauroyl tail group (LA) 
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Lipid14 myristoyl tail group (MY) 
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Lipid14 palmitoyl tail group (PA) 
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Appendix III – Golden ten GAFF atom types and charges 
 
DASB (DAS) 
 
  
235 
 
Name Type Charge 
C1 ca -0.233643 
C2 ca -0.149535 
C3 ca 0.238467 
C4 ca 0.218171 
C5 ca -0.195167 
C6 ca -0.050309 
H1 ha 0.188299 
H2 ha 0.15429 
H3 ha 0.171101 
C7 cg 0.409266 
N1 n1 -0.478533 
N2 nh -0.860877 
H4 hn 0.389182 
H5 hn 0.389182 
S ss -0.323287 
C8 ca 0.027179 
C9 ca -0.110368 
C10 ca 0.045669 
C11 ca -0.206529 
H6 ha 0.141457 
C12 ca -0.061022 
C13 ca -0.178028 
H7 ha 0.158323 
H8 ha 0.080811 
H9 ha 0.158323 
C14 c3 -0.031828 
H10 h1 0.090697 
H11 h1 0.090697 
N3 n3 -0.23685 
C15 c3 -0.234056 
H12 h1 0.097209 
H13 h1 0.097209 
H14 h1 0.097209 
C16 c3 -0.08181 
H15 h1 0.063033 
H16 h1 0.063033 
H17 h1 0.063033 
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Diprenorphine (DIP) 
 
 
Name Type Charge 
C1 c3 0.069699 
C2 c3 -0.264839 
C3 c3 0.083389 
C4 c3 0.076462 
C5 c3 0.073654 
C6 c3 0.02676 
C7 c3 0.146649 
C8 ca -0.189523 
C9 ca -0.033703 
C10 c3 -0.040325 
C11 ca -0.202418 
H1 ha 0.154856 
C12 ca -0.290302 
C13 ca 0.360659 
C14 ca 0.082401 
H2 hc 0.109619 
H3 hc 0.131796 
H4 h1 0.081561 
H5 hc 0.040096 
H6 ha 0.192499 
H7 hc 0.040096 
H8 h1 0.158192 
H9 hc 0.131796 
O1 oh -0.614561 
H10 ho 0.437657 
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O2 os -0.3006 
C15 c3 -0.070414 
H11 hc 0.033851 
H12 hc 0.033851 
N n3 -0.393445 
C16 c3 -0.11029 
H13 h1 0.082222 
H14 h1 0.082222 
C17 c3 -0.172127 
H15 h1 0.110575 
H16 h1 0.110575 
C18 cx -0.041461 
C19 cx -0.337425 
C20 cx -0.337425 
H17 hc 0.130311 
H18 hc 0.154611 
H19 hc 0.154611 
H20 hc 0.154611 
H21 hc 0.154611 
O3 os -0.336436 
C21 c3 -0.177036 
C22 c3 -0.025589 
H22 hc 0.036606 
H23 hc 0.036606 
C23 c3 0.249924 
C24 c3 0.131114 
H24 h1 0.020835 
H25 h1 0.020835 
H26 h1 0.020835 
C25 c3 -0.250986 
H27 hc 0.07039 
H28 hc 0.07039 
H29 hc 0.07039 
C26 c3 -0.250986 
H30 hc 0.07039 
H31 hc 0.07039 
H32 hc 0.07039 
H33 hc 0.091196 
H34 hc 0.091196 
O4 oh -0.747926 
H35 ho 0.466437 
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Fallypride (FAL) 
 
 
Name Type Charge 
C1 c3 0.109893 
H1 h1 0.052731 
H2 h1 0.052731 
F f -0.273807 
C2 c3 0.001408 
H3 hc 0.038884 
H4 hc 0.038884 
C3 c3 -0.045841 
H5 hc 0.036857 
H6 hc 0.036857 
C4 ca -0.017543 
C5 ca -0.19865 
C6 ca 0.154985 
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H7 ha 0.173125 
C7 ca 0.005307 
C8 ca 0.025289 
O1 os -0.246645 
C9 c3 -0.039408 
H8 h1 0.078622 
H9 h1 0.078622 
H10 h1 0.078622 
C10 c 0.435433 
O2 o -0.591988 
N1 n -0.078172 
C11 c3 0.068358 
C12 c3 -0.01202 
H11 h1 0.009723 
C13 c3 -0.11454 
H12 hc 0.028359 
H13 hc 0.028359 
C14 c3 -0.036538 
H14 hc 0.045154 
H15 hc 0.045154 
H16 h1 0.041627 
H17 h1 0.041627 
N2 n3 -0.020693 
C15 c3 -0.01091 
H18 h1 0.042371 
H19 h1 0.042371 
H20 hn 0.046396 
C16 c3 -0.122515 
H21 h1 0.082372 
H22 h1 0.082372 
C17 c2 -0.130856 
H23 ha 0.12714 
C18 c2 -0.403051 
H24 ha 0.162491 
H25 ha 0.162491 
C19 ca -0.190072 
H26 ha 0.154748 
O3 oh -0.500042 
H27 ho 0.423931 
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Flumazenil (FLU) 
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Name Type Charge 
C1 c 0.466522 
C2 ca -0.010557 
C3 ca -0.004808 
C4 c3 -0.188087 
C5 cc -0.001207 
H1 h1 0.130107 
C6 cc 0.233917 
H2 h5 0.124533 
C7 cd 0.050106 
C8 ca -0.218291 
C9 ca -0.141413 
H3 ha 0.164431 
C10 ca -0.192467 
C11 ca 0.243574 
H4 ha 0.167422 
H5 ha 0.188548 
N1 na 0.06589 
N2 n -0.061551 
N3 nd -0.597787 
O1 o -0.545078 
H6 h1 0.130107 
C12 c 0.773701 
O2 o -0.630764 
C13 c3 -0.18595 
H7 h1 0.10283 
H8 h1 0.10283 
H9 h1 0.10283 
O3 os -0.355133 
C14 c3 0.243648 
H10 h1 0.032765 
H11 h1 0.032765 
C15 c3 -0.262497 
H12 hc 0.074177 
H13 hc 0.074177 
H14 hc 0.074177 
F f -0.183471 
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MDL100907 (MDL) 
 
 
Name Type Charge 
C1 ca -0.2199 
C2 ca -0.218516 
C3 ca 0.023676 
C4 ca 0.176716 
C5 ca 0.109532 
C6 ca -0.132569 
H1 ha 0.164835 
H2 ha 0.171414 
O1 os -0.339038 
C7 c3 0.038982 
H3 h1 0.06113 
H4 h1 0.06113 
H5 h1 0.06113 
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C8 c3 0.083307 
H6 h1 0.105203 
O2 oh -0.676713 
H7 ho 0.436998 
C9 c3 0.040476 
C10 c3 -0.108559 
C11 c3 -0.108559 
C12 c3 -0.051998 
H8 hc 0.065146 
C13 c3 -0.051998 
H9 hc 0.065146 
H10 h1 0.060426 
H11 h1 0.060426 
H12 hc 0.078071 
H13 hc 0.065146 
H14 h1 0.060426 
H15 h1 0.060426 
H16 hc 0.065146 
N n3 -0.350929 
C14 c3 0.030813 
H17 h1 0.054744 
H18 h1 0.054744 
C15 c3 -0.029473 
H19 hc 0.050448 
H20 hc 0.050448 
C16 ca -0.002594 
C17 ca -0.196622 
C18 ca -0.196622 
C19 ca -0.207737 
H21 ha 0.166813 
C20 ca -0.207737 
H22 ha 0.166813 
C21 ca 0.29482 
H23 ha 0.159214 
H24 ha 0.159214 
F f -0.209262 
H25 ha 0.148503 
O3 os -0.320253 
C22 c3 -0.174354 
H26 h1 0.117325 
H27 h1 0.117325 
H28 h1 0.117325 
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NPA 
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Name Type Charge 
C1 c3 0.017444 
C2 ca 0.013476 
C3 ca -0.01468 
C4 c3 -0.020488 
C5 c3 -0.057963 
C6 ca 0.01848 
C7 ca 0.002833 
C8 ca -0.016496 
C9 ca -0.230411 
H1 ha 0.168241 
C10 ca -0.262635 
C11 ca 0.175367 
C12 ca 0.221433 
H2 hc 0.060333 
H3 h1 0.055266 
H4 hc 0.038611 
H5 ha 0.170262 
N n3 -0.472721 
H6 hc 0.038611 
H7 h1 0.055266 
C13 ca -0.138936 
H9 ha 0.15172 
C14 ca -0.208529 
H10 ha 0.152633 
C15 ca -0.16925 
H11 ha 0.142488 
O1 oh -0.558146 
H12 ho 0.448485 
O2 oh -0.6227 
H13 ho 0.46123 
C16 c3 -0.000651 
H14 h1 0.065205 
H15 h1 0.065205 
C17 c3 0.086405 
H16 hc 0.034111 
H17 hc 0.034111 
C18 c3 -0.270395 
H18 hc 0.058685 
H19 hc 0.058685 
H20 hc 0.058685 
C19 c3 0.014968 
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Raclopride (RAC) 
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Name Type Charge 
C1 ca -0.037887 
C2 ca 0.09578 
C3 ca -0.120134 
C4 ca 0.288759 
C5 ca -0.037887 
C6 ca -0.054034 
H1 ha 0.147165 
Cl1 cl -0.086342 
Cl2 cl -0.086342 
O1 oh -0.542092 
H2 ho 0.444588 
O2 os -0.292443 
C7 c 0.578245 
O3 o -0.564637 
C8 c3 -0.063558 
H3 h1 0.098178 
H4 h1 0.098178 
H5 h1 0.098178 
N1 n -0.386276 
H6 hn 0.29901 
C9 c3 -0.248555 
H7 h1 0.143034 
H8 h1 0.143034 
C10 c3 0.066019 
C11 c3 -0.024432 
H9 h1 0.074542 
C12 c3 0.013405 
C13 c3 -0.080612 
H10 hc 0.030859 
H11 hc 0.030859 
H12 h1 0.049531 
N2 n3 -0.291615 
H13 hc 0.038899 
H14 h1 0.049531 
H15 hc 0.038899 
C14 c3 0.040775 
H16 h1 0.044045 
H17 h1 0.044045 
C15 c3 -0.210142 
H18 hc 0.057145 
H19 hc 0.057145 
H20 hc 0.057145 
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Rolipram (ROL) 
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Name Type Charge 
C1 c3 0.043279 
C2 c3 0.040685 
C3 c3 -0.044205 
C4 c 0.603574 
H1 h1 0.049587 
H2 h1 0.049587 
H3 hc 0.060019 
H4 hc 0.049919 
H5 hc 0.049919 
N n -0.583145 
H6 hn 0.354635 
O1 o -0.604164 
C5 ca -0.076027 
C6 ca -0.301017 
C7 ca -0.151499 
C8 ca -0.151499 
H7 ha 0.203072 
C9 ca 0.178342 
H8 ha 0.134024 
C10 ca 0.178741 
H9 ha 0.134024 
O2 os -0.407952 
O3 os -0.249221 
C11 c3 -0.058249 
H10 h1 0.07961 
H11 h1 0.07961 
H12 h1 0.07961 
C12 c3 0.141069 
C13 c3 -0.081261 
C14 c3 -0.081261 
H13 h1 0.067557 
C15 c3 0.012676 
H14 hc 0.048414 
H15 hc 0.048414 
C16 c3 0.012676 
H16 hc 0.048414 
H17 hc 0.048414 
H18 hc -0.001593 
H19 hc -0.001593 
H20 hc -0.001593 
H21 hc -0.001593 
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Spiperone (SPI) 
 
Name Type Charge 
C1 ca -0.230442 
C2 ca -0.158267 
C3 ca -0.058901 
C4 ca -0.158267 
C5 ca -0.230442 
C6 ca 0.336344 
H1 ha 0.165934 
H2 ha 0.173625 
H3 ha 0.173625 
H4 ha 0.165934 
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F f -0.199497 
C7 c3 -0.111281 
H5 hc 0.00763 
H6 hc 0.00763 
C8 c3 0.201918 
H7 hc -0.007141 
H8 hc -0.007141 
C9 c3 -0.114783 
H9 h1 0.057295 
H10 h1 0.057295 
N1 n3 -0.225467 
C10 c3 -0.09405 
H11 h1 0.077069 
H12 h1 0.077069 
C11 c3 -0.069973 
C12 c3 0.122533 
C13 c3 -0.069973 
H13 hc 0.065794 
H14 hc 0.065794 
C14 c3 -0.09405 
H15 h1 0.077069 
H16 h1 0.077069 
H17 hc 0.065794 
H18 hc 0.065794 
O1 o -0.540897 
C15 c3 0.002116 
H19 h2 0.088084 
H20 h2 0.088084 
N2 nh -0.164987 
C16 ca 0.030472 
C17 ca -0.081813 
C18 ca -0.081813 
C19 ca -0.171766 
H21 ha 0.079179 
C20 ca -0.171766 
H22 ha 0.079179 
C21 ca -0.163639 
H23 ha 0.145263 
H24 ha 0.145263 
H25 ha 0.135412 
C22 c 0.443962 
N3 n -0.433501 
H26 hn 0.340088 
C23 c 0.543506 
O2 o -0.521963 
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WAY100635 (WAY) 
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Name Type Charge 
C1 ca -0.17856 
C2 ca -0.22254 
C3 ca -0.060643 
C4 ca 0.048423 
C5 ca 0.169393 
C6 ca -0.187725 
H1 ha 0.159084 
H2 ha 0.1525 
H3 ha 0.108332 
H4 ha 0.132306 
O1 os -0.17203 
N1 nh -0.280803 
C7 c3 -0.033331 
C8 c3 0.009143 
C9 c3 -0.088197 
H5 h1 0.066338 
C10 c3 -0.080411 
H6 h1 0.066338 
N2 n3 -0.411713 
H7 h1 0.100276 
H8 h1 0.100276 
H9 h1 0.066338 
H10 h1 0.100276 
H11 h1 0.100276 
H12 h1 0.066338 
C11 c3 -0.115782 
H13 h1 0.119011 
H14 h1 0.119011 
C12 c3 -0.061664 
H15 h1 0.111634 
H16 h1 0.111634 
N3 n -0.19761 
C13 ca 0.324448 
C14 ca -0.210385 
C15 ca -0.058424 
H17 ha 0.129473 
C16 ca 0.135514 
C17 ca -0.210372 
H18 ha 0.145797 
H19 ha 0.1323 
C18 c 0.355409 
C19 c3 0.027428 
C20 c3 -0.001012 
C21 c3 0.056742 
C22 c3 0.030288 
H20 hc -0.007309 
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C23 c3 0.012918 
H21 hc -0.007309 
C24 c3 0.015554 
H22 hc -0.013481 
H23 hc -0.013481 
H24 hc -0.005157 
O2 o -0.490304 
N4 nb -0.40039 
H25 hc -0.007309 
H26 hc 0.043325 
H27 hc -0.007309 
H28 hc -0.013481 
H29 hc -0.005157 
H30 hc -0.013481 
H31 h4 0.101432 
C25 c3 -0.167837 
H32 h1 0.101883 
H33 h1 0.101883 
H34 h1 0.101883 
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